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ABSTRACT 
In Canada, parasitism in people and well-managed animal populations is less common now than 
a century ago, likely due to accessible anthelmintics, heightened public awareness, and improved 
sanitation.  Some zoonotic parasites, such as Echinococcus canadensis are now rarely diagnosed 
in people, but persist mainly in northern populations where diagnostic services are limited.  
Veterinary services are also limited in these areas, and as a result, human and animal incidence 
data does not exist, is outdated, or underestimates the true incidence.  We closed this knowledge 
gap in certain areas of western Canada by determining the prevalence of E. canadensis and other 
zoonotic parasites in wildlife (wolves [Canis lupus] and ungulates; Chapters 2 and 3), domestic 
dogs (Canis familiaris; Chapters 4 and 5), and people (Chapters 6-8).  Using a One Health 
framework, we also explored parasite control practices and potential policy solutions for rural 
and remote communities (Chapters 8 and 9).   
During post-mortem examination, we observed E. canadensis in approximately 11% (11/105) of 
elk [Cervus canadensis], and 21% (34/165) of wolves. Our examination of historical post-
mortem reports of ungulates demonstrated that E. canadensis is distributed throughout Canada, 
except for the high Arctic islands, the Maritime provinces, and the island of Newfoundland. Our 
analysis of dog feces collected throughout Saskatchewan suggested that patent taeniid (Taenia or 
Echinococcus spp.) infection was rare (0-4%), and that rural and northern dogs had higher 
endoparasitism than urban dogs.  Sero-surveillance for four zoonoses (E. canadensis, 
Toxoplasma gondii, Trichinella, and Toxocara canis) by enzyme-linked immunosorbent assay 
indicated similar results - that people in northern SK (65% of 201) had higher exposure to one or 
more parasites than those in southern SK (12% of 113).  Using patient health records, we 
reported annual incidence rates for clinical illness for the following zoonotic parasites: 
echinococcosis – 1.4/1 000 000; toxoplasmosis- 1.7/1 000 000; and toxocariasis-0.06/1 000 000.  
In the final chapter we compared the cost of treating human echinococcosis cases with a 
prevention program based on dosing dogs with praziquantel at 6 week intervals in the Kelsey 
Trail region, where human incidence is highest.  Based on direct healthcare costs, such a 
program is not currently cost saving, but could become so if echinococcosis incidence increased.  
Preventative programs should be considered for high risk communities, which are often 
economically marginalized and lack appropriate resources to effectively control zoonotic 
parasitism.  Putting One Health into action may require integrated human-animal healthcare 
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services, introduction of community-based animal health workers, and increased 
transdisciplinary research to improve access to and uptake of preventative healthcare services for 
parasitic zoonoses in northern and remote communities.      
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CHAPTER 1 - INTRODUCTION 
Parasite surveillance in a One Health context 
One Health overview 
“Between animal and human medicine there is no dividing line -nor should there be.” 
~ Rudolph Virchow (1821-1902) 
In both veterinary and human medicine, trends pertaining to research, diagnostics and treatment 
tend to appear and disappear.  One such trend, ‘One Medicine’, was introduced approximately 
one hundred years ago, centered around a centuries old belief that supported holistic and 
inclusive strategies for studying human and veterinary medicine (1,2).  Over the last century, the 
two disciplines diverged, and appeared to undergo a silo effect, each becoming increasingly 
specialized.  Research in these fields became increasingly reductionist, and focused on 
understanding medicine at the molecular level (3).  Recently, ‘One Medicine’ re-appeared under 
the banner of ‘One Health’ (2,4). This concept recognizes the health links between people, 
animals, and environment, and strives to re-unite those working in related fields at all levels of 
research and government (2).  This regained interest might be due to the marked increase in 
emerging infectious disease (EID) events, of which 60% are of non-human animal origin 
(zoonotic) (5).  These events often have drivers that relate to the environment (deforestation, 
human encroachments, climate change); animals (intensification of animal production, 
wildlife/livestock translocation); and economics (trade globalization, poverty) (5,6).  Emerging 
infectious diseases can cause catastrophic loss of human and/or animal life, as demonstrated by 
the 2014 Ebola outbreak in Africa, and are one of the greatest challenges currently facing 
wildlife conservation efforts (7,8).  As well, EIDs can cause severe economic losses, especially if 
livestock culls are imposed, trade barriers are implemented, or if the direct and indirect costs of 
treating human patients are high (2,5).   
 
Zoonotic disease is a frequent focus of One Health related research; however, many other 
human-animal connections also affect health (4).  Animals can inflict non-infectious injuries on 
people, including bites, kicks or scratches, and people can inflict poor welfare conditions on 
livestock and companion animals, loss of habitat on wildlife, and widespread environment 
contamination that affects everyone (eg. DDT). On a more positive note, people benefit greatly 
from laboratory animals, livestock, working animals (equids, bovids, dogs [Canis lupus 
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familiaris], etc), wildlife, and guide animals. ‘Zooeyia’ is a term recently coined to represent the 
health benefits that people experience by interacting with animals, pets in particular (9).  For 
example, people who own dogs appear to exercise more frequently, regardless of season or 
gender, and this in turn positively influences risk factors for obesity, heart disease, and joint pain 
(9).  Pets can also improve mental health and feelings of social connectedness, among other 
psychosocial benefits (9).  ‘Zoobiquity’ is also a relatively new term for comparative medicine, 
and describes the physical and behavioural health issues shared by people and animals (10).  
Zoobiquity proponents investigate shared human/animal health problems by studying 
phylogenetics and shared environmental conditions. The overall objective is to improve 
diagnostic capabilities and treatment options for people and animals by building collaborative 
relationships between human and animal health providers.  Similarly, the term ‘syndemic’, 
characterized as multiple afflications that interact to cause greater than expected disease burden, 
was coined in 1994 to recognize the value of integrating social science into the One Health 
equation (11,12).  Proponents urged policy makers to take social determinants of health into 
consideration when planning and implementing preventative health policies.  For example, they 
argued that the high levels of substance abuse, HIV/AIDS, and violence concomitantly observed 
in urban core areas in the United States were inextricably linked, forming clusters due to 
underlying causes such as low socioeconomic status (11,12).  Preventative healthcare strategies 
are only likely to succeed if these underlying causes are identified and resolved.  In another 
example, patients co-infected with HIV and Mycobacterium bovis had lower survival than those 
with HIV alone, highlighting the increased zoonotic risk for those patients with compromised 
immunity who come in contact with animals or infected animal products (11).  Rock et al. (2009) 
proposed modifying the definition of syndemic to include human-animal interactions: 
 
Two or more afflictions that interact synergistically within the context of 
specific physical and social environments, especially as a result of inequality 
within and between human populations, to produce excess disease burdens in a 
human population, an animal population, or multiple such populations (11). 
 
Although One Health discussions often focus on animal-human health, environmental 
and economic drivers are important to take into consideration.  Environments in flux, 
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such as those experiencing deforestation, urbanization and climate change, strongly 
influence species distributions, abundance, and even survival.  Climate change, for 
example, is thought to have contributed to a large proportion (29%) of vector-borne EID 
events over the last decade (5).  Environmental factors also contribute to human-wildlife 
conflicts, including infectious disease transmission, crop damage, and physical injury, 
especially when important resources (food, water, space) become limited.  As well, 
environments can act as reservoirs for infectious pathogens (eg. anthrax), and influence 
psychological wellbeing.   
 
Environmental degradation has many drivers, and economic wellbeing may be the most 
important.  Low socio-economic status is a major risk factor for health disparity and 
EID events, as well as an incentive for engaging in high risk employment activities that 
may have long term consequences (and costs) in the One Health context (5).  Human 
health disparities caused by the connection between economy and environment are 
considered ‘wicked’ problems, or more simply, social messes, and are unlikely to be 
resolved soon, if ever (13).  This is especially true when a powerful group generates 
profits at the expense of the environment, while another group, usually marginalized or 
poor, suffers the consequences.  In Canada, petroleum extraction from the bituminous 
sands in northern Canada is extremely contentious because it has a high economic 
reward for the country, but is also high risk for habitat disruption, water contamination, 
and adverse health effects for people/animals in an area inhabited primarily by those of 
Indigenous descent (14).   
 
Human and animal adverse health events can inflict large economic burdens, both on 
individuals and the government.  As a result, public policy relating to public health and 
livestock health are strongly influenced by economic arguments (cost-benefit or cost-
efficacy).  Therefore, managers of programs intending to improve community health by 
prevention or treatment must take economic drivers, costs, and potential consequences 
into account, in addition to factors such as feasibility, efficacy, and acceptability.  
 
 
4 
 
Population level research in rural, remote, and Indigenous communities in Canada 
In Canada, and around the world, people residing in rural regions have poorer overall health, and 
shorter life expectancy, than those residing in urban settings (15).  According to Health Canada, 
social and physical environments as well as socio-economic status are the most relevant 
determinants of health impacting rural communities (16).  Other factors include gender, culture, 
education/literacy, access to health services, employment conditions, and support networks (16).  
The definition of ‘rural’ has at least six widely accepted definitions in Canada, and this can lead 
to confused communication between researchers and policy makers (15,17–19).  The current 
Statistics Canada definition classifies rural residents as those residing in areas with a population 
less than 1000 persons and with a population density less than 400 persons per square kilometer 
(20).  Two other descriptors exist under the umbrella of rural population: ‘remote’ and 
‘northern’.  Respectively, these terms describe areas where a community is physically separated 
(eg. no road access year-round), or at the southern limit of discontinuous permafrost.  Both 
remote and northern communities experience a degree of physical isolation beyond that of rural 
communities, and in Canada, many struggle with issues relating to food security, high cost of 
living, housing shortages, employment, and lack of services (medical, veterinary, tele-
communication) (21). Perhaps in response to these challenges, the proportion of Canadians 
residing in rural regions has plummeted over the last century (from 87% in 1851 to 19% in 
2011), leaving behind a high demographic proportion of aging seniors and young children 
(18,22).  Rural health practitioners face many challenges, such as professional and social 
isolation, that motivate a strong culture of collaboration, creativity in using and procuring human 
and physical resources, and flexibility in navigating technological challenges and climate 
extremes (23).  As a result, many rural practitioners may already be well-equipped to operate in a 
One Health framework.  
 
Indigenous groups, including those who self-identify as First Nations, Metis, Inuit, and 
Aboriginal, currently make up 4% of Canadians, and are the fastest growing segment of the 
population (24).  Approximately half of all Indigenous people in Canada reside in rural, remote 
and northern regions, and similar to Indigenous groups elsewhere in the world, have poorer 
health outcomes, a lower life expectancy, and a higher burden of disease than non-Indigenous 
groups (19,25–27).  In particular, Indigenous groups in Canada are over-represented for health 
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issues pertaining to high infant/child mortality, high incidence of infectious disease (eg. 
HIV/AIDS, hepatitis, tuberculosis), malnutrition, poor maternal health, addiction to alcohol and 
banned substances, lifestyle diseases (eg. obesity, diabetes), and interpersonal violence (27,28).  
Indigenous communities in the far north can face significant challenges in obtaining medical 
services, which may include limited access to diagnostic technology, lack of patient 
confidentiality, long distances to medical centres, high turnover of medical professionals, and 
lack of cultural awareness from health providers (15,29).  These communities are vulnerable to 
impacts of climate change and might have the greatest need for integrated One Health 
surveillance, where human, animal and environmental data are collected and analyzed 
simultaneously (3,30).  One reason for their vulnerability is that many Indigenous groups remain 
strongly connected to the land and to wildlife for spiritual, cultural, and nutritional reasons.  This 
puts some people at higher risk of exposure to parasites of animal origin (eg. trichinellosis, 
toxoplasmosis); in particular, those who process animal carcasses or ingest the raw meat of game 
animals (31–33).   
Despite the potential value of participatory community-based research for both communities and 
researchers, some Indigenous communities are reluctant to engage.  This is partially due to 
researchers who behaved unethically in the past, resulting in strained relationships with academic 
institutions, lost trust, and a reluctance to collaborate with new researchers (34).  New standards 
called ‘OCAP (Ownership, Control, Access, Possession) principles’ have become the gold 
standard for ensuring fair dealings in community participatory research settings (34).  These 
guidelines recommend involving residents at all research levels (proposal, data collection, data 
analysis, dissemination of results, policy), using culturally appropriate behaviour/language, and 
ensuring that risks and/or benefits are shared (34).  Advantages to this approach are the 
improvement in local capacity, and the ability for communities to conduct self-driven research 
programs.   Holistic health and beliefs of inter-connectedness among people, animals and the 
environment are concepts shared among many Indigenous cultural groups. These concepts are 
well aligned with One Health, and may be readily accepted by communities wishing to 
participate in One Health related research.   
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Parasitology surveillance in a One Health context 
Perhaps one of the greatest challenges to the paradigm shift from current health practices to an 
integrative One Health approach is persuading individual researchers, health practitioners, and 
government agencies of various disciplines to work collaboratively.  Barriers to interdisciplinary 
collaboration include role/turf rivalries (competing for responsibilities), physician dominance of 
decision-making, language (eg. different meanings of the same acronym, discipline specific 
jargon), data separation (eg. segregating human and animal data), misaligned goals, and the 
difficulty in extrapolating health outcomes in one species to another (35,36).  Despite these 
barriers, collaboration among multiple disciplines is valuable, and lack of collaboration between 
veterinarians and physicians is a missed opportunity for early detection of zoonotic disease 
outbreaks. For example, West Nile Virus first emerged in birds in New York city (USA) in 1999, 
and Minamata disease (a neurological illness associated with mercury) first emerged in Japanese 
cats in 1956; neither event was communicated with human health authorities (2,36–38).  Joint 
human-animal health surveillance and services are critical for translating the theory of One 
Health into practice (3).  This requires new tools, such as secure methods of collecting and 
sharing surveillance data between agencies, the creation of aggregated human-animal 
surveillance databases, and strategies for conducting community-level surveillance in developing 
countries (3,36).  It also requires funding that is specifically designated for integrative health 
projects (2). 
 
The use of animals as sentinels for shared environmental threats or emerging diseases is not new, 
and recent work in remote regions of British Columbia and the Northwest Territories highlights 
the roles of dogs as potential sources and sentinels for human and wildlife infection with 
zoonotic pathogens (38–40).  Some of the key requirements for sentinel hosts are that they are 
highly exposed, highly sensitive/susceptible, they rapidly exhibit clinical signs or detectable 
immune or molecular responses, and are not endangered species (41).  Ideally, they are not an 
infection source for people or an amplifying host for the agent or pathogen.  Dogs in northern 
and remote environments may be at higher risk of endoparasitism than urban dogs due to lack of 
veterinary services and more frequent exposure to wildlife parasites.  In turn, they may act as 
bridging hosts (Figure 1-1), enabling the indirect transfer of zoonotic parasites between people 
and wildlife. When people feed dogs infected meat or when dogs scavenge wildlife carcasses on 
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then own, they can become infected and then shed infective parasite stages into areas inhabited 
by people.  Parasite transmission can also occur in the opposite direction (eg. Giardia 
transmission from people to dogs to wildlife).  Canine parasite surveillance for the purposes of 
improved public health has many advantages.  These include reductions in cost, in-situ 
environmental pathogen exposure levels, decreased concern for ethics/privacy in comparison 
with human sampling, and the non-invasive nature of fecal and blood analysis.  In Canada, 
domestic dogs could act as sentinels for a wide range of zoonotic pathogens, including 
Echinococcus spp., Toxocara canis, Giardia, Diphyllobothrium, and Borrelia burgdorferi (Lyme 
disease).   
PEOPLE
DOGSWILDLIFE
Dog owners aid 
transmission by 
feeding raw meat
 
Figure 1-1: Schematic of domestic dogs as bridging hosts between wildlife and people (arrows 
signify pathogen transmission routes). 
 
To fully embrace a One Health or ‘shared risk’ approach to zoonotic parasite management, 
researchers must move beyond the simple use of animals as sentinels, and conduct human and 
animal surveillance in communities concurrently (3,36,42).  This approach would ideally be 
participatory in nature, allowing community members to collect, analyze, and disseminate data; 
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and also be multi-disciplinary, including social scientists and anthropologists in addition to 
veterinarians and physicians (3,11,34,42).  To date, joint human-animal parasite surveillance has 
occurred infrequently in Canada, with the exception of testing harvested wildlife in concert with 
human incidence of exposure or disease (33,43).   
 
Human hydatid disease, caused by Echinococcus canadensis (the cervid strain of E. granulosus), 
was historically most prevalent in northern and Indigenous areas of Canada, especially where 
sled dogs were the predominant mode of transportation (44,45).  Infected canids contaminate the 
environment by shedding eggs that are infective to cervids and people, and although the lifecycle 
is primarily sylvatic, domestic dogs can act as bridging hosts for E. canadensis transmission.  
Although the incidence of this disease decreased dramatically in the past century, northern and 
Indigenous residents are still at higher risk of infection than non-Indigenous Canadians residing 
in the south (46).  In 2008, a 6-year old child from northern Saskatchewan (SK) was diagnosed 
with a cerebral hydatid cyst (47).  Subsequent serological surveillance within the child’s 
community demonstrated that 11% (12 of 106) of residents had been previously exposed to the 
parasite and that 6% (9 of 155) of environmentally collected canine fecal samples contained eggs 
of E. canadensis (47).  In this case, the opportunity to conduct community level human and 
animal sampling simultaneously offered many advantages, such as identifying dogs as an 
infection source for people and assessing risk factors for human exposure. Echinococcus 
canadensis is an ideal pathogen to study using a One Heath framework because this parasite 
circulates among people, animals (wild and domestic), and the environment, in addition to 
causing serious global economic losses (48).  It is unlikely to ever be fully eradicated in Canada 
due to the presence of wildlife reservoir hosts, and, in certain regions, might benefit from 
changing environmental factors such as climate change (49).  Long term echinococcosis control, 
especially in high risk communities, will require support from the veterinary community and 
public health officials.  The public is best equipped to prevent echinococcosis infection when 
residents understand E. canadensis transmission routes and control strategies, and when they 
have access to drugs required to treat patent infection in the definitive host. 
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 The work in this thesis expands the current understanding of E. canadensis prevalence and 
distribution in western Canada, and builds on previous work exploring transmission of zoonotic 
pathogens among people, animals, and the environment (47,50).            
 
Overview of Echinococcus canadensis in Canada, Alaska, and Greenland 
Echinococcus granulosus is a species complex of taeniid cestodes responsible for cystic hydatid 
disease in people world-wide. According to the World Health Organization, hydatid disease is 
one of the most expensive parasitic zoonoses to treat and prevent world-wide (48). Life cycles of 
E. granulosus involve carnivore definitive hosts and herbivore intermediate hosts, and various 
species/strains utilize different assemblages of domestic livestock, wildlife, and people (51). 
Adult cestodes, which are quite small (2-7 mm), reside in the small intestines of definitive hosts 
and shed eggs that are immediately infective for intermediate hosts. Ingested eggs release 
oncospheres that penetrate the intestinal wall of the new host, undergo tissue migration, and 
eventually create unilocular cysts containing larval protoscolices in organ tissue (most often liver 
or lung). People are considered accidental hosts, in which cysts form but may not develop fertile 
protoscolices (45). 
 
Species and strains  
There are at least 10 genotypes of the E. granulosus species complex that circulate in different 
host assemblages worldwide (52). The pastoral strains (G1-3, E. granulosus sensu stricto) which 
circulate among domestic livestock and dogs, are not thought to be present in northern North 
America, although they have been introduced into sheep rearing regions of the western 
continental USA (45). In northern Canada, two genotypes (G8 and G10) circulate in largely 
sylvatic cycles involving cervids and wild canids (Figure 1-2); only the G8 genotype has been 
reported in Alaska (52,53). It is possible that one or both of these genotypes may have been 
introduced into the North American Arctic along with infected reindeer imported from Siberia 
and Fennoscandia in the early part of the twentieth century (45,52); both G8 and G10 strains 
have been identified in Fennoscandia (54). 
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Figure 1-2: Sylvatic lifecycle of Echinococcus canadensis. 
 
The taxonomic status of the E. granulosus species complex is somewhat controversial. Initial 
phylogenetic analyses based on mitochondrial DNA suggested that the G6-G10 genotypes be 
unified as the species E. canadensis (52,55).  However, more recent phylogenetic analyses based 
on nuclear DNA suggest that only the G8 and G10 cervid strains be unified under the name E. 
canadensis, and the G6, G7 and G9 strains (in camels, pigs, and people, respectively) be unified 
as E. intermedius (54). Therefore, in this thesis, E. canadensis will be used when referring to the 
cervid strain(s) present in North America, differentiated into the G8 and G10 genotypes where 
relevant.  
 
Geographic distribution  
Echinococcus canadensis is present across northern Canada and Alaska but is not established in 
Greenland (45). In Canada, E. canadensis is present in all provinces and territories with the 
exception of the East Coast (provinces of Nova Scotia, Prince Edward Island, New Brunswick 
and the island of Newfoundland) where wolves (Canis lupus) have been historically absent (44). 
Indeed, E. canadensis remains common in northern North America wherever wolves and 
ungulates co-exist (44˚N – 68˚N), however it may be absent in the High Arctic islands due to the 
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low year-round density of ungulate intermediate hosts (44,49,56). This parasite is not present on 
the island of Newfoundland due to the extirpation of wolves in the early part of the twentieth 
century, even though ungulate intermediate hosts (moose, Alces alces, and caribou, Rangifer 
tarandus) are now abundant. However, recent colonization by coyotes (Canis latrans) may 
enable local transmission of E. canadensis.   
 
Transmission, prevalence, and animal health impact  
The sylvatic strains of E. canadensis cycle primarily between canid definitive hosts and cervid 
intermediate hosts via sympatric predator-prey relationships. In Canada and Alaska, the larval 
cysts are detected most commonly in moose and caribou/reindeer; however, other ungulate 
intermediate hosts have been reported, including wapiti (Cervus elaphus), muskoxen (Ovibos 
moschatus), mountain goats (Oreamnos americanus), American bison (Bison bison) and black-
tailed deer (Odocoileus hemionus) (57–62). Cysts in microtine rodents, reported earlier, are most 
likely to be E. multilocularis (63); gray squirrels (Sciurus carolinensis) have been experimentally 
infected with E. granulosus (61). Adult cestodes have been reported in the intestinal contents of 
wolves, coyotes and domestic dogs (44,49,64,65). According to Rausch (66) historical reports of 
red fox (Vulpes vulpes) and arctic fox (V. lagopus) infected by E. granulosus in Alaska and the 
Northwest Territories were misclassified (E. multilocularis was a more likely candidate). Foxes 
are no longer considered to be natural hosts of E. granulosus (66). 
 
In sub-Arctic and Arctic regions of North America, the prevalence of infected animals is highly 
variable among different host species and between locations, and comparisons are difficult due to 
a range in detection effort and methods. In intermediate hosts, moose in northern Alaska were 
reported to have a higher prevalence of infection than those in the south (24% and 4%, 
respectively), and 0.5 to 6% of caribou were infected (59,67,68). Between 3% and 5% of 
Alaskan reindeer were reported infected with E. canadensis (45,61). In Canada, moose in the 
Yukon Territories were infected at high prevalence (43%), as were caribou/reindeer in the 
Northwest Territories (20-35%). In sub-Arctic and temperate regions of Canada, elk were 
infected at a somewhat lower prevalence (6-21%) (61). Sporadic cases in ungulates in northern 
regions of SK, Manitoba and Labrador have also been reported (57,69,70).  
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Detection of Echinococcus spp. infection in definitive hosts has historically relied on collection 
of adult cestodes from the intestines during necropsy. Identification of Echinococcus eggs 
detected in feces is complex as eggs are indistinguishable from other taeniid species; therefore, 
molecular methods are required for identification, which have only recently been applied in 
North America. Using these methods, 6% of fecal samples from free-ranging dogs in one 
community in northern SK contained eggs of E. canadensis (G10) (47), but in other 
communities, only eggs of Taenia spp. were detected (71).  Several Taenia spp. have 
distributions in wild canids that overlap E. canadensis in the North, including T. crassiceps, T. 
pisiformis and T. polyacantha (65). Taeniid eggs were detected in 5% of 423 wolves in 
Greenland, but were not identified further (72).  
 
In Alaska, based on recovery of adult cestodes at necropsy, 30% of 200 wolves were infected 
with adult cestodes of Echinococcus spp., with sled dogs (10-22%) also reported as common 
hosts (45,59,67). A similar prevalence (also based on necropsy) is reported in wolves in the 
Yukon Territory (22%; N=89) as well as in the Northwest Territories (24%; N=21) (73). One 
survey of dogs culled from eight towns in the Northwest Territories reported a 12% prevalence 
(4/33) of E. canadensis (56). 
 
The overall impact of E. canadensis infection on intermediate hosts is unknown, but varies 
according to parasite load, cyst location and host species. In moose intermediate hosts, hydatid 
cysts (metacestodes) are present in various organs (lung, liver, spleen, heart, kidneys), while in 
wild reindeer, cysts are generally restricted to the lungs (45,74). High intensities of hydatid cysts 
in moose are thought to increase the likelihood of predation by wolves or human hunters, 
possibly due to decreased stamina and pulmonary function as a result of space-occupying lung 
lesions (75, 76). Infected canid definitive hosts do not appear to be at risk of increased morbidity 
or mortality, and generally experience no adverse effects. 
 
Transmission, prevalence, and public health impact  
People are exposed to E. canadensis through the accidental ingestion of eggs passed in the feces 
of definitive hosts (wolves, coyotes, and dogs). These eggs are immediately infective once they 
have passed into the environment, and may adhere to the coat of an animal and a wide variety of 
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surfaces (77). Theoretically, hunters and trappers of wild carnivores could be at risk due to their 
close contact with carnivore hides, feces and intestines.  Dog owners who reside in endemic 
areas could also be at risk. Although the relative significance of these exposure routes is 
currently unknown, it is likely that people are predominantly infected though ingestion of 
contaminated surface water, produce, and soil. The eggs of Echinococcus spp. and related 
taeniids are extremely resistant to extremes of temperature and humidity and can persist in the 
environment for several years. Dogs are considered important “bridging hosts” between people 
and wildlife due to their non-selective diet and their close contact with people (45). Subsistence 
hunting within a community, where dogs have access to offal and carcasses, is also considered 
an important risk factor for human exposure to E. canadensis (47). However, people are not 
infected through consumption of meat or organs from wild game but instead through contact 
with feces of dogs that have scavenged carcasses or been fed offal. 
 
Cystic hydatid disease in people is most often characterized by unilocular fluid-filled cysts in the 
liver and lungs, although aberrant locations such as the brain have also been documented 
(47,78,79). Symptoms can include coughing, anorexia, fever, shortness of breath, chest or 
abdominal pain, and functional neurological deficits if cysts are associated with the brain, nerves 
or spinal cord (79,80). Echinococcus canadensis has been considered to be less likely to cause 
anaphylactic shock and secondary seeding than the pastoral strain(s) of E. granulosus (81). 
Autochthonous cases of cystic hydatid disease in Canada and Alaska do not commonly result in 
fatality; however, infection with the G8 strain has been known to cause severe clinical disease, 
and most recently, death (53,81). Treatment options for hydatid disease include surgical removal, 
benzimidazole chemotherapy and PAIR (puncture-aspiration-injection-reaspiration) therapy (82).  
In ideal circumstances a physician might use a “watch and wait” strategy to monitor and treat 
this disease; however, the limited availability of medical imaging equipment and geographic 
barriers to accessing medical care may make this approach impractical in northern communities 
(82–84). 
 
Human cystic hydatid disease did not appear in Canadian literature until 1883, and until the 
1950s, most cases were detected in immigrants from Iceland, an area historically endemic for the 
pastoral variant of E. granulosus (60). In Alaska, the first human case was recorded in 1941 
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(85,86). Human hydatid disease is reportable to Alaskan state public health authorities; peak 
numbers of cases were detected from 1953 to 1973, nearly all of which were Indigenous people 
(45). Cases of autochthonous hydatid infection were reported with increasing frequency in 
Canadian Indigenous populations in the latter half of the twentieth century, mainly due to 
incidental observation of cysts during tuberculosis screening (84). Similar to Alaska, 99% of 141 
cystic hydatid cases in Canada in the 1950’s occurred in Indigenous people (56). 
 
In 1952, Indian Health Services and the Institute of Parasitology in Canada initiated efforts to 
determine the prevalence of infection in Indigenous communities using the Casoni skin test. 
Initial efforts used antigen obtained from Australian sheep cysts; this was soon replaced by 
antigen obtained from reindeer in Aklavik (YT), resulting in greater test sensitivity (60,78). 
Between 1954 and 1957, positive Casoni skin test results were found in 6 to 52% of people 
across northern Canada (N=3,429). Prevalence was lower in Alaska, where the skin test 
employed did not use antigens of E. canadensis (87). Cultural practices including food 
preparation, acquisition of locally acquired foods, outdoor food storage, and the presence of large 
working dog populations may have significantly increased the risk of hydatid infection in the 
middle of the twentieth century.  
 
Today, imported and authochthonous cases of cystic hydatid disease occur infrequently in North 
America, in part due to the eradication of E. granulosus in Iceland, global efforts to control the 
disease, and the gradual phasing out of sled dogs as a method of transportation in the North. In 
Alaska, where human cases are reportable, zero to three cases per year in Indigenous and other 
residents have been reported since 1973. In Canada, neither human nor animal cases are 
nationally reportable (although laboratory confirmed cases in animals are annually notifiable to 
the World Organization for Animal Health), so surveillance is limited to case reviews and 
serosurveillance.  
 
A review of hospital records in Edmonton hospitals, which act as referral centres for northern 
Alberta and the Northwest Territories, identified 42 cases of suspected or confirmed cystic 
hydatid disease between 1991 and 2001 (79).  Indigenous patients were over-represented in this 
group, as 41% self-identified as Indigenous, compared with the 5% of Albertans and 3% of 
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Canadians who self-identified as Indigenous in 2001. These results are supported by Gilbert et al. 
(46), who reviewed hospital cases using ICD codes for Echinococcus/hydatid disease across 
Canada between 2001 and 2005 (N=108). In this review, people living north of the 55
th
 parallel 
were 4.88 times (95% CI 2.52-9.44) more likely to be hospitalized for echinococcosis than the 
average Canadian (2.9 cases versus 0.72 cases per 1,000,000 people annually). Hospital records 
also indicate that women may be at higher risk of developing hydatid disease than men (RR 1.92, 
95% CI 1.29-2.87) (46,79,88). 
 
Casoni skin tests have been replaced with serological testing, based on IgG ELISA, in northern 
and Indigenous communities (89). Seroprevalence in Inuit and James Bay Cree in Quebec (0.1-
8.3%) and First Nations in Saskatchewan (11%) indicate that northern and Indigenous 
populations, especially in western Canada, continue to be at risk for exposure to E. canadensis 
(47,90–92). However, the association between positive serology and clinical cystic hydatid 
disease is unclear. As well, this disease is under-diagnosed due to a variety of factors including 
many asymptomatic cases, non-specific symptoms, the long progression of the disease, and 
waning awareness in the medical community. Therefore, these factors should be considered 
when interpreting the apparent decline in prevalence of cystic hydatid disease in human 
populations in North America.  
 
Future impact of climate and landscape change 
The worldwide distribution of strains in the E. granulosus species complex demonstrates that this 
group of cestodes transmits well in different climates and in a wide variety of hosts (93); 
however, species and genotypes may vary in hardiness (48,49).  Echinococcus canadensis is 
particularly well adapted to cold northern climates. Eggs passed in the feces of definitive hosts 
can survive in the environment for several years before infecting a new host; eggs and cysts may 
survive even longer if encased within a protective barrier (eg. snow, feces, sewage, or a host 
carcass) (48). Temperatures above +35˚C or below -30˚C can damage eggs, while temperatures 
above 60˚C or below -70˚C completely inactivate them (93–95). Regardless of temperature, 
Echinococcus eggs are sensitive to desiccation at low humidity and are inactivated within 1 day 
at 0% relative humidity (RH) and within 4 days at 25% RH (48,95). Diker et al. (96) tested the 
viability of hydatid cysts from sheep (E. granulosus) at a variety of temperature and RH 
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combinations in the laboratory, and estimated environmental survival times for cysts in discarded 
carcasses: 3 to 36 days in winter (-10 to 0˚C), 12 to 28 days in spring/autumn (10 to 20˚C) and 3 
to 4 days in summer (30 to 40˚C) (96). This has limited application to northern North America, 
where winter air temperatures drop far below -10˚C and the species present is E. canadensis. Egg 
and cyst viability experiments demonstrate that the duration of cold and freeze-thaw cycles are 
more important to inactivation than the magnitude of cold (87). 
 
Density increases in moose populations are associated with increasingly aggregated distributions 
and increases in prevalence of E. canadensis (76). The northern distribution of moose in Canada 
and Alaska is thought to be limited by snow cover and vegetation; however, warming trends that 
increase food availability could allow moose to move further north (97). Woodland and barren-
ground caribou populations are currently decreasing, as a result of anthropogenic and natural 
environmental changes, but could potentially be replaced by other ungulate hosts suitable for 
harbouring E. canadensis, such as moose and wapiti (98,99). If snow cover decreases by 10 to 
20%, as predicted, the High Arctic could become more supportive of densely populated predator-
prey food webs and might become a new area for emergence of E. canadensis (100). 
 
Arctic temperatures over the last two thousand years were warmest in the period between 1950 
and 2000, despite a previous cooling period (101).  Mean annual precipitation in the Canadian 
Arctic has increased 2 to 25% over the last 62 years (102). With regard to effects on transmission 
of E. canadensis in the future, novel weather patterns may alter sympatric territories of predator-
prey systems or egg survival in the environment, possibly resulting in the emergence of hydatid 
disease in new areas, as well as retreat from warming areas (eggs have decreased survival in 
warmer temperatures). Warming winter temperatures could increase the window of opportunity 
for hydatid cysts (which are freeze susceptible) to survive before infecting a new definitive host. 
Increased precipitation in the north is protective for eggs against desiccation, but could also limit 
the accessibility of eggs on vegetation for ingestion by intermediate hosts (49). Climate change 
could cause breakdowns in sanitation infrastructure, potentially reducing access to clean water 
through events such as water contamination with eggs of Echinococcus (1,103). Finally, 
emergence of a related species (E. multilocularis) as a result of increased globalization, climate 
and landscape change, and altered interfaces with wildlife reservoirs serves as an important 
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reminder about the versatility of these cestodes (49,93,104,105).  
 
Conclusions 
In Canada, the incidence of cystic echinococcosis in people is low; however, this disease remains 
over-represented in vulnerable populations, including those residing in northern and Indigenous 
communities.  The recent arrival of molecular tools to differentiate between Echinococccus 
species and genotypes at all life stages is an important step forward for differentiating stain 
virulence and documenting emergence or control in geographic locales.  These tools have yet to 
be fully employed in Canada, but have important applications in 1) estimating human risk, 2) 
documenting distribution changes of Echinococcus spp. in people, pets and wildlife, and 3) 
supporting taxonomic changes to the genus Echinococcus, which might encourage changes to 
animal import laws that would reduce the risk of new strains emerging in Canada.  Decreasing 
echinococcosis incidence further will require a One Health approach where both human and 
animal health practioners collaborate to implement and evaluate control programs in high risk 
communities. 
 
Thesis Objectives 
This thesis focuses on zoonotic endoparasites, and specifically E. canadensis, which affect 
people, wildlife and companion animals in Saskatchewan, Canada.  Its objectives are as follows: 
(1) To measure the prevalence of E. canadensis and other zoonotic endoparasites in: 
a) wildlife 
b) dogs 
c) people 
(2) To review strategies for Echinococcus control in people and pets (dogs and cats). 
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Graphical Abstract  
 
Figure 1-3: Graphical abstract – a theoretical framework for exploring zoonotic parasites in rural 
communities using a One Health approach. 
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Graphical Abstract 
Abstract 
The geographic and host distribution, prevalence and genotypes of Echinococcus granulosus (E. 
canadensis) in wild ungulates in Canada are described to better understand the significance for 
wildlife and public health.  We observed E. granulosus in 10.5% (11/105) of wild elk (wapiti; 
Cervus canadensis) in Riding Mountain National Park, Manitoba, examined at necropsy, over 
two consecutive years (2010-2011).  Molecular characterization of hydatid cyst material from 
these elk, as well as three other intermediate wildlife host species, was based on sequence of a 
470 bp region of the NADH dehydrogenase subunit 1 (NAD1) mitochondrial gene.  In moose 
(Alces alces), elk, and caribou (Rangifer tarandus)  from northwestern Canada, the G10 
genotype was the only one present, and the G8 genotype was detected in a muskox (Ovibos 
moschatus) from northeastern Canada.  On a search of the national wildlife health database 
(1992-2010), cervids with hydatid cysts were reported in all provinces and territories except the 
Atlantic provinces, from which wolves (Canis lupus) are historically absent.  Of the 93 cervids 
with evidence of hydatid cysts, 42% were elk, 37% were moose, 14% were caribou, and 6% 
were white-tailed and mule deer (Odocoileus virginianus  and Odocoileus hemonius).  In these 
animals, 83% had cysts in lungs only, 8% in both lungs and liver, 3% in liver alone, and 6% in 
other organs.  These observations can help target surveillance programs and contribute to a better 
understanding of the E. granulosus species complex in Canadian wildlife. 
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Introduction 
Echinococcus granulosus is a species complex of cyclophyllid cestodes belonging to the 
Taeniidae family, consisting of at least 10 distinct genotypes (G1-G10), each of which circulates 
in unique host assemblages (1).  Only the sylvatic genotypes (G8 and G10) occur in Canada (1) 
and have little veterinary significance; however, the livestock genotypes (G1-G3), which have a 
global distribution, are responsible for extensive economic damage due to livestock production 
losses and human illness (2). Molecular evidence and older morphological studies suggest that 
the G8 and G10 genotypes would best be re-classified as a separate species (Echinococcus 
canadensis) (1,3–5).  Echinococcus canadensis is thought to be distributed across Canada, 
except in the Maritime Provinces and the island of Newfoundland where wolves were extirpated 
(6).  It is also unlikely to occur in the High Arctic Islands where harsh climate conditions and a 
low density of intermediate hosts provide natural barriers for successful transmission between 
wolves [Canis lupus] and ungulates (7).  
The North American sylvatic genotypes cycle between definitive canid hosts (such as wolves 
and coyotes [Canis latrans]) and cervid intermediate hosts (mainly caribou [Rangifer tarandus], 
moose [Alces alces], and elk [aka. wapiti; Cervus canadensis])(6). Domestic dogs with access to 
raw viscera from infected cervids can also act as definitive hosts (8) and, because of their close 
proximity to people, should be regularly de-wormed or denied viscera to avoid zoonotic 
transmission.  Infected canids harbour adult tapeworms in their small intestine, shedding gravid 
proglottids and infective eggs into the environment in feces.  These eggs, once ingested by a 
suitable ungulate intermediate host, penetrate the walls of the small intestine as oncospheres, and 
eventually develop into unilocular larval cysts in various organs (most often lungs (6,9,10)).  
Neither the definitive nor intermediate wildlife hosts appear to suffer serious adverse effects 
(10,11); however, heavily infected cervids are more likely to succumb to predation, either by 
wolves or by people (12,13).  This may be a result of decreased pulmonary function, or in the 
case of intense disseminated infection, poor body condition and decreased stamina. 
 
Surveillance for E. canadensis in Canadian wildlife is most often conducted opportunistically 
when animals are found dead, as part of community hunts, or when a large cull is undertaken.  
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Hydatid cysts recovered from Canadian wildlife and farmed ungulates are often dismissed as 
incidental findings, and even those recovered from human infections are seldom characterized at 
the molecular level. Thus, limited information is available regarding the geographical 
distribution and pathogenicity of the G8 and G10 genotypes.   In this paper we present results 
from a genotypic analysis of hydatid cysts recovered from elk, caribou, moose, and muskox 
(Ovibos moschatus) in Canada, as well as a cross-Canada overview of hydatid cysts detected by 
pathologists in wild ungulates at the various nodes of the Canadian Cooperative Wildlife Health 
Centre (CCWHC; www.ccwhc.ca)(14) . 
 
Materials and Methods 
Origin of ungulate tissues 
Elk (N=105) removed from Riding Mountain National Park (RMNP), Manitoba (MB) as a part 
of a Mycobacterium bovis control program were examined for presence of hydatid cysts in 2010 
and 2011 (15).  Cysts were also obtained from one adult male moose found dead in RMNP in 
2011, as well as hunted animals including one elk from RMNP, one caribou from Tasiujaq, 
Quebec and one muskox from Kugluktuk, Nunavut.  Cysts from RMNP animals were recovered 
by visual inspection and systematic palpation of organ tissue, followed by excision of all cyst-
like masses.  They were bagged separately, labelled, and stored chilled (~5˚C) for 1 day until 
they could be transported to the University of Saskatchewan for identification.  The caribou and 
muskox samples were stored at -20˚C prior to shipping. Each hydatid cyst was pierced using a 22 
GA needle and drained.  One drop of fluid from each specimen was placed on a slide with a 
cover-slip in order to identify protoscolices under a light microscope.  Presence of protoscolices 
and flame cell activity was used to determine fertility and viability, respectively (16).  The 
hydatid liquid and remaining cyst material were placed in 70% ethanol and stored at room 
temperature.    
 
Molecular characterization 
To confirm that the cysts collected were indeed hydatid, DNA was extracted from 200μL of 
hydatid fluid using the DNeasy Blood and Tissue Kit (Qiagen Inc., Valencia, CA).  Primers were 
used to amplify a 470 bp segment of the NADH dehydrogenase subunit 1 (NAD1) mitochondrial 
gene as previously described (17,18).  PCR products were resolved using electrophoresis (110 V, 
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30 min) on ethidium bromide stained 1.5% agarose gels, and products were visualized under UV 
light.  PCR products that produced positive bands were purified using ExoSAP-IT (Affymetrix 
Inc., Santa Clara, CA), and sent for sequencing at the National Research Council Plant 
Biotechnology Institute (Saskatoon, SK).  Sequences were aligned using the Staden Software 
Package (Pregap 4, Gap 4) and compared to other sequences stored in GenBank
TM
 (National 
Center for Biotechnology Information). 
 
CCWHC search 
The CCWHC maintains a national database of wildlife disease occurrences investigated by staff 
at the five Canadian veterinary colleges (AB, SK, ON, QC, PEI) and the Animal Health Centre 
(BC Ministry of Agriculture.  In general, whole carcasses or animal tissues were submitted for 
diagnostic examination to the CCWHC by biologists, conservation officers, and hunters. In 2011, 
we searched the database using the terms ‘Echinoc’, ‘granulosus‘, and ‘hydati‘, (to include both 
English and French phrases) in any of the comments or morphological diagnosis fields.  The 
results were limited to ungulates and the years 1992 to 2010. 
 
Statistical analysis 
Data were entered into a Microsoft
TM
 Excel spreadsheet, checked for errors and analyzed using 
SPSS (version 19; Chicago, Illinois, USA).  Dichotomous outcome variables were entered into 2 
x 2 contingency tables, and the statistical significance between proportions were determined by 
Fisher’s Exact Test at the 5% level. 
 
Results 
Occurrence 
The overall prevalence of hydatid cysts in the sample of elk from RMNP was 10.5% (11/105) 
(Table 2-1). The prevalence did not differ significantly by sex with 14.6% in the 48 adult males 
collected in 2010, and 7% in 57 adult females in 2011 (p-value = 0.338). The number of cysts 
per infected elk ranged from 1 to 4; all cysts were found in lung tissue, except 1 in spleen (Table 
2-2).  There were very few intact protoscolices in the hydatid fluid; half of the animals were 
infected with sterile cysts, and no protoscolices exhibited flame activity.  In contrast, protoscolex 
density was high in the 7 cysts present in the moose from RMNP. 
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Table 2-1: Reported prevalence of Echinococcus canadensis in moose (Alces alces), caribou 
(Rangifer tarandus), elk (Cervus canadensis) and deer (Odocoileus spp.) from Canada. 
Prevalence 
% (N) 
Location
 
Province Citation 
Moose 
30 (96) Moose Mountain PP
a
, Prince Albert-
Nipawin area, Hudson Bay 
SK (34) 
68 (100) Wells Gray PP BC (9) 
71 (17) 
43 (14) 
40 (43) 
17 (53) 
Lake of the Woods 
Kapuskasing 
N/A 
Elk Island NP
b
 
ON 
ON 
SK, AB 
AB 
(3) 
52 (62)  
0 (22)  
15 (39) 
Northern/western AB 
Cypress Hills PP 
Elk Island NP 
AB (21) 
67 (54) Chapleau Crown Game Preserve ON (10) 
58 (45) Mont Tremblant NP QC (12) 
42 (114) 
32 (76) 
0 (50) 
Reserve La Verendrye 
Reserve des Laurentides 
Reserve Matane 
QC 
QC 
QC 
(35) 
44 (580) Southwest QC QC (36) 
0 (16) Eastern ON ON (37) 
47 (224) Southwest QC QC (25) 
73 (51) N/A AB (23) 
Caribou 
21 (14) Wholdaia Lake, Northern SK SK, NT (34) 
21 (14) 
20 (517) 
N/A 
Reindeer Depot 
SK 
NT 
(3) 
1 (159) Northern Labrador NL (22) 
4 (488) North-central Canada MB, SK, NT (24) 
Elk 
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16 (280) Elk Island NP AB (3) 
11 (359) 
16 (949) 
38 (193) 
Cascade and Red Deer valleys 
Bow Valley 
Jasper NP 
AB (20) 
21 (94) N/A AB (23) 
11 (105) Riding Mountain NP MB This study 
Deer (White-tailed) 
0.3 (353) Sleeping Giant PP ON (6) 
7 (28) Moose Mountain PP SK (34) 
44 (9) 
28 (7) 
Lake of the Woods 
Moose Mountain PP 
ON 
SK 
(3) 
0 (147) N/A AB (23) 
Deer (Mule) 
0 (263) N/A AB (23) 
a
PP = Provincial Park; 
b
NP = National Park 
 
Table 2-2: Description of hydatid cysts found in the lung tissue of wild elk (Cervus canadensis), 
muskox (Ovibos moschatus), moose (Alces alces) and caribou (Rangifer tarandus) in Canada.  
Elk and moose were from Riding Mountain National Park (Manitoba). 
ID # Year Host 
Species 
# cysts Protoscolex 
Density
a
 
Genotype  Accession 
# 
(GenBank) 
1281 2010 Elk 1 0 G10 KC505418 
1300 2010 Elk 4  0 G10 KC505419 
1235 2010 Elk 4  0 G10 KC505417 
1284 2010 Elk 1 0 G10 KC505416 
1394 2010 Elk 1 0 G10 KC505415 
1037 2010 Elk 1 0 G10 NS 
1156 2010 Elk 2  A -0 
B- 2 
G10 KC520777 
101 2011 Elk 1 0 G10 KC520779 
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1435 2011 Elk 1
b
 0 G10 NS 
1444 2011 Elk 1 0 G10 KC520780 
1292 2011 Elk 1 10 G10 KC520776 
1325 2011 Elk 2  A -0 
B- 1 
G10 KC520778 
OM-06 2010 Muskox
c
 2  0 G8 NS
e
 
76095 2011 Moose 7  20-200 (range) G10 KC520775 
102 2011 Caribou
d
 1 0 G10 KC520781 
a
Number of protoscolices/mL hydatid fluid (A,B used in the case of multiple cysts per animal); 
b
Spleen tissue; 
c
Kugluktuk, Nunuvut; 
d
Tasiujaq, Quebec; 
e
NS = Not submitted. 
 
Molecular characterization 
PCR products of the NAD 1 locus were successfully amplified and sequenced in all 15 samples.  
The samples recovered from all cervids were identified as the E. granulosus G10 genotype, most 
closely related to GenBank accession nos. AF525297.1 (19) and DQ144041.1 (1).  The cyst 
recovered from the muskox was most closely related to the G8 genotype (GenBank accession no. 
EU151429.1) (5).  
 
Historical records 
In total, 93 reports of cystic hydatid infection were retrieved from the CCWHC database.  These 
included 39 elk, 34 moose, 13 caribou, 3 white-tailed deer (Odocoileus virgianus), 3 mule deer 
(Odocoileus hemionus) and 1 unknown species.  The majority of positive tissue submissions 
originated from the western prairies (Saskatchewan 33%, Alberta 18%, Manitoba 2%), followed 
by the northern territories (Northwest Territories 15%, Yukon Territories 5%, Nunavut 1%), 
central Canada (Ontario 18%, Quebec 3%), and finally British Columbia 4% in the Pacific west 
(Figure 2-1).  There were no reports from Atlantic Canada.  Reports spanned a geographic range 
between 44˚N to 68˚N and 73˚W to 135˚W (Figure 2-1). The majority of infected animals had 
hydatid cysts in lung only (83%), followed by 3% in the liver only, 2% in the kidney, and 1% 
each in the spleen and skeletal muscle.  Nine of 93 animals had cysts in more than one site (lung 
and liver [N=7]; lung, liver, kidney and spleen [N=1]; lung and heart [N=1]). Only moose and 
37 
 
caribou harboured cysts in organs other than the liver and lungs, and moose had the highest 
number of cysts per animal.   
 
Figure 2-1: Geographic locations where Echinococcus canadensis cysts were recovered from 
wild ungulate hosts as reported in the literature (1952-present), the CCWHC database (1992-
2010), and this study [YK: Yukon Territories; NT: Northwest Territories; NU: Nunavut; BC: 
British Columbia; AB: Alberta; SK: Saskatchewan; MB: Manitoba; ON: Ontario; QC: Quebec; 
NB: New Brunswick; PE: Prince Edward Island; NS: Nova Scotia; NL: Newfoundland and 
Labrador]. 
 
Discussion 
Occurrence 
A review of Canadian literature (1952-present) suggests that ungulate species are not equally 
suitable as intermediate hosts for E. canadensis. Intensity of infection appears to be low in 
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muskoxen, white-tailed deer, and mule deer whereas moose, elk, and caribou appear to be highly 
competent hosts, with higher prevalence and intensity of infection in areas co-inhabited by 
coyotes or wolves (3,6,20–24).  In moose and caribou the intensity of infection, as defined by the 
number and size of cysts, is positively correlated with age (9,12,21,25), and possibly gender 
(females>males) (20,24).  The overall apparent prevalence of cystic hydatid infection in the 
RMNP elk was similar to that reported in elk by other studies conducted in Western Canada 
(Table 2-1).  The scarcity of protoscolices in RMNP  elk support previous suggestions that elk 
are less suitable as intermediate hosts of E. canadensis than moose (3).  Our results do not 
support previous reports of higher infection in females than males; however, our sample size was 
small.   
 
Molecular characterization 
We did not detect the livestock genotypes (G1-3) of E. granulosus in wildlife, which could 
support the belief that these genotypes are not present in Canada.  Alternately, ungulates are 
likely poor hosts for these genotypes, but so few cervid isolates have been characterized 
genetically that it difficult to draw conclusions at the present time.  Our results failed to identify 
mixed infection in the animals sampled; however, we did not amplify DNA from all individual 
cysts from each animal.  Molecular identification is important for sterile cysts as the differences 
in viability among genotypes in different host species is not yet known.  It also serves as a 
method of definitive diagnosis, as identification based on gross or histological examination in the 
absence of protoscolices is difficult.  No immediate conclusions can be drawn from these data 
regarding the proposed new taxonomic status of E. canadensis; however, this molecular 
characterization of hydatid cysts serves as a point of comparison for future biogeographical 
studies of hydatid infection in intermediate hosts.   
  
Historical records 
The records retrieved from the CCWHC database over the last few decades confirm the ongoing 
transmission of E. canadensis in most of northern, western, and central Canada. They also 
identified geographic locations in northern Ontario, British Columbia, Nunavut and the 
Northwest Territories where E. granulosus had not previously been reported by the literature.  
Many factors influence the prevalence and distribution of sylvatic parasites over time, including 
39 
 
climatic variation, migration or extirpation of host species and land use changes. To our 
knowledge, no data have been published in the last several decades that adequately describe the 
distribution of E. canadensis in Canadian ungulates.  Surveillance to detect emergence is 
especially important in areas of newly established host assemblages, such as the island of 
Newfoundland, where coyotes and moose now intermingle (26).  Our results based on passive 
surveillance suggest that E. granulosus transmission is not occurring in Atlantic Canada; 
however active surveillance is needed to confirm this conclusion. The historical data indicate that 
the majority of hydatid cysts found in ungulates were located in lungs, which supports the 
findings of previous reports (6,9,10), suggesting that surveillance could focus on examining lung 
tissues.  
 
Several factors presented limitations in this study.  We have no reports of E. canadensis in 
domestic livestock, as the database focuses on wildlife surveillance; however it is thought that 
this parasite rarely infects domestic ungulates (with the exception of farmed reindeer and elk) 
(1,3,27). The data contained in each report is limited by the quality of tissue submitted, whether 
the pathologist had access to the entire carcass, and whether the pathologist reported the cysts, 
often considered as incidental findings.  Most CCWHC records did not state the infection 
intensity (# of cysts per animal), fertility, or viability. We are unable to report the prevalence of 
hydatid disease in Canadian wildlife, as the number carcasses examined by CCWHC during the 
study period is unknown.  As well, sampling bias, as previously described, and low sample size 
numbers would make any estimate unreliable. The absence of reports from Nunavut and northern 
Labrador could be due the lack of proximity and the relative difficulty in transporting tissue 
samples to any of the CCWHC nodes. 
 
Conclusions 
This is the first cross-Canada review of E. granulosus in wild ungulates to be published since 
1963 (3).  Human echinoccocosis remains a public health concern at northern latitudes and in 
some Indigenous communities where people live in close proximity to areas co-habited by 
moose and wolves (8,28).  Hydatid infection in people was historically endemic to certain 
Canadian populations (29); however, changing risk factors, the advent of widespread 
anthelmintic use in domestic dogs, and public health education have decreased the risk of 
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infection (30,31).  Most recently, the annual overall incidence rate of echinococcosis in 
Canadians was estimated to be 0.72 cases per million people; however, this rate is likely to be an 
underestimate because definitive diagnosis of clinical cases is difficult (28).  Historically, 
autochthonous cases of human echinococcosis in Canada were believed to be less serious than 
cases caused by the imported livestock genotype.  However, this medical paradigm was 
challenged in 1999 when two Alaskan patients diagnosed with hepatic echinococcosis (G8 
genotype) experienced severe sequelae, including one fatality (32,33).  Historical records of 
cystic hydatid disease are useful for both veterinary and medical professionals as they help 
define the potential distribution, and the risk of infection.  Transmission and distribution of E. 
canadensis may increase as a result of rapid climate and landscape change, in combination with 
increased globalization of travel and trade, suggesting that national surveillance of this parasite 
will continue to be important for both human and animal health (31).  This is especially true for 
areas where canids and ungulates have only recently come into close proximity. 
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Transition Statement 
Echinococcus canadensis has an indirect lifecycle that requires both ungulate intermediate hosts 
(Chapter 2) and canid definitive hosts.  This chapter characterizes the prevalence and genetic 
make-up of Echinococcus species in wolves (Canis lupus) from western Canada.  Because 
wolves shed a variety of potentially zoonotic pathogens, the prevalence of both E. canadensis 
and other endoparasites are reported. 
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Abstract 
Wolves (Canis lupus) are large apex predators that eat a wide variety of prey species, have long 
migration routes, and could facilitate the spread of different helminth species from endemic areas 
to non-endemic areas.  Echinococcus species are important parasites of wildlife, domestic 
animals, and people worldwide; however, little is known about the prevalence, intensity and 
genetic diversity of Echinococcus tapeworms in Canadian wildlife.  Intestinal helminths, 
including Echinococcus tapeworms, were harvested from the intestines of 92 of 165 (56%) 
wolves from ten sampling regions in the Northwest Territories, Manitoba, and Saskatchewan, 
and identified to genus level by microscopic examination.  Molecular methods, used to 
determine species and/or genotypes of cestodes, identified Echinococcus canadensis (34/165; 
21%), E. multilocularis (12/165; 12%), Taenia krabbei (26/165; 16%), T. multiceps (3/165; 2%), 
T. hydatigena (7/165; 4%), and Diphyllobothrium latum (4/165; 2%).  Mixed infections of E. 
canadensis/E. multilocularis, as well as of the G8/G10 genotypes of E. canadensis were 
observed.  These findings suggest that wolves may be an important definitive host for both E. 
canadensis and E. multilocularis in western Canada.  This is the first report of wolves naturally 
infected with E. multilocularis in North America, and of wolves harbouring mixed infections 
with multiple species and genotypes of Echinococcus.  These observations provide important 
information regarding the distribution and diversity of zoonotic species of Echinococcus in 
western North America, and may be of interest from public health and wildlife conservation 
perspectives. 
 
Keywords: Echinococcus granulosus; wolf; Canada; genotype; geographic distribution 
 
Key Findings 
- Wolves in western Canada were infected with Echinocccus multilocularis and E. 
canadensis  
-  Wolves harbored mixed infections of E. multilocularis/E. canadensis and E. canadensis 
G8/G10 genotypes 
- Wolves may play a far greater role in transmitting E. multilocularis than previously 
thought 
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Introduction  
In Canada, most wolves reside in Holarctic regions (30 000 – 60 000 animals), and food sources 
may include small mammals, large ungulates, reptiles, amphibians, and fish, depending on the 
region (1).  This helps to explain the high parasite richness (number of parasite species) found in 
wolves (2).  A meta-review of the literature identified 72 helminth species (27 cestode spp, 16 
trematode spp, 28 nematode spp, and one acanthocephalan) observed by post-mortem 
examination of wolf intestines, coproantigen testing, muscle biopsy, or fecal analysis (2).  
Previous helminths identified in tundra wolves from the YK and NT include Diphyllobothrium 
spp., Taenia spp., E. canadensis, Toxascaris leonina, and Spirocerca spp. (3).   
 
Echinococcus species are cestodes that cycle among domestic and sylvatic animals, with 
occasional spillover into people. Two zoonotic Echinococcus species are distributed in Canada – 
Echinococcus canadensis and Echinococcus multilocularis.  Previously, E. canadensis was 
known as the sylvatic strain of E. granulosus (or the G8 and G10 cervid genotypes); however, 
recent molecular evidence based on mitochondrial genes support the nomenclature change (4–7).  
Echinococcus canadensis utilizes large canids (wolves, coyotes [Canis latrans] and dogs [Canis 
familiaris]) as definitive hosts; and ungulates, primarily cervids (moose [Alces alces], elk 
[Cervus canadensis], caribou [Rangifer tarandus], and deer [Odocoileus spp.]) as intermediate 
hosts (8).  Echinococcus canadensis has a widespread distribution across Canada, and is found in 
every province and territory except the Maritime Provinces and the island of Newfoundland 
(8,9).  Echinococcus multilocularis is reported only in western Canada and is thought to occur as 
two geographically and genetically segregated populations (ie. the Northern Tundra Zone and the 
North Central Region) (10).  Echinococcus multilocularis predominantly utilizes smaller 
carnivores (coyotes, dogs, foxes [Vulpes spp], and domestic cats [Felix catus]) as definitive hosts 
and a wide variety of small mammals as intermediate hosts (eg. tundra voles [Microtus 
oeconomus], deer mice [Peromyscus maniculatus], and brown lemmings [Lemmus 
trimucronatus]), although aberrant intermediate hosts (such as people, domestic dogs, etc.) do 
occasionally occur (11–13). 
 
Wolves have long been considered the most important definitive host for E. canadensis, but with 
the exception of one experimentally infected animal, wolves infected with E. multilocularis have 
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not been reported in North America (2,11,14–16).  This could be explained by a variety of 
factors, including the difficulty in harvesting and identifying adult cestodes of Echinococcus 
species (in part due to zoonotic risk), wolf predation preferences, and variable host specificity.  
The recent advent of molecular tools has facilitated species level differentiation, as well as 
identification of genotypic variations.  The objectives of this study are to report the occurrence 
and identity of Echinococcus cestodes harvested from Canadian wolves, and to better define the 
geographic and host distribution of these and other intestinal parasites.  
 
Materials and Methods 
Wolves were harvested by trappers, hunters, and wildlife personnel from Saskatchewan (SK), 
Manitoba (MB) and the Northwest Territories (NT) for other purposes (2009 to 2012), and 
intestines were submitted for examination under University of Saskatchewan animal care 
research ethics approval protocol 20090126.  The small intestines were ligated, excised, and 
frozen at -80°C for a minimum of 3 days prior to processing, in order to inactivate eggs of 
Echinococcus infective for people (10).  Intestinal helminths, including Echinococcus strobilate 
adults, were harvested from the intestines of wolves using the scraping, filtration, and counting 
technique (17), morphologically identified to genus level, and stored in 70% ethanol.  Intensity 
was estimated for Echinococcus spp. cestodes by counting the number of individuals in two 10% 
aliquots, and calculating the average number of cestodes per wolf.  Freezing and ethanol fixation 
precluded definitive morphological identification of the adult cestodes to species level.  To 
identify Echinococcus spp. cestodes, two to nine individual, intact, adult cestodes were selected 
from each wolf, and DNA was extracted from individual cestodes (18).  PCR analysis of each 
worm was conducted using taeniid specific primers to amplify a 470 bp region of the NADH 
dehydrogenase subunit 1 (NAD1) mitochondrial gene of E. canadensis (19).   A 395 bp region of 
NAD1 of E. multilocularis was amplified using species-specific primers for any samples that did 
not amplify using the primers for E. canadensis (20).  To identify Taenia and Diphyllobothrium 
spp., one or two individuals of each species were selected from each infected wolf, and DNA 
was extracted from approximately 0.1 g of tissue using the DNeasy Blood and Tissue Kit 
(Qiagen Inc., Valencia, CA).  Two different regions of the cytochrome c oxidase subunit 1 
(CO1) mitochondrial gene were amplified: a 446 bp amplicon for Taenia spp. and a 437 bp 
amplicon for Diphyllobothrium spp. (21,22).  PCR products were resolved by electrophoresis 
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(110V, 30 mins) on a 1.5% agarose gel stained by RedSafe nucleic acid staining solution 
(ChemBio Ltd, Hertfordshire, UK), and viewed under UV light.  PCR products with positive 
bands were purified using QIAquick PCR Purification Kit (Qiagen Inc., Valencia, CA), and sent 
for sequencing (Macrogen Inc., Seoul, Korea).  Forward and reverse DNA sequences were 
aligned using a Staden Software Package (Pregap 4, Gap 4).  The aligned sequences were 
entered into GenBank 
TM
 (National Center for Biotechnology Information) and compared by 
BLASTn search to previously published sequences for identification. 
 
Results 
We examined 165 wolves (72 female, 92 male, 1 unknown), of which 15 were juvenile, 104 
were adult, and 46 were of unknown age.  One or more adult helminth species were detected in 
92 of 165 wolves (prevalence of 56%).  Intestinal parasite prevalence (based on morphological 
identification) was as follows: Taenia spp. (46/165; 28%), Toxascaris leonina (28/165; 17%), 
Diphyllobothrium spp. (5/165; 3%), Alaria spp. (8/165; 5%), Uncinaria stenocephala (1/165; 
0.6%), and Echinococcus spp. (48/165; 29%) (Table 3-1).  The median intensity of Echinococcus 
infection was approximately 2200 worms (range: 5, 24250). 
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Table 3-1: Location and occurrence of Echinococcus species infection in wolves examined by 
necropsy (Canada). 
Province
a
 Sample 
size (N) 
Location/region Infection Prevalence
b
 
No. infected (%) 
   Echinococcus E. 
canadensis
 c
 
E. 
multilocularis
 c
 
NT 25 Southern Slave 
Region  
8 (32) 4 (16) 1(4) 
NT 19 Northern Slave 
Region  
3 (16) 3 (16) 1 (5) 
NT 29 Sahtu Region 12 (41) 6 (21) 4 (14) 
NT 8 Fort Macpherson 2 (25) 2 (25) 0 (0) 
NT 17 Aklavik 1 (6) 1 (6) 0 (0) 
NT 24 Inuvik 3 (13) 3 (13) 0 (0) 
NT 17 Tuktoyatuk 1 (6) 1 (6) 0 (0) 
NT 6 Paulatuk 2 (33) 2 (33) 0 (0) 
SK 5 Prince Albert 
National Park 
3 (60) 3 (60) 1 (20) 
SK 1 Key Lake 0 (0) - - 
SK 11 Unknown 11 (100) 8 (73) 3 (27) 
MB 3 Riding Mountain 
National Park 
2 (67) 1 (33) 2 (67) 
Total 165  48 (29) 34 (21) 12 (7) 
a
 NT – Northwest Territories; SK – Saskatchewan; MB - Manitoba 
b 
Based on morphological identification  
c 
Based on molecular identification of selected cestodes (2-9 per wolf); samples from 9 wolves 
could not be identified beyond the genus level 
 
Echinococcus cestodes were successfully characterized using molecular techniques in 39 of the 
48 infected wolves.  Based on NAD1 sequence data, E. multilocularis was identified in 12 
wolves, representing a minimum prevalence of 7% (12 of 165 wolves). Seven of the E. 
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multilocularis positive wolves were co-infected with E. canadensis G10.  The minimum 
prevalence of E. canadensis in these wolves was 21% (34 of 165). Of these, 20% (33 of 165) had 
E. canadensis G10, 4% (6 of 165) had E. canadensis G8 (5 had both genotypes).  Other 
helminths identified using CO1 sequence data were as follows: T. krabbei (26/165; 16%), T. 
multiceps (3/165; 2%), T. hydatigena (7/165; 4%), and Diphyllobothrium latum (4/165; 2%).  
Co-infection by Echinococcus spp. and Taenia spp. was observed in 17 of 165 (10%) wolves.   
 
Sequences from the G10 genotype of E. canadensis were most similar (99% identical) to a 
reindeer isolate from Finland (accession no. AF525297.1), and sequences from the G8 genotype 
were most similar (99% identical) to a moose isolate from the USA (AB235848.1).  Sequences 
from E. multilocularis cestodes were most similar (99-100% identical) to a human liver cyst 
from Poland (JX266826.1), an M2 European genotype (AJ237640.1), and a European-type 
haplotype found in a domestic dog from British Columbia, Canada (JF751034.1).  Sequences of 
suitable length and quality were submitted to Genbank
TM
 and assigned accession nos. as follows: 
E. canadensis G8 KC848478-KC848483; E. canadensis G10 KC848484-KC848493; E. 
multilocularis KC848462-848477. 
 
Only E. canadensis G10 was found in all ten of the sample regions (Figure 3-1).  Echinococcus 
multilocularis was found in the five most southern regions of MB, SK and the NT, while E. 
canadensis G8 was found in Prince Albert National Park (PANP) in SK, and the South Slave, 
Sahtu, and Inuvik regions of the NT.  Mixed infections of E. multilocularis and E. canadensis 
G10 were observed in Riding Mountain National Park (RMNP) in MB, PANP, and in the Sahtu 
region.  
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Figure 3-1: The occurrence of Echinococcus multilocularis and E. canadensis (genotypes G8 and 
G10) in wolves across ten sampling regions in Canada (N=165; NT – Northwest Territories, SK 
– Saskatchewan, MB – Manitoba). 
 
Discussion 
To our knowledge, this is the first report of E. multilocularis in naturally infected North 
American wolves (2,11,15,16).  Wolves infected by E. multilocularis have previously been 
reported in Europe, Russia and China (2,11,23).  Our study suggests that the significance of 
wolves for sylvatic transmission of this cestode in North America may be significantly 
underestimated. Previously, the northern distribution of this parasite was thought to track that of 
the Arctic fox (Vulpes lagopus), which was considered to be the most important definitive host at 
Arctic latitudes (16).  We found a minimum infection prevalence of 7% in 165 wolves; similarly 
the prevalence of E. multilocularis in Arctic foxes in mainland regions of Alaska and the western 
Canadian Arctic is 2-9% (16).  Compared to canids from RMNP (24), our reported median 
infection intensity of adult Echinococcus cestodes is higher than that previously reported in 
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wolves, and is far higher than that of red foxes.  Wolves travel long distances and could 
contribute to range expansion of E. multilocularis (25).  Wolves are known to consume a wide 
variety of prey species, including ungulates and rodents (26).  Tundra wolves utilize rodents as a 
greater part of their diet than timber wolves, and would be expected to encounter E. 
multilocularis with higher frequency (3,26,27), but our results suggest the opposite – that timber 
wolves residing in southern regions of western Canada also encounter E. multilocularis.  This 
most likely reflects a high prevalence of infection in rodent intermediate hosts as well as 
maintenance in other definitive hosts, including coyotes, red foxes, dogs, and cats.   
 
This is the first demonstration of wolves naturally infected with multiple species and genotypes 
of Echinococcus, although mixed infections have previously been reported in dogs (28–30).  
Mixed infections of Echinococcus species and genotypes may be explained by the finding that 
exposure to larval stages of Echinococcus (hydatid cysts) by definitive hosts does not elicit a 
sufficient immune response to prevent a subsequent infection (31). Presumably, a definitive host 
could develop mixed infections through the consumption of various intermediate hosts 
harbouring different species and genotypes of Echinococcus.  Mixed infections probably occur 
more frequently than suggested by our results, as this study was limited by the number of adult 
Echinococcus cestodes processed per wolf, and by the number of cestodes for which we 
successfully amplified DNA.   We observed co-infection of wolves with E. canadensis G8/G10 
genotypes in SK and NT, and co-infection with E. multilocularis/E. canadensis G10 in MB, SK 
and NT.  Although we did not find E. canadensis G8 strain in a mixed infection with E. 
multilocularis, this likely reflects the relative rarity of this genotype as well as the need for more 
widespread geographic sampling.  Mixed infections with Taenia spp. were observed in 17 of 165 
(10%) wolves sampled, suggesting that cross-protective immunity does not occur. 
 
The Taenia species observed in the NT wolves have distributions that span several continents, 
and utilize different host assemblages that depend on regional availability of definitive and 
intermediate hosts (32).  Possible intermediate hosts for these species in Canada include moose, 
caribou, deer, elk, or muskoxen for T. hydatigena; big horn sheep (Ovis canadensis), Dall sheep 
(O. dalli), moose, deer, or caribou for T. krabbei; and snowshoe hare (Lepus americanus), or 
caribou for T. multiceps.  Only caribou, muskoxen, moose, and snowshoe hare would be likely to 
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be found in the northern region of the NT where our samples were collected.  The finding of D. 
latum is consistent with previous surveillance of wolves in the NT (3), and is predictable based 
on the close vicinity of the sampling locations to the Beaufort Sea as well as multiple lakes.  
Wolves become infected by ingesting infected tissues of marine or freshwater fish, such as pike 
(Esox lucius), yellow perch (Perca flavescens) or walleye (Sander vitreus) (33).  Toxascaris and 
Uncinaria were the only nematode species observed in these wolves, similar to other parasite 
surveillance work in NT and the Yukon Territories, where Spirocerca was the only other 
nematode reported (3).  This result may support previous observations that Toxascaris and 
Uncinaria are more cold adapted than other closely related nematode species (eg. Toxocara 
canis and Ancylostoma caninum).  Other helminths that may have been missed due to the 
sampling technique include worms found in the stomach (eg. Physaloptera), cecum (eg. 
Trichuris), and other locations (eg. Trichinella).  
  
Our findings of Echinococcus in wildlife may cause concern in both the animal and public health 
sectors.  Echinococcus infection does not cause significant pathology in definitive hosts, and 
although hydatid cyst growth in ungulate hosts is usually asymptomatic, pulmonary infections 
may restrict vital capacity and endurance.  Limited evidence is available to demonstrate that 
infected ungulates are more likely to be removed from herds by hunters or natural predators 
(34,35).  In contrast, rodents are seriously compromised by their role as intermediate hosts of E. 
multilocularis (36).  Echinococcus species are zoonotic, and although people are aberrant dead-
end hosts, infection can cause severe long-term health consequences, including death (37).  
Cystic hydatid disease associated with E. canadensis is thought to be less pathogenic than that 
associated with the pastoral species in the E. granulosus species complex; however, severe 
clinical disease has been reported in people infected with the G8 strain in Alaska (38).  Alveolar 
echinococcosis caused by E. multilocularis is especially dangerous for people, and the western 
coast of Alaska has been considered a highly endemic focus.  This may in part reflect the unique 
ecology of the disease (especially on islands in the Bering Strait) as well as the possibility of 
Asian strains of this parasite (39).  More work is needed to determine the significance of finding 
European-type strain(s) of E. multilocularis in wolves in northern and western Canada, and their 
relationship to strains elsewhere in the circumpolar North.  The observation of E. multilocularis 
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in wolves is an important finding for wildlife managers, veterinarians, and public health 
personnel in western Canada.   
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Transition Statement 
Dogs (Canis familiaris) are infected with many of the same endoparasites as wolves, including 
E. canadensis, and can be important sources of zoonotic parasite transmission by bridging the 
gap between people and wildlife.  Dogs are infected with E. canadensis and other endoparasites 
by hunting and scavenging, or when they are fed raw offal, especially in rural and remote areas 
where dogs have easy access to wildlife.  Historically in Canada, Indigenous people were at 
higher risk of exposure to E. canadensis than European settlers.  This chapter examines the 
prevalence of endoparasites in rural and remote Indigenous communities in Saskatchewan, 
Canada, where parasite control methods are limited and dogs often roam freely.  
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Abstract 
Indigenous communities may have increased risk of exposure to zoonotic parasites including 
Echinococcus granulosus, Toxocara canis, Toxoplasma gondii, Diphyllobothrium spp., and 
Giardia duodenalis, for which dogs may serve as sentinels for, or sources of, human infection. 
Fecal samples were collected from dogs and the environment in 5 Indigenous communities 
across Saskatchewan and Alberta (N=58, 62, 43, 66 and 25). Parasites in individual fecal 
samples were quantified using fecal flotation and a commercial immunofluorescent antibody test 
for Giardia and Cryptosporidium. Overall, the prevalence of intestinal parasitic infection was 20-
71%, which is 5-16 times higher in Indigenous communities than in a nearby urban centre in 
Saskatchewan. The overall prevalence of T. canis, Diphyllobothrium and taeniid eggs in dog 
feces was, respectively, 11.8%, 4.9% and 1.2% in our study, compared with 0-0.2% in urban 
dogs. Giardia cysts present in 21% of samples were identified as zoonotic genotype Assemblage 
A.  
 
Introduction 
Parasitic infections acquired by zoonotic transmission can cause serious illnesses in people, and 
can financially burden healthcare systems (1,2). In 1882 (3), Canadian data demonstrated that 
cystic hydatid disease, caused by the zoonotic parasite Echinococcus granulosus, was over-
represented in Indigenous populations compared to non-Indigenous Canadians, and this trend has 
not changed (4,5).  More recently, surveillance of people residing in northern Indigenous 
communities across Canada has raised concerns regarding the sero-prevalence of exposure to 
parasitic zoonoses, including Echinococcus, Toxoplasma, Trichinella, and Toxocara (2,6–11).  
 
Dogs act as bridging hosts between wildlife and people and can serve as sources of human 
infection with Echinococcus spp., Toxocara canis, and zoonotic genotypes of Giardia through 
shedding infective parasite eggs and cysts in feces (12–14).  For other parasites, such as 
Toxoplasma, Trichinella, and Diphyllobothrium, dogs may serve as sentinels of shared 
environmental risks for humans consuming the same wild game or fish (15).
 
 The widespread use 
of anthelmintics has greatly decreased the risk of dogs developing patent parasitic infections in 
areas where veterinary services are available; however, many northern and remote areas of 
Canada do not have access to these services or products (15). 
62 
 
 
Currently, a knowledge gap exists in our understanding of the prevalence and significance of 
zoonotic parasites in people, wildlife and domestic animals in northern and Indigenous 
communities in Saskatchewan. Research in other areas of northern Canada (Nunavut, northern 
Ontario and Nunavik) indicates that people residing in these areas may be at higher risk of 
exposure to parasitic zoonoses because of a combination of unique risk factors. Large free-
roaming dog populations, a reliance on locally acquired food, limited veterinary and/or medical 
services, and contaminated water sources are all factors that increase risk of parasite exposure 
(12,14,15). 
 
Surveillance of dogs in remote Indigenous communities has identified a broad range of 
potentially zoonotic parasites, including: nematodes (Uncinaria and Trichuris), cestodes 
(Diphyllobothrium, Dipylidium, and Echinococcus), trematodes (Metorchis) and protozoa 
(Giardia and Cryptosporidium) (12,14–17).  In the 1970’s, surveillance demonstrated that dogs 
in 2 remote areas were disproportionately parasitized, as compared to those in 5 urban areas of 
SK.  Parasites with zoonotic potential (T. canis, Metorchis, taeniids, Diphyllobothrium and 
Uncinaria) had 5-52 times greater overall prevalence in dog feces from remote communities than 
urban communities (14,17). More recently, dog fecal samples collected from one Saskatchewan 
reserve in 2008 were 85, 153, and 8 times more likely to be infected with T. canis, Giardia, and 
Cryptosporidium, respectively, than dog feces collected in Saskatoon in 2008-2009 (18,19).
 
 In 
addition, both humans and dogs on this reserve were infected with E. granulosus, the cause of 
cystic hydatid disease in people (8).  In the current study, we examined feces from dogs in 
Indigenous areas of the Canadian Prairies to measure the prevalence of zoonotic parasites.  
 
Materials and Methods 
Dog feces 
Between 2009 and 2011, dog feces were collected from 5 Indigenous rural or remote 
communities from public health regions in Saskatchewan (SK; Sunrise, Mamawetan Churchill 
River [MCR-A and B], and Keewatin Yatthe [KY]) and Alberta (AB; Chinook Health [CH]) 
under University of Saskatchewan animal care research ethics approval 2009-0126.  Fecal 
samples were obtained directly from the rectum (N = 135) of dogs brought to mobile veterinary 
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clinics, or from the ground (N = 124).  In 4 communities samples were simultaneously collected 
at the clinic and from the ground along major thoroughfares, on school properties, from the yards 
of consenting dog owners, at parks and playgrounds, and at the local landfill. Fecal samples were 
rejected if they appeared grey or white in colour (an indicator of age of sample). All samples 
were sealed in labelled plastic bags and kept cool for the duration of the sampling period (1-2 
days). Fecal samples were then stored at -80˚C for at least 5 days to inactivate eggs of 
Echinococcus spp. Parasite eggs were quantified in approximately 5 grams (wet weight) of feces 
from each sample using a modified Wisconsin fecal flotation and light microscopy to identify to 
the family or genus level (20). Approximately 1 g of feces from each sample was screened for 
Giardia cysts and Cryptosporidium oocysts, using a sucrose gradient flotation followed by a 
commercially available antibody fluorescence assay (Waterborne Inc.; New Orleans, LA) (21). 
In cases where a sufficient amount of fecal matter was available for only one assay, the 
Wisconsin test was prioritized. 
 
Giardia genotyping  
Molecular methods were used to identify the genotypic assemblages of Giardia cysts in 
individual fecal samples from MCR-A (SK) and CH (AB) regions (number of positive samples 
=15 and 21, respectively). DNA was extracted from cysts using the DNeasy Blood and Tissue 
Kit (QIAGEN Inc., Valencia, CA). A 511-bp segment of the β–giardin gene was amplified using 
a two-step nested PCR procedure (22).  PCR products were resolved using ethidium bromide 
stained 1.5% agarose gels, and products were visualized under ultraviolet UV light. PCR 
products were purified using the QIAquick gel extraction kit (QIAGEN Inc., Valencia, CA) 
before DNA sequencing with the secondary PCR primers. DNA sequencing was performed at 
the National Research Council Plant Biotechnology Institute (Saskatoon, SK). 
 
Taeniid egg speciation  
In the CH region community, taeniid eggs from canine feces were identified to species level 
using PCR followed by DNA sequencing. DNA was extracted from eggs using the DNeasy 
Blood and Tissue Kit (QIAGEN Inc., Valencia, CA). A segment of the nicotinamide adenine 
dinucleotide (NADH) dehydrogenase subunit 1 (NAD1) gene was amplified using primers for an 
approximately 500-bp region of this mitochondrial gene (JB11 5’-AGA TTC GTA AGG GGC 
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CTA ATA-3’ and JB12 5’-ACC ACT AAC TAA TTC ACT TTC-3’).  PCR was run according 
to the following sequence: initial denaturation (94˚C for 3 minutes), 40 amplification cycles 
(94˚C for 15 seconds, 50˚C for 30 seconds, 72˚C for 30 seconds), final extension (72˚C for 1 
minute). Ethidium bromide stained agarose gel electrophoresis was used to visualize the PCR 
products, followed by PCR product purification and DNA sequencing as described above. 
 
Results 
In the 5 communities sampled, 20-71% of fecal samples from client owned dogs and/or the 
environment contained eggs or cysts of at least one species of parasite, and approximately 45% 
of these positive samples contained multiple parasite species (Table 4-1). Free-roaming dogs did 
not have significantly higher odds of shedding parasites than client-owned dogs in MCR-A, 
MCR-B or KY at the 95% confidence level, although a trend was apparent (Table 4-2). Overall, 
nematode infections were most common, with T. canis, Toxascaris leonina, and Uncinaria 
stenocephala infection in 12%, 16% and 8% of 254 samples, respectively. Giardia cysts and 
Cryptosporidium oocysts were identified in 21% and 4% of 231 samples, respectively, while 
tapeworms [taeniids (1%), Diphyllobothrium (5%)] and coccidia [Isospora (6%)] were less 
common.   
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Table 4-1: Prevalence of intestinal parasite eggs, cysts and oocysts in canine feces collected in 
Indigenous communities across Alberta and Saskatchewan public health regions, as identified 
through quantitative sucrose flotation and immunofluorescent assay. 
 Chinook 
Health  
Mamawetan 
Churchill River A 
Mamawetan 
Churchill River B 
Sunrise Keewatin 
Yatthe  
Community ID CH MCR-A MCR-B SR KY 
Month/Year 09/2009 09/2011 06/2010 11/2011 05/2010 
Toxocara 9/62 
(15%) 
9/58  
(16%) 
7/66  
(11%) 
2/25 
(8%) 
2/43  
(5%) 
Toxascaris 25/62 
(40%) 
8/58  
(14%) 
3/66  
(5%) 
1/25 
(4%) 
3/43  
(7%) 
Uncinaria 0/62 
(0%) 
20/58  
(34%) 
0/66 
(0%) 
0/25 
(0%) 
0/43 
(0%) 
Taeniid 2/62 
 (3%) 
0/58 
(0%) 
1/66  
(2%) 
0/25 
(0%) 
0/43 
(0%) 
Diphyllobothrium 0/62 
(0%) 
10/58  
(17%) 
1/66  
(2%) 
0/25 
(0%) 
1/43 
 (2%) 
Isospora 3/62 (5%) 2/58  
(3%) 
3/66  
(5%) 
0/25 
(0%) 
7/43  
(5%) 
Giardia 13/40 
(22%) 
21/57  
(37%) 
5/66  
(8%) 
1/25 
(4%) 
0/43 
(0%) 
Cryptosporidium 4/40  
(10%) 
1/57  
(2%) 
1/66  
(2%) 
1/25 
(4%) 
1/43  
(2%) 
*Overall  38/62 
(61%) 
41/58 
 (71%) 
15/66  
(23%) 
5/25 
(20%) 
11/43 
(26%) 
*Overall prevalence measured as the number of samples containing at least one parasite species 
divided by the total number of samples 
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Table 4-2: Comparison of parasite prevalence in feces collected from dogs brought to remote 
animal health clinics (client owned) versus feces collected off the ground (environmental) in 
three Indigenous Saskatchewan communities 
Public Health Region 
Sampling Site 
Client Owned Environmental Odds 
Ratio 
95% Confidence 
Interval 
MCR-A 25/40 (63%) 16/18 (89%) 4.8 1.0-23.9 
MCR-B 4/16 (25%) 11/55 (20%) 1.0 0.3-3.7 
KY 3/17 (18%) 8/26 (31%) 2.1 0.5-9.3 
 
 
Giardia genotyping was successful in 90% (19/21) and 87% (13/15) of samples from CH and 
MCR-A, respectively. All were zoonotic genotype Assemblage A (GenBank Accession nos. 
JQ978656--JQ978688). These sequences all contained a cytosine at position 606 of the β-giardin 
gene (numbered relative to G. duodenalis Portland I, X85958), consistent with their 
identification as subassemblage AI within assemblage A (23). 
 
NAD1 sequence from taeniid eggs in a fecal sample from the CH region was similar to Taenia 
pisiformis (88% identical over 491 nucleotides to AJ239109) (GenBank Accession no. 
JQ917875). The remaining sample had a low egg count (5 eggs per gram) and did not amplify on 
PCR. 
 
Discussion 
Sources and sentinels  
Our study suggest that dogs in remote and rural areas can act as both sources and sentinels for 
human exposure to zoonotic parasites, as reported previously (15,24,25). Parasites of known 
public health concern were found in all communities. For some of these parasites, pets are a 
potential source of human exposure. For example, people can become accidental hosts for larvae 
of the roundworm Toxocara spp. when they ingest eggs passed in pet feces, or possibly, larvae 
encysted in paratenic hosts (24). Toxocariasis can cause ocular and visceral larval migrans, and 
is the most frequent parasitic zoonoses passed from pets to people in the United States (14,26–
30).  Clinical toxocariasis may be less common in Canada, with toddlers at highest risk (31). Dog 
67 
 
ownership was not an important risk factor for seropositivity for T. canis in Canada, emphasizing 
the importance of environmental contamination by free-ranging dogs for transmission of this 
zoonosis (31,32). Canids, including domestic dogs, are a definitive host for tapeworms in the 
Taeniidae family, and pass eggs infective to people in their feces. At the microscopic level, all 
Taeniid eggs appear alike, and molecular techniques are needed to identify species (8). We found 
non-zoonotic T. pisiformis in southern Alberta, but other species, including Taenia crassiceps 
and E. granulosus, are potentially present, and mixed infections would not necessarily have been 
detected by the techniques that we used.  
 
Dogs may be a source of human infection, but also a potential recipient of infection from human 
sewage (33).
 
Giardia duodenalis has been identified in a variety of wildlife species and 
companion animals in Saskatchewan, including dogs, coyotes and beavers (Castor canadensis; 
18,19,34,35). It is most often spread by direct contact or via contaminated food and water 
sources (36). In our study, 2 to 37% of dog fecal samples from four communities were positive 
for G. duodenalis, and the zoonotic genotype A was confirmed in dogs in two communities. 
Himsworth et al (18) found a prevalence of 61% in dog feces from another Indigenous 
community in SK, while Gaunt et al (19) found a prevalence of 0.4% in dogs from an urban 
centre in SK. However, prevalence of Giardia is generally underestimated in surveillance studies 
due to the sporadic shedding of cysts, poor sensitivity of flotation assays, and the potential for 
subclinical infection (36). Giardia duodenalis Assemblage A has been identified in dogs in SK, 
AB and the Northwest Territories, and is considered zoonotic due to its lack of host specificity 
(hosts include dogs, cats and people) (15,18,37). Assemblage A is known to be more virulent in 
people than other genotypes, and should be considered a potential risk to public health in the CH 
and MCR regions where we identified infection in dogs (34,38).  
 
For other parasites, dogs are not direct sources of human infection but instead serve as sentinels 
for parasites that are acquired by both people and dogs through common routes of exposure. For 
example, cestodes in the genus Diphyllobothrium (most likely D. latum or D. dendriticum) 
cannot be transmitted directly from dogs to people. Instead, both are infected through the 
consumption of infective plerocercoids in raw or undercooked fish (38).  Dogs may also serve to 
amplify the abundance of this cestode in the environment. For animal sentinels to be useful for 
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public health purposes, they must be highly susceptible, highly exposed, and show a detectable 
response. Since dogs in remote and Indigenous communities are often free-ranging, have access 
to human food and garbage, and carcasses of local fish and wildlife, they are highly exposed and 
thus make excellent sentinels.  
 
Disparities and community-specific parasite profiles 
Dogs in Indigenous and northern communities in western Canada had a markedly higher 
prevalence of parasite shedding than dogs in a nearby urban centre (19). This finding is most 
likely attributable to factors such as age, reproductive status, gender, housing, geographic region, 
diet, and access to veterinary care (13,39). For example, dogs brought to mobile veterinary 
clinics in Indigenous communities are quite young (mean age = 1-2 years), likely because older 
animals have already been sterilized. Free ranging dogs in these communities are also young, 
possibly as a result of dog management practices (eg. dog shoot days) and high natural mortality 
in many communities. Juvenile dogs are more likely than adults to shed parasites, which may in 
part account for the high prevalence that we observed.  
 
Our study revealed a distinct profile of parasite shedding and exposure in each community, even 
those in relatively close proximity; likely the result of variation in risk factors such as access to 
harvested wildlife, human garbage, clean water, and veterinary services (28).
 
However, it is also 
important to note that parasite shedding is affected by season, which varied among the sample 
collections. One possible explanation for the low prevalence of Uncinaria infection was freezing 
at -80˚C, which may have rendered the eggs unidentifiable. As well, some fecal samples 
collected from the ground may have originated from the same animal, causing the population 
prevalence to be over or under-estimated depending on whether the animal was shedding parasite 
eggs. Sample collectors were unable to distinguish dog feces from the feces of wild canids, such 
as wolves or coyotes; however, these wildlife are considered unlikely within the communities.  
 
Identifying local risk factors and developing community specific parasite profiles can 
significantly aid veterinarians and health professionals in introducing locally effective animal 
and human health interventions. Key messaging in knowledge translation includes administering 
a broad-spectrum dewormer to companion animals regularly (at least once a year), removing and 
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disposing of animal waste regularly, cooking meat and fish consumed by both people and pets, 
and washing hands prior to eating and after handling animals or animal waste (28). Population 
control of free-roaming dogs, and preventative healthcare for owned dogs are crucial 
components to decreasing environmental contamination; many parasite eggs and cysts can 
survive months to years in the environment and are resistant to commonly available 
disinfectants. This will require improved access to veterinary products and services currently 
unavailable in the entire northern one-half of SK. Finally, our work suggests that surveillance of 
parasites in companion animals is a potential tool for detection of zoonotic risks for people, and 
could be used to evaluate the efficacy of animal and public health interventions. Using sentinels 
in this way could benefit communities by producing rapid, discrete, and economical estimates of 
human health risk, and simultaneously improving both animal and public health. Additional 
investigation into this application for animal sentinels requires exploring the relationship of 
prevalence levels and parasite species between people and companion animals. 
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Transition Statement 
Chapter 4 demonstrated that dogs in rural and remote Indigenous communities have a higher 
level of endoparasitism than that reported in owned dogs in Saskatoon.  It remains unclear 
whether Saskatchewan (SK) dogs that are in closer proximity to veterinary clinics (urban and 
southern rural communities) also have high levels of endoparasitism.  We did not detect 
Echinococcus canadensis infection in any of the dogs reported in Chapter 4, but we did observe 
such infections during a national study of Canadian companion animal shelters in 2009-2010 
(Villeneuve et al, in prep).  Regina Humane Society (RHS) is one of the largest animal shelters 
in SK, and it re-homes companion animals that originated in urban and rural communities across 
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the southern half of the province.  This chapter reports the results of fecal parasite testing 
conducted for RHS dogs, including molecular work to differentiate between infection by Taenia 
spp. and E. canadensis.  As well, we present an analysis of risk factors, such as geographic 
origin, associated with endoparasitism.  
 
Abstract 
We report the results of fecal parasite surveillance in dogs surrendered to the Regina Humane 
Society, Saskatchewan, Canada, between May and November 2013.  Overall, 23% of 231 dogs 
were infected with at least 1 intestinal parasite.  Endoparasite infection was positively associated 
with rural origin (P=0.002) and age (<12 months; P<0.001). 
 
Introduction 
Considerable differences exist in endoparasite prevalence and species diversity for pet 
populations at national, state, and regional levels, underscoring the importance of determining 
region-specific parasite profiles (1).  These parasite profiles change over time due to factors such 
as parasite emergence and pet population structure and dynamics, and should be re-assessed 
regularly.  Prevalence of canine parasites is often higher in rural or remote communities than city 
centres, due to limited or absent veterinary services, feeding non-commercial food to pets, access 
to untreated water, and/or the presence of large free-roaming dog populations (2–5).  Companion 
animals, dogs in particular, can act as bridging hosts between wildlife or livestock and people for 
numerous zoonotic parasites.  Regular surveillance is needed to develop regionally-appropriate 
anthelmintic treatment regimens in order to reduce parasite transmission among dogs, and from 
dogs to people. 
  
The Regina Humane Society (RHS) is located in Regina, Saskatchewan (SK; 50.4547° N, 
104.6067° W), a major population centre in southern Saskatchewan.  It accepts dogs surrendered 
from all areas of the province. Dogs are treated with anthelmintic (pyrantel pamoate) upon entry 
to the shelter to minimize the risk of parasite transmission among animals, and from dogs to 
people.  Ideally, a fecal examination would be performed on each dog at intake to determine 
correct anti-parasitic treatment; however, limitations in human and financial resources make this 
unfeasible.  The goals of this study were to 1) determine the prevalence and intensity of parasites 
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in dogs at intake to help guide initial deworming protocols at the (RHS); and 2) determine if a 
dog’s geographic origin (rural or urban), age, reproductive status and/or gender are associated 
with fecal parasite status. 
 
Materials and Methods 
Fresh fecal samples were collected from dogs upon admission to the RHS (May-November 
2013), and within a day of anthelmintic treatment.  Samples were stored at 4˚C for up to 5 d prior 
to shipping to the University of Saskatchewan where processing occurred.  Eggs, cysts, and 
oocysts were identified to family or genus level according to morphology and morphometrics by 
an experienced observer (for example, eggs of Uncinaria were measured to ensure that they were 
distinguished from those of Ancylostoma).  Fecal egg counts (FEC) were performed on 4 g wet 
weight (ww) of sample using a double centrifugation sucrose modified Stoll flotation (6).  
Giardia spp. cysts were isolated from a subset of samples using quantitative sucrose gradient 
centrifugation followed by an immunofluorescence assay on 4 g (ww) of feces (Giardi-a-Glo, 
Waterborne, New Orleans, Louisiana, USA) (7).   
 
To identify taeniid eggs to the species level, DNA was extracted from feces using the E.Z.N.A. 
Stool DNA Kit (Omega Bio-tek, Norcross, Georgia, USA), and amplified using a 446 nucleotide 
segment of the cytochrome c oxidase subunit 1 (cox1) mitochondrial gene (8).  Amplicons were 
purified using the QIAquick PCR Purification Kit (Qiagen, Valencia, California, USA), sent for 
sequencing (Macrogen, Seoul, Korea), and entered into GenBank
TM
 (National Center for 
Biotechnology Information) for comparison to previously published sequences.   
 
Geographic origin (rural versus urban), age, gender, and reproductive status (intact, 
spayed/neutered) were recorded for all dogs.  Rural origin was defined using the Statistics 
Canada definition for the 2011 Census (ie. an area with a human population less than 1000, and a 
population density <400 persons/km
2
) (9).  Data were entered into a spreadsheet and checked for 
errors.  Fisher’s exact test was used to identify associations between overall fecal parasite status 
(positive for 1 or more parasite species) and demographic data (gender, reproductive status, 
rural/urban, age) (SPSS version 20; IMB Corporation, Armonk, New York, USA).  Associations 
between individual parasite infections and descriptors, and between rural location and 
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reproductive status were also explored.  Statistical significance was assessed using 2-sided P-
values at the 5% level. 
 
Results 
Two hundred and thirty-one dogs (118 male, 112 female, 1 unknown) were surrendered to the 
RHS during the study period, from 38 communities mainly located in southern Saskatchewan 
(Figure 5-1).  Of these dogs, 18% (42 of 231) had been de-sexed (25% of males and 13% of 
females), and 31% (73 of 230) were under the age of 1 y.  Seventy-five percent (173 of 230) 
came from 1 of 5 urban population centres (Regina, White City, Lumsden, Moose Jaw or 
Balgonie), while the remainder came from 1 of 33 rural communities (Figure 5-1).  Origin and 
gender data were missing for 1 dog.  Overall, 23% (52/231) of dogs were positive for at least 1 
parasite species, including nematodes (Toxocara canis, Toxascaris leonina, Uncinaria 
stenocephala), cestodes (Diphyllobothrium spp., Taenia pisiformis), and protozoans (Giardia 
spp., Isospora spp., Sarcocystis spp.) (Table 5-1).  Overall infection prevalence was 3.5 times 
higher in puppies (43% of 73) than adults (12% of 157), and approximately 2 times higher in 
dogs from rural areas compared to dogs from urban centers (Table 5-1).  Both age (P<0.001) and 
rural origin (P=0.002) were significantly associated with infection, while gender (P=0.177) and 
reproductive status (p=0.100) were not.    
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Table 5-1. Parasite prevalence and intensity in urban and rural dogs surrendered to the Regina 
Humane Society May-November 2013 (N=231). 
 Urban  
N (%) 
Rural  
N (%) 
Total 
N (%) 
Overall Intensity (eggs/cysts/oocysts/g )  
Mean, Median, Minimum-Maximum  
Sample size 172 (75) 58 (25) 231
a
   
Cestodes     
Diphyllobothrium 1 (0.6) 2 (3) 3 (1.3) 381, 575, 10-588 
Taenia pisiformis 1 (0.6) 0 1 (0.4) 3
b 
Nematodes     
Dioctophyma renale 1 (0.6) 0 1 (0.4) 1
b
 
Toxascaris 3 (2) 2 (3) 5 (2) 656, 128, 5-3000 
Toxocara canis 7 (4) 12 (21) 19 (8) 648, 372, 2.5-5188 
Trichuris 0 1 (2) 1 (0.4) 3
b
 
Uncinaria 0  1 (2) 1 (0.4) 48
b
 
Trematodes     
Alaria 4 (2) 3 (5) 7 (3) 313, 25, 5-1875 
Metorchis 1 (0.6) 0 1 (0.4) 56
b
 
Protozoans     
Isospora 7 (4) 2 (3) 9 (4) 2769, 233, 3-11680 
Sarcocystis 4 (2) 5 (9) 9 (4) 886, 153, 3-5540 
Giardia
c
  7 (9.5) 5 (16) 12 (11) 2339, 767, 17-12450 
Overall
d
 30 (17) 22 (38) 52 (23)  
a
Location data missing for 1 sample  
b
Intensity data based on 1 value  
c
Giardia test conducted on subset of total samples (75 urban, 31 rural, 105 total) 
d
Overall prevalence was calculated as the number of dogs infected with at least 1 parasite type 
divided by the total sample number 
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Figure 5-1. Geographic origin of dogs surrendered to the Regina Humane Society (Regina, 
Saskatchewan, Canada) in May-November 2013 (n=231). 
 
Only T. canis, Sarcocystis spp., Giardia spp., and Isospora spp. occurred with sufficient 
frequency to be assessed for associations with descriptors.  Eggs of T. canis were associated with 
young dogs (P<0.001), rural origin (P<0.001), and intact reproductive status (P=0.028).  The 
presence of Sarcocystis was positively associated with rural origin (P=0.047); Isospora and 
Giardia were both positively associated with puppies (P=0.005 and P=0.025, respectively).  
Geographic origin was not significantly associated with reproductive status (P=0.430).   
 
Discussion 
Dogs surrendered to the RHS in the summer of 2013 had a prevalence of fecal endoparasite 
shedding (23%) that was almost 6 times higher than that of dogs from the closest city 
(Saskatoon) of similar size (10).  Infection prevalence was almost twice that reported from an 
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American national survey of dogs brought to veterinary clinics (1).  Helminth and protozoan 
fecal parasite shedding, in particular T. canis, Isospora and Giardia were most common in 
juvenile dogs.  Young animals are more susceptible to parasitic infections probably due to 
behavior and/or reduced immunocompetency. This is consistent with other surveillance studies 
conducted in both Canada and the United States (1,11,12). Good husbandry practices are 
important to prevent both prenatal transmission of T. canis and neonatal transmission of Giardia 
and Isospora in these young animals.  Endoparasitism and fecal shedding of T. canis and 
Sarcocystis occurred more frequently in rural dogs than urban dogs.   
 
Of the 5 dogs that originated in rural central Saskatchewan (Otter Lake, Pelican Narrows and 
Onion Lake), 4 were infected with at least 1 parasite, and all were sexually intact.  This may 
reflect the relative difficulty of accessing veterinary services in these locations, and is consistent 
with a previous study demonstrating that endoparasitism in dogs from rural indigenous 
communities was 5-16 times higher than in dogs residing in a nearby urban centre (5,10).  For 
some parasites, the primary route of infection is through predation or scavenging of wild fish and 
game, such as taeniid and Diphyllobothrium tapeworms, the intestinal trematodes Alaria and 
Metorchis, the giant kidney worm Dioctophyma renale, and the protozoan Sarcocystis. This 
suggests that prevalence of these parasites should be higher in rural animals; however, these 
parasites were not significantly more common in fecal samples from rural origin dogs than urban 
origin dogs in this study.  This could be explained by limitations in intake data for dogs, such as 
detailed travel history, dietary information, past living conditions (eg. indoor/outdoor), and prior 
access to regular veterinary care.  As well, some rural communities were close to urban centres 
and those dogs might have had risk factors more similar to their urban counterparts.  Likewise, 
many urban communities in western Canada have significant green spaces that are shared with 
wildlife, and off-leash areas often have access to local rivers and lakes. 
 
We observed Giardia spp. prevalence (11%) in RHS dogs that was almost 3 times higher than 
the American national estimate, but only slightly higher that that found in smaller-scale Canadian 
surveys (~7%) (1,11,13).  Giardia spp. infection is known to occur more frequently in young 
dogs, and conditions of crowding (eg., shelters, kennels) (11,13).  This is because cysts are 
environmentally resistant and immediately infective when passed in the feces (14).  The 
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prevalence of this parasite was not significantly higher in rural dogs than urban dogs, 
demonstrating the widespread distribution of this parasite, and the tendency of dogs to drink 
available surface waters. 
 
The majority of dogs in this study came from Regina and small surrounding communities where 
veterinary care is available within a reasonable driving distance.  In spite of this, endoparasite 
prevalence in rural dogs was high, suggesting several possible scenarios: 1) rural dogs were more 
likely to be stray/free-roaming, 2) rural dogs are more exposed (ie. higher levels of 
environmental contamination or increased access) or more susceptible (ie. younger 
demographics), or 3) deworming attitudes and compliance differ between urban and rural pet 
owners.  Rural dogs were as likely to be de-sexed as urban dogs, demonstrating that rural pet 
owners in southern SK have access to veterinary care for their animals.  Our finding that sexually 
intact dogs were more likely to shed T. canis than non-intact dogs is supported by a large study 
(N=1 213 061) in the USA where intact dogs had a higher risk of shedding T. canis, Ancylostoma 
spp., and Trichuris spp. (15).  Possible explanations include the young age of most sexually 
intact dogs, sexually intact dogs encountering parasites more frequently through roaming 
behaviour, reactivation of somatic Toxocara larvae during pregnancy, and spay/neuter status 
acting as an indicator for improved animal care (including prophylactic use of dewormers, and 
feeding a commercial diet) (15).  Increased focus on client education regarding regular 
anthelmintic use and parasite prevention measures may be appropriate for rural dog owners.    
 
Pyrantel pamoate, the anthelmintic currently in use at RHS, is indicated for treatment of T. canis, 
T. leonina, Ancylostoma caninum, and U. stenocephala in dogs (16).   When administered 
according to manufacturers’ instructions, prophylaxis with pyrantel pamoate at intake should 
have successfully treated 77% (178 of 231) of dogs surrendered to the shelter.  The RHS and 
other shelters could consider running fecal flotations on high risk dogs (puppies and those from 
remote locations), or switching to a broad-spectrum anthelmintic (one that would also target 
cestodes and possibly trematodes) to maximize parasite removal.  Unless molecular methods are 
used, it is not possible to distinguish eggs of zoonotic species of Echinococcus (including E. 
canadensis and E. multilocularis in this region) from non-zoonotic Taenia spp., such as T. 
pisiformis.  Therefore, shelter animals shedding taeniid eggs should be treated with praziquantel 
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or an effective cestocide prior to adoption to minimize risks to public health.  Specific treatments 
for protozoan parasites are probably not indicated, given the asymptomatic nature of infection, 
with the exception of Isospora, which can cause clinical outbreaks of coccidiosis in kennels, and 
zoonotic genotypes of Giardia, especially for dogs adopted into high-risk households (those with 
children under 5, or people with chronic medical conditions or immunosuppression).   
 
Conclusions 
These findings emphasize the increased potential for parasitic infection in and zoonotic 
transmission from shelter dogs, especially those of young age and rural origin.  Simple measures, 
such as deworming, limiting pet access to wildlife and domestic livestock, and prompt removal 
of animal waste from kennels, are all cost-effective methods of limiting the risk of animal and 
human illness due to parasites. 
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Transition Statement 
People residing in remote and northern communities may be at increased risk of exposure to 
zoonotic parasites due to high levels of endoparasitism in free-roaming dogs, limitations to water 
infrastructure, traditional food preparation methods, and a close reliance on country foods.  In 
previous chapters we examined wolves (Chapter 3) and dogs (Chapters 4 and 5) as potential 
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sources of Echinococcus canadensis infection.  Chapter 6 uses a One Health approach to 
determine if people in a remote and northern Indigenous community have high exposure levels to 
E. canadensis and other parasitic zoonoses.  This was accomplished by measuring human sero-
prevalence of 4 zoonotic parasites, identifying risk factors associated with exposure, and 
determining endoparasite levels in dogs.   
 
Abstract 
We report the results of a joint human-animal health investigation in a Dene community in 
northern Saskatchewan, where residents harvest wildlife (including moose, bear, elk, and fish), 
live in close contact with free roaming dogs, and lack access to permanent veterinary services.  
Fecal analysis of owned and free-roaming dogs over two consecutive years (N=92, 103) 
identified several parasites of public health concern, including Toxocara canis, Diphyllobothrium 
spp., Echinococcus/Taenia, Cryptosporidium spp. and Giardia spp.  Administration of pyrantel 
pamoate to a subset of dogs (N=122) in the community in the first year was followed by reduced 
shedding of T. canis and other roundworms in the second year, demonstrating the potential utility 
of canine de-worming as a public health intervention.  Using direct agglutination tests with 
confirmatory indirect fluorescent antibody test, 21% of 47 dogs were sero-positive for exposure 
to Toxoplasma gondii.   Using enzyme-linked immunosorbent assay (ELISA) sero-prevalence 
rates in 201 human volunteers were as follows: Toxoplasma gondii (14%), Echinococcus 
granulosus (48%), Toxocara canis (13%) and Trichinella spp. (16%). Overall 65% of 
participants were sero-positive for at least one parasite.  A survey administered to volunteers 
indicated few associations between widely accepted risk factors for parasite exposure and 
serological status, emphasizing the importance of environmental transmission of these parasites 
through soil, food, and waterborne routes.   
 
Author Summary 
Parasites are ubiquitous, and while some parasitize only one host, others are capable of crossing 
species barriers.  Zoonotic parasites move between animals and people, and in some cases cause 
significant veterinary, medical and/or public health problems.  Such parasites may be more 
prevalent in areas where veterinary and medical services are scarce, and especially if sanitation 
infrastructure is suboptimal.  Additional risk factors include reliance on country foods, proximity 
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to pets that come in contact with wildlife, and eating undercooked or raw fish and game.  We 
visited one northern Indigenous community over two consecutive years to determine the 
prevalence of internal parasites in dogs, as well as to demonstrate the effect of selective 
deworming on reducing environmental contamination by zoonotic parasites.  In addition, we 
collected blood samples and administered surveys to human volunteers in order to explore the 
relationship between exposure to four zoonotic parasites and several widely accepted risk factors 
for exposure (eg. pet ownership).  Our findings indicate that levels of parasite exposure in this 
community were higher than similar studies conducted in other Canadian Indigenous 
communities.  Public health interventions that utilize a one health strategy by integrating 
medical, veterinary and environmental expertise may be the most effective approach in reducing 
human and animal exposure to parasites in this community. 
 
Introduction 
Northern Indigenous peoples have recently been identified as being at high risk for acquiring 
parasitic zoonoses due to socioeconomic factors and a close relationship with the land (1).  
Hunting and fishing are common activities in northern Saskatchewan where consumption of 
country foods is an integral part of a traditional Dene diet and a very important contribution to 
food security in regions where commercial foods are often expensive, unavailable, and 
nutritionally inadequate (2).  Free-roaming dogs continue to play important roles in Indigenous 
communities as wildlife deterrents, security, companion animals, and occasionally transport (3).   
Human exposure to zoonotic parasites might be above average in these communities if free-
roaming dogs have access to raw game or fish and subsequently shed infective stages of parasites 
in areas frequented by people.  Other risk factors for exposure to zoonotic parasites include 
contaminated or inadequately treated drinking water, handling and consumption of locally caught 
and inadequately cooked game or fish, challenges of waste disposal in remote environments, 
and/or absence of veterinary services (4–6).   
 
Recently, the prevalence of intestinal parasitic infection in dogs was reported to be as high as 
71% in northern Saskatchewan (7). Several genera of zoonotic parasites have been identified in 
dog populations including Echinococcus/Taenia, Giardia, Cryptosporidium, Toxocara and 
Diphyllobothrium, for which dogs may serve as sources or sentinels for human exposure (6,7).  
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Few studies have simultaneously sampled people as well as free-roaming dog populations to 
determine their role as sources or sentinels for human infection with parasitic zoonoses (8).  A 
number of human sero-prevalence studies have been conducted in northern and predominantly 
Indigenous regions of Canada; however, none of these has focused on Dene communities in 
northwestern Canada, which share many of the same socioeconomic and public health concerns 
as Inuit in Nunavut, and Inuit and Cree in Nunavik and the James Bay region of northern Quebec 
(9–16).  Zoonotic infectious such as echinococcosis and trichinellosis occur more frequently in 
northern and Indigenous populations; however, incidence rates of other zoonotic parasites are 
currently unknown for northern Saskatchewan (17).  
 
We conducted research relating to veterinary public health in one Indigenous community in the 
Keewatin Yatthé (KY) health authority over a two year period (2010, 2011).  The KY region is 
located in the northwestern part of Saskatchewan, and is one of three public health regions that 
encompass northern Saskatchewan (14).   Approximately 10 600 people reside in this area, of 
which 94% self-identify as Indigenous (primarily Métis, Dene and Cree); a proportion similar to 
that seen in James Bay and Nunavik, Quebec.  Social determinants of health significantly 
contribute to health inequities in this population, and include the high cost of food, housing 
shortages, low income, and high unemployment.  People in this health region have shorter life 
expectancy, higher all-cause mortality, and higher rates of chronic and communicable disease 
(including diarrheal outbreaks, tuberculosis, hepatitis C and HIV/AIDS) than the provincial 
average (14).    
 
In this paper we study canine endoparasitism and human exposure to four parasites of medical 
concern: Echinococcus granulosus, Trichinella, Toxocara canis and Toxoplasma gondi.  Social 
and behavioural risk factors for exposure to these parasites are also explored.  
 
Materials and Methods 
Participants 
In 2011, we visited one community in northern Saskatchewan with an approximate population of 
2400 people and, primarily through word of mouth, recruited 201 volunteers over the age of 4 
years (female N=77; male N=124).  In addition, we sampled dog feces collected from the ground 
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and samples from client-owned dogs brought to a veterinary service clinic in the community in 
2010 and 2011. 
 
Human serology and risk factor assessment 
Approximately 5 mL of whole blood was collected directly into serum-separator tubes (BD; 
Franklin Lakes, NJ) and kept refrigerated.  Tubes were centrifuged at 3000 rpm for 10 minutes 
within 8 hours of collection, and sera transferred to snap-top mini centrifuge tubes. Serum 
samples were sent to the National Reference Centre for Parasitology (McGill University, 
Montreal, QC) and tested for IgG antibodies against T. gondii (Diagnostic Automation/Cortez 
Diagnostics, Inc, Calabasas, CA), Trichinella spp., Toxocara canis and E.  granulosus by using 
an in-house developed IgG and IVD Research (Carlsbad, CA) enzyme-linked 
immunosorbent assay (ELISA).  Criteria for interpretation of serology results are provided in 
Table 6-1.  Equivocal results were designated as sero-negative.  Each participant was also asked 
to respond to a survey (Appendix C) pertaining to risk factors for parasite exposure.  Questions 
addressed pet ownership, feeding practices, barriers to veterinary care, hunting, fishing and 
personal consumption of country foods.  Not all participants completed the surveys in entirety, 
and some small children were grouped under their parents’ surveys.   
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Table 6-1: Results of serological analyses and criteria for sero-status in people. 
Parasite Measurement Criteria and this study’s results 
  Negative Equivocal Positive 
Toxocara canis Optical 
Density 
<0.25 ≥0.25 to <0.35 ≥0.35 
 
Number Samples  164/201 10/201 27/201 
Trichinella Optical 
Density 
<0.25 ≥0.25 to <0.35 ≥0.35 
Number Samples  149/201 19/201 33/201 
Echinococcus 
granulosus 
Optical 
Density 
<0.35 
 
≥0.35 to <0.45 
 
≥0.45 
 
Number Samples  77/201 27/201 97/201 
Toxoplasma gondii Units IgG 
(IU/mL) 
<1 
 
NA ≥1 
 
Number Samples  173/201 - 28/201 
 
Canine fecal surveillance 
Approximately 300-400 dogs were estimated to reside in this community.  We conducted canine 
fecal collection and analysis in this community during the month of June over two consecutive 
years (2010: N=92; 2011: N=103) to test the effectiveness of anthelmintic administration as a 
public health intervention.  Fecal samples were obtained by rectal collection from client-owned 
dogs brought to a mobile veterinary service clinic (2010: N=31; 2011: N=34), as well as by 
ground collection throughout the community (2010: N=61; 2011: N=69) as a measure of 
environmental contamination.  All dogs (N=122) brought to the mobile clinic in 2010 were 
treated with pyrantel pamoate (Pyran; Vetroquinol, Lavaltrie, QC) as per label dose, and owners 
were given additional medication along with instructions to repeat the treatment after 7-10 days.  
The ratio of male to female dogs brought to the clinic was approximately one to one, and all 
intact animals were desexed.  Approximately half of the clinic animals were within one year of 
age.   
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For feces obtained from the ground around the community, fresh fecal samples were collected 
but older samples (grey or white) were not collected.  Samples were stored in sealed plastic bags 
and kept in coolers with ice during the collection period (1-2 days).  Feces were transported to 
the University of Saskatchewan (Saskatoon, SK) and stored at -80 degrees Celsius for five days 
to inactivate taeniid eggs.  A quantitative sucrose centrifugation flotation was used to quantify 
and identify parasite eggs and cysts from approximately 5 grams wet weight of feces (modified 
from (18)).  Giardia spp. cysts and Cryptosporidium spp. oocysts were identified using a sucrose 
gradient flotation and a commercial immunofluorescent assay (Waterborne Inc.; New Orleans, 
LA) on approximately 1 gram wet weight of feces (19).   
 
Canine sero-surveillance 
We conducted sero-surveillance of Toxoplasma gondii for dogs brought to the mobile veterinary 
service clinic in this community in 2011 (N=47).  Approximately 3 mL of whole blood was 
collected directly into serum-separator tubes (BD; Franklin Lakes, NJ), and chilled on ice.  Sera 
were collected as described for the human study.   Sera were analyzed for the presence of 
antibodies to T. gondii at the University of Saskatchewan (Saskatoon, SK) using a modified 
direct agglutination test (Biomerieux Toxo-Screen DA kit; Montreal, QC) at a 1:40 dilution.  
Samples with equivocal results on this test were re--tested using an indirect fluorescent antibody 
test (IFAT; VMRD, Pullman, WA).  
 
Ethics 
All participants provided written informed consent and those under the age of 18 provided 
written consent from a parent or guardian to participate.  Individual serology results were mailed 
back to the participant and/or their primary care physician. The human study was reviewed and 
approved by the University of Saskatchewan Biomedical Research Ethics Board (REB 11-07), as 
well as by the Keewatin Yatthé Health Region and the community leader. The animal fecal and 
serology studies were reviewed and approved by the University of Saskatchewan Animal 
Research Ethics Board (2009-0126 and 2010-0159, respectively), which adheres to the Canadian 
Council on Animal Care (CCAC) standards.  Dog owners provided consent for their animals to 
be sampled, while consent for ground collection of dog feces was provided by the community 
leader.   
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Statistical methods 
Human serology and survey data were entered into a spreadsheet and analysed using logistic 
regression to identify associations between outcomes (sero-status) and risk factors (SPSS, 
Chicago, Illinois, USA).  The strength of association between an outcome and variables was 
reported as an odds ratio (OR) with 95% confidence intervals (CI) (OpenEpi version 2.3.1, 
Atlanta, GA, USA).  Risk factors were tested for statistical significance in a multivariate model 
using manual backward elimination. Risk factors were considered confounders if their inclusion 
or exclusion changed the effect estimate of another risk factor by more than 10%. In the case of 
correlated risk factors, only one was included in the final model.  A chi-square test was used to 
determine if proportions were significantly different (p-value < 0.05). 
 
Results 
 Human serology and risk factor assessment 
Of 77 women and 124 men (N=201) sampled, 65% had been exposed to at least one of four 
zoonotic parasites (Table 6-2).  The participation rate was approximately 8%; however, a number 
of potential volunteers were turned away due to limited phlebotomy supplies.  The prevalence of 
diagnostically relevant titres was as follows: E. granulosus 47.8% (96/201), T. canis 13.4% 
(27/201), Trichinella 16.4% (33/201) and T. gondii 13.9% (28/201).  Of those who were sero-
positive, 24% had been exposed to 2 parasites, and 8% had been exposed to 3; no person had 
been exposed to all 4 zoonoses.  Co-exposure occurred most commonly between E. granulosus 
and Trichinella (19/201; 9.5%), with similar proportions between E. granulosus and the 
emaining parasites: T. canis (17/201; 8.5%) and T. gondii (14/201; 7%).   
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Table 6-2: Sero-surveillance for Echinococcus granulosus, Trichinella, Toxocara canis and 
Toxoplasma gondii in northern Indigenous regions (Canada) (9–13,15,16).  All studies were 
conducted by a single laboratory using the same tests except Tanner et al (10). 
Reference Location Sample 
Size (N) 
Toxoplasma 
gondii 
Echinococcus 
granulosus 
Toxocara 
canis 
Trichinella 
spp 
 Sero-prevalence (%) 
(11) James Bay, 
QC 
250 5 4 3 1 
(12) James Bay, 
QC 
267 9 0.7 4 0 
(13) Inuvialuit, 
NT 
362 4 0.6 0.6 0.6 
(14) Nunatsiavut, 
NU 
310 7 0.3 1 1 
(16) Nunavik, 
QC 
917 60 8 4 1 
(10) Northern 
QC 
1195 30 2 10 2 
(15) Mistissini, 
QC 
50 10 0 4 0 
This study 
 
Northern 
SK 
201 14 48 13 16 
 
The survey (Appendix C) identified several practices that could potentially expose people to 
zoonotic parasites (Table 6-3).  Nearly all participants ate locally acquired foods including meat, 
fish, mushrooms and berries.  Popular methods of wild game and fish preparation included 
drying, smoking or cooking; while raw foods were rarely consumed.  Of dog and cat owners, 
74% fed raw meat and 70% fed fish to their pets on a regular basis.  Participants aged 5-17 had 
higher odds of exposure to T. canis (OR 3.4 95% CI 1.2-10) than those over the age of 
seventeen; and feeding dogs non-commercial dog food increased the odds of exposure by 15 
times (95% CI 1.8-126).  Increased odds of exposure to T. gondii were observed in participants 
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older than fifty (OR 9.4 95% CI 1.1-77) and those who did not own pets (OR 3.8 95% CI 1.3-
11.3); however, gender and hunting/trapping are probable confounders for pet ownership.   
 
Table 6-3: Potential risk factors for exposure to four zoonotic parasites in a northwestern 
Saskatchewan community. 
Risk Factor Odds Ratios (95% Confidence Interval) 
 Sample 
Size (N) 
Toxoplasma 
gondii 
Echinococcus 
granulosus 
Toxocara 
canis 
Trichinella 
Gender (male) 201 2.2 (0.9-5.3) 1.2 (0.7-2.1) 1.9 (0.8-4.8) 1.5 (0.7-3.4) 
Does not 
hunt/trap 
188 1.5 (0.7-3.6) 1.9 (1.1-3.4) 1.2 (0.5-2.8) 0.5 (0.3-1.2) 
Wild game 
consumption 
196 0.5 (0-4.9) 0.3 (0-2.9) 0.5 (0-4.5) 0.2 (0-1.4) 
Does not own a 
pet 
199 3.8 (1.3-11.3) 1.2 (0.7-2.1) 1.3 (0.5-3.1) 1.8 (0.8-4.2) 
Non-commercial 
pet diet 
73 0.4 (0.4-3.8) 1.9 (0.7-5.0) 15 (1.8-126) 1.0 (0.2-4.0) 
Age 5-17* 174 0.2 (0-2) 1.8 (0.7-4.6) 3.4 (1.2-10) 2.0 (0.7-5.8) 
Age over 50** 68 9.4 (1.1-77) 0.3 (0.1-0.8) 0.4 (0.1-1.3) 0.4 (0.1-1.5) 
*compared with all other ages 
**compared with 5-17 age group 
 
Canine feces and serum 
Examination of canine feces identified five parasite genera of relevant zoonotic potential in this 
community, including Diphyllobothrium, Toxocara, Echinococcus/Taenia, Cryptosporidium and 
Giardia.  Ground collected fecal samples had more parasites (2010: 51% 31/61: 2011: 35%, 
24/69) than fecal samples of dogs brought to the clinic (2010: 48%, 13/31; 15%, 5/34).  Chi-
squared analysis indicates that the decrease in overall prevalence of endoparasitism from 2010 
(48%; 42/92) to 2011 (28%; 29/103) is statistically significant (p-value 0.005) (Table 6-4).  
During this time period overall decreases were noted in roundworms (Toxocara 9%, Toxascaris 
5%, Uncinaria 11%); while the prevalence of tapeworms increased (Taeniid 4%, 
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Diphyllobothrium 13%).  Examination of client-owned dogs in this region in 2011 demonstrated 
an exposure prevalence of 21% (10/47) to T. gondii.   
 
Table 6-4: Prevalence of canine intestinal parasites identified through quantitative sucrose 
flotation and immunofluorescent assay. 
 Prevalence (%) 
 
 
 Intensity  
Mean, Median, Minimum-Maximum (eggs 
per gram) 
Community ID KY-2010 KY-2011  KY-2010 KY-2011 
Toxocara 8/92 
 (9%) 
0/103 
(0%) 
 77, 70, 10-230 0 
Toxascaris 10/92 
(11%) 
6/103  
(6%) 
 2316, 31, 3-22500 1652, 64, 5-9660 
Uncinaria 10/92 
(11%) 
0/103 
(0%) 
 174, 34, 3-1005 0 
Taeniid 0/92 
(0%) 
4/103  
(4%) 
 0 124, 123, 3-248 
Diphyllobothrium 2/92  
(2%) 
16/103 
(15%) 
 586, 586, 8-1165 1795, 23, 3-15000 
Isospora 1/91  
(1%) 
0/103 
(0%) 
 *470, 470 0 
Giardia 11/89 
(12%) 
2/95  
(2%) 
 185, 100, 33-733 183, 183, 33-333 
Cryptosporidium 14/98  
(14%) 
4/95  
(4%) 
 83, 50, 33-200 417, 250, 133-1033 
*Overall  42/92 
(48%) 
29/103 
(28%) 
   
*Overall prevalence was calculated as the number of samples with at least one parasite type 
divided by the total sample number. 
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Discussion 
This study shows that the prevalence of exposure to zoonotic parasites for residents of 
northwestern Saskatchewan is higher than previously reported in other Canadian sero-prevalence 
studies.  As well, dogs residing in this area appear to encounter and be infected by potentially 
zoonotic parasites at higher levels than dogs residing in Saskatoon (a provincial urban centre) 
(20).  Exposure to T. canis, T. gondii and possibly E. granulosus was observed in both people 
and dogs, indicating that dogs may act as sources and sentinels for human infections.  Wild meat 
consumption, pet ownership and hunting/trapping are generally considered to increase the risk of 
exposure to zoonotic parasites; however, our analysis indicated that there might be a slight 
overall protective effect. This demonstrates the complexity of parasite transmission routes and 
the possibility of protective immunity and /or traditional knowledge regarding harvesting and 
preparation of wild foods.   
 
Echinococcus granulosus is a cyclophyllid cestode with a worldwide distribution, causing 
serious veterinary, medical and economic concerns for highly endemic regions (21).  Human 
infection with E. granulosus causes hydatid disease, or echinococcocis, which is generally 
characterized as the formation of larval cysts in the liver and lungs.  The average annual 
incidence rate of hydatid disease in Canada is 0.72 cases per million people, and is higher in 
women than men (RR 1.92, 95% CI 1.29-2.87) and north of the 55
th
 parallel (RR 4.88, 95% CI 
2.52-9.44) (17).  Hospital records in both Canada and the United States show Indigenous people 
to be at higher risk of infection (22,23).  In another recent study conducted in a Saskatchewan 
Indigenous community, 11%  of 103 people were sero-positive for E. granulosus, and at least 
two cases of hydatid disease were identified (8; S. Skinner, unpubl. data).  The sero-prevalence 
of 48% to E. granulosus in the current study is substantially higher than the 0-4% reported in 
other Indigenous communities of similar northern latitude, analysed using the same test and by 
the same laboratory, the National Reference Centre for Parasitology (9–13,15,16).  We are not 
aware of any clinical cases in this community at the current time; however, there is no formal 
surveillance for this parasite in Canada. There is a strong possibility that the unexpected level of 
exposure is due to cross-reactions with other helminths.  Diphyllobothriasis cases are relatively 
common in this region [J. Irvine, unpubl. data], and other possibilities include the liver fluke, 
Metorchis conjunctus, and various Taenia species.   We know that Diphyllobothrium is present 
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in dogs in this community (Table 6-4), and Metorchis has historically been reported in dogs, 
wolves and people in SK (5,24–26). 
 
Trichinella nematodes have long been associated with consumption of undercooked pork; 
however, livestock production practices have virtually removed this parasite from the domestic 
Canadian swine herd (27,28).  North American wildlife may be infected with one of five 
zoonotic genotypes of Trichinella, and consumption of these animals has been the primary cause 
of Canadian trichinellosis outbreaks since the 1970s (27–32).  In northern Saskatchewan, 
exposure is most commonly attributed to the consumption of wild bear meat (Ursus 
americanus); while in Inuit regions of Nunavut and Nunavik, exposure is associated with 
consumption of marine mammals such as walrus (Odobenus rosmarus;29,32–36).  The national 
annual incidence rate of trichinellosis is only 0.09 cases per million people; however, rates are 
significantly higher in Nunavut and Nunavik (42 cases per million people)(17).  In Canadian 
northern and Indigenous communities the sero-prevalence for Trichinella in people ranges 
between 0 - 5.5%, which is far lower than our reported exposure prevalence of 16.4%. 
Antibodies to this parasite can persist up to 19 years, making it difficult to detect recent changes 
in exposure frequency (37). 
 
Toxocara canis is an ascarid nematode that cycles primarily among canids, and commonly 
infects domestic dogs in Canada and around the world.  People may become exposed through 
accidental ingestion of eggs shed in dog feces, or by ingestion of tissue cysts in the undercooked 
meat of paratenic hosts.  Toxocariasis, characterized by visceral or ocular larval migrans, is not 
commonly reported in Canada, but may cause serious health effects.  In our study youth were 
more likely to be exposed than adults, consistent with observations that children are at highest 
risk for infection when they play in sand or soil contaminated by dog feces, or due to pica (38–
40).  We found that dog ownership was not a risk factor for exposure to T. canis, similar to one 
other study in Canada (41), thus supporting the importance of environmental (versus direct) 
transmission of this parasite.  Feeding non-commercial diets to family dogs significantly 
increased the odds of human exposure to T. canis.  This may be due to increased transmission to 
dogs via the paratenic host route, followed by human contact with eggs shed in dog feces.   
Alternatively, feeding non-commercial pet diets may correlate with other variables, such as 
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poverty and occupational exposures to soil, that put people at risk of exposure (42,43).  Sero-
prevalence for Toxocara was between 0.7-4% in recent studies in Inuit and Cree communities in 
northern Canada (10–13,15,16).  Our reported prevalence of 13.4% is therefore much higher than 
that observed in Canadian communities north of the 60
th
 parallel, consistent with observations of 
restricted survival of T. canis eggs at colder temperatures (40,44–46). It is on par with the 13.9% 
reported in the general population of the United States between 1988 and 1994, although this was 
dominated by samples from the southern USA where this parasite may have increased levels of 
transmission (42).  Reducing risk of exposure to this parasite could focus on regular deworming 
of dogs, timely disposal of feces (the eggs are not immediately infective), and preventing dogs 
from defecating in areas where children play.    
 
Toxoplasma gondii has a global distribution, and is one of the most important parasites in the 
Canadian North (1).  This protozoan has a complex lifecycle involving felids as definitive hosts 
and a wide variety of vertebrate species as intermediate hosts.  In our study population, routes for 
dog exposure include feeding raw meat to dogs, ingestion of garbage and wildlife.  As well, sero-
positive status in dogs is associated with age, diet, hospitalization, and health status; a sample of 
young, stray dogs had the lowest level of sero-positivity (47,48).  We observed a lower level of 
exposure to T. gondii in our population (21%) than dogs tested in Alberta, the Northwest 
Territories and Ontario (33- 63%) (4,48), which may be due to the relatively young population 
sampled.    
 
Dogs are not known to spread T. gondii to people, however, our finding suggest that people in 
the community may be at risk due to shared exposure routes. People become infected by 
ingesting or handling raw meat, ingesting contaminated drinking water, handling infective cat 
feces, or by congenital transmission, blood transfusion or organ transplant (49).  We report a 
sero-prevalence of 13.9%, which is comparable to the NHANES estimate of 10.8% in the United 
States (50), and generally higher than that reported elsewhere in Canada using the same test in 
the last 6 years (5-10%).  Inuit in Nunavik, Quebec have one of the highest sero-prevalences 
reported (30-60%), and are thought to have a unique constellation of risk factors including 
gender (female>male), drinking water sources, regular disinfection of water reservoirs, and 
limited education (9–13,15,16,51). Exposure to T. gondii in the Keewatin Yatthé region was 
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statistically higher with age (>50 years), and with those who did not own a pet; however, 
confounding variables might nullify the effect of pet ownership on sero-status. 
 
Saskatchewan currently has the highest incidence rate of Human Immunodeficiency Virus (HIV) 
in Canada, at double the national average.  Indigenous patients are disproportionally affected, 
and represented 79% of HIV/AIDS cases in 2009 (52,53).  HIV/AIDS is a serious risk factor for 
development of clinical toxoplasmosis.  Mortality attributed to toxoplasmosis in AIDS cases in 
Europe and the United States is estimated to be 30% and 10%, respectively (49,54).  The higher 
proportion of immune-compromised individuals in northern Saskatchewan combined with 
limited veterinary services, frequent contact with wildlife, and lifting of previously restrictive 
climate conditions, may lead to emergence of previously uncommon zoonotic pathogens (eg. T. 
gondii and Cryptosporidium) as public health concerns. 
 
The prevalence of endoparasitism in client-owned dogs from this community was similar to 
levels previously found in remote areas of Saskatchewan (5,55).  Ground-collected fecal samples 
did not represent the true parasite prevalence in this community as multiple samples may have 
originated from the same animal.  However, this method is an effective tool for estimating the 
overall level of environmental contamination as well as for identifying local parasites of zoonotic 
concern; in this case T. canis, taeniid tapeworms, Diphyllobothrium, Giardia, and 
Cryptosporidium.  The voluntary nature of human and canine recruitment was another limitation 
of this study; however, we considered this strategy as crucial in building trust with the 
community.  The purpose of blood testing was not revealed during recruitment, and only 17% of 
participants were aware that pathogens could move between animals and people. Thus, people 
with concerns of parasite exposure were not more likely to participate. Sampling of client-owned 
animals was biased towards pets with owners who considered veterinary services important.  
However, we considered this effect minimal, because all dog owners permitted blood and/or 
fecal collection and all veterinary services were cost-free.  Shedding of roundworm eggs (T. 
canis, Toxascaris and Uncinaria) decreased in 2011, following administration of pyrantel 
pamoate to dogs brought to the mobile veterinary service unit in 2010.  This could reflect drug 
effectiveness, decreased transplacental and transmammary transmission of T. canis due to 
spaying female dogs, and/or the effect of having fewer puppies, which are the primary source of 
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environmental contamination.  Alternately, the observed concomitant decreases in protozoa, 
which are not affected by pyrantel pamoate, suggest that changes in parasite prevalence may 
result from factors such as annual climate variations and altered animal husbandry practices.  
Whatever the cause, the overall decrease of parasitism in dogs bought to the clinic and in 
environmental contamination is a benefit to public health; however, the increased prevalence of 
cestode eggs demonstrates the additional need for cestocidal treatment to reduce risks to human 
health.  Finally, this study reinforces that surveillance and management of zoonoses in remote 
areas requires a One Health approach incorporating both veterinary and public health 
interventions, tailored to concerns at the local level. 
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CHAPTER 7 - People, pets, and parasites: One Health surveillance in southeastern 
Saskatchewan 
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Transition Statement 
Chapter 6 found that one Dene group had a far higher risk of exposure to Echinococcus 
canadensis than the general Canadian population.  Food preparation methods, cultural practices, 
dietary preferences, and access to game differ between Indigenous groups, and between 
geographic locations.  The purpose of the following chapter was to compare endoparasite 
exposure levels in a vastly different human population - one that is rural, southern, and 
Saulteaux. 
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Abstract 
Residents of remote and Indigenous communities might experience higher exposure to some 
zoonotic parasites than the general North American population.  Human sero-surveillance 
conducted in 2 Saulteaux communities found 113 volunteers exposed as follows: Trichinella 
(2.7%), Toxocara canis (4.4%), Echinococcus (4.4%), and Toxoplasma gondii (1.8%).  In dogs, 
41% of 51 fecal samples were positive for at least one intestinal parasite, 3% of 77 were sero-
positive for Borrelia burgdorferi, and 21% of 78 for T. gondii.  Echinococcus exposure was 
more likely to occur in non-dog owners (odds ratio [OR]:11.4, 95% confidence interval [CI]:1.2-
107, P=0.03); while T. canis was more likely to occur in children (ages 4-17) (OR:49, 95% 
CI:3.9-624; P=0.003), and those with a history of dog bites (OR:13.5, 95% CI:1.02-179; 
P=0.048).  Our results emphasize the utility of dogs as sentinels for emerging pathogens such as 
Lyme disease, and the need for targeted surveillance and intervention programs tailored for 
parasite species, cultural groups and communities.   
 
Introduction 
Zoonotic parasites are ubiquitous, and challenge public health systems in both urban and rural 
environments, even within developed countries in North America.  Waterborne outbreaks of 
Cryptosporidium, Giardia and Toxoplasma gondii have all occurred in Canadian cities in recent 
years, accompanied by extensive public health messaging to help protect urban residents (1,2).  
As compared to urban residents, rural, remote, and northern residents may encounter parasites 
more frequently, and by mechanisms that are covert, due to alternative water sources, reliance on 
wild game/fish, and closer relationships with wildlife, livestock, and the land.  Consumption of 
undercooked or raw meat by people has been linked to food-borne outbreaks, including 
trichinellosis in northern Saskatchewan and toxoplasmosis in northern Quebec (3,4).  Companion 
animals, dogs in particular, can facilitate zoonotic transmission of parasites by acting as a source 
of infection for people, and as a bridge between wildlife and people.  Echinococcus and 
Toxocara spp. are two such examples, and are acquired by people through accidental ingestion of 
eggs shed in dog feces.  On the other hand, surveillance of dogs can play a critical role in 
preventing human illness, serving as sentinels for infection when they are exposed at higher 
levels and earlier than people during vector range expansion or disease emergence in a region.   
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Indigenous peoples of Canada are reported to be at higher risk of exposure to some zoonotic 
parasites than non-Indigenous peoples, with potentially life-threatening consequences (5–7).  
Seropositivity is an indicator of exposure to a pathogen, and requires diagnostic follow-up testing 
to determine if an individual is actively infected.  Some zoonoses, such as echinococcosis and 
toxocariasis, are likely under-detected and under-reported due to non-specific or asymptomatic 
case presentation, imperfect detection methods, and the prolonged period between infection and 
illness. Because most Canadian sero-prevalence studies are conducted in northern and/or remote 
Indigenous communities, sparse information is available for the general Canadian population or 
for southern Indigenous groups, even though the risk factors for parasite exposure may be 
similar. Saulteaux Ojibway reside in communities scattered across British Columbia, Alberta, 
Saskatchewan, Manitoba and Ontario.  This project was conducted in collaboration with two 
Saulteaux Treaty 4 communities in southeastern Saskatchewan, where country foods are 
frequently consumed, even though the residents live within a one hour driving distance of an 
urban centre (~100 km).  The goal of this paper is to explore levels of human and canine 
exposure to parasites in a southern, rural and Indigenous area of Saskatchewan.  We chose to 
measure human exposure to Trichinella, Toxoplasma gondii, Echinococcus, and Toxocara canis, 
as these pathogens have been studied in several other Canadian Indigenous communities, and 
offer a good basis for comparison.    
 
Materials and Methods 
Human participants 
This study was conducted in collaboration with members of two neighboring Saulteaux 
communities located geographically in the Sunrise Health Region of southeastern Saskatchewan.  
These rural communities house approximately 423 and 757 residents, and are surrounded by 
agricultural lands used primarily for cash-crop farming (8).  Planning and implementation of this 
project occurred in collaboration with key community members at a community camp-out and 
while working together on a digital storytelling project.  We recruited participants >4 years of 
age by word of mouth and by posters displayed in community gathering spaces.  Sample 
collection occurred during two community events: 1) a low cost pet health clinic organized by 
the research team, and 2) the annual Treaty Days celebration.   
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 Human serology and risk factor assessment 
Each adult participant first completed a survey pertaining to risk factors for parasite exposure, 
including dietary habits, pet ownership, use of veterinary services, history of dog bites, and 
hunting practices.  Parents were asked to complete surveys on behalf of their children.  
Approximately 3-5 mL of blood was then collected from each participant into serum separator 
tubes (BD, Franklin Lakes, NJ) and refrigerated overnight.  Samples were centrifuged at 3500 
rpm for 10 minutes, and sera were pipetted into snap-top micro-centrifuge tubes.  Sera were 
frozen at -20°C until transported to the National Reference Centre for Parasitology (McGill 
University, Montreal, QC) and analyzed by in-house and IVD Research (Carlsbad, CA) 
developed enzyme-linked immunosorbent assays (ELISA) for immunoglobulin G antibodies 
against Echinococcus, Toxocara canis, Trichinella, and Toxoplasma gondii.  ELISA results were 
interpreted according to criteria in Table 7-1, with equivocal results treated as negative.    
 
Table 7-1: Criteria for serological evaluation of four zoonotic parasites and results of sero-
surveillance in two Saulteaux communities in southeastern Saskatchewan (N=113). 
Parasite Measurement Criteria  and results 
  Negative Equivocal Positive 
Toxocara canis Optical 
Density 
<0.25 0.25-0.35 >0.35 
Number Samples  106 2 5 
Trichinella Optical 
Density 
<0.25 0.25-0.35 >0.35 
Number Samples  106 4 3 
Echinococcus 
granulosus 
Optical 
Density 
<0.35 0.35-0.45 >0.45 
Number Samples  107 1 5 
Toxoplasma gondii Units IgG 
(IU/mL) 
<1 NA ≥1 
Number Samples  111 NA 2 
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Dog serology 
Blood samples were collected from dogs at their homes in November 2011 (n=32), and again in 
November 2012 (n=46) from dogs brought to a remote service veterinary clinic. If the dog 
became unduly stressed or fractious, we discontinued sampling.  A standard veterinary history 
intake form was filled out for each animal brought to the remote clinic, including age, gender, 
vaccination and deworming history, and observations of ectoparasites.  Approximately 3 mL of 
blood was collected from each dog into serum separator tubes, and samples were kept on ice 
during transport to the University of Saskatchewan.  Tubes were spun at 3500 rpm for 10 
minutes and sera were frozen at -20˚C.  Exposure to T. gondii was determined using an indirect 
fluorescent antibody test (IFAT; VMRD, Pullman, WA) at a serum dilution of 1:50.  We 
evaluated exposure to four vector-borne pathogens (Dirofilaria immitis, Borrelia burgdorferi, 
Anaplasma phagocytophilum, and Ehrlichia canis) using SNAP 4Dx Plus tests (IDEXX 
Laboratories, Inc.; Westbrook, Maine) according to manufacturer instructions. Both tests were 
validated for use in dogs. 
 
 Canine fecal surveillance   
Canine fecal samples were collected in November 2011 (N=25), and again in June 2013 (N=26) 
from dog owners’ yards and roadways.  Only one fecal sample was collected per property to 
avoid collecting multiple samples from the same dog.  Fecal samples were individually bagged, 
stored on ice, and brought to the University of Saskatchewan Zoonotic Parasite Research Unit 
for processing.  Following a 3-day freezing period at -80˚C (to inactivate zoonotic Echinococcus 
eggs), samples were analysed for parasite eggs using a modified double centrifugation and 
quantitative sucrose Stoll flotation
 
(9).   Briefly, 4 grams wet weight (ww) of each sample was 
homogenized in 40 mL dH2O and strained through a single layer of 40-60 weight cheesecloth, 
using a tongue depressor to squeeze out excess water.  A 5 mL sterile syringe (BD; Franklin 
Lakes, NJ) was used to transfer a 10% aliquot of fecal slurry into a 15 mL test tube, which was 
then filled to the top with dH2O.  Test tubes were centrifuged (1500 rpm, 10 min) and the 
supernatant poured off.  The pellet was re-suspended in Sheather’s sucrose flotation solution (spp 
gravity 1.26) by vortexing (maximum speed), filled to the top with Sheather’s, and a cover slip 
(22 x 22 mm) was applied.  After a second period of centrifugation (1500 rpm, 10 min), the 
cover slip was placed on a labelled glass slide and viewed under a microscope at 10-40x 
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magnification.  Helminth ova and cysts were counted for the entire slide, and used to calculate 
the total eggs or cysts per gram of feces.  An additional sucrose gradient flotation and 
immunofluorescent assay was used to isolate Giardia cysts and Cryptosporidium oocysts (10).  
Briefly, 2-4 grams feces (ww) were homogenized in 8 mL sterile saline, strained through a 
double layer of cheesecloth, and transferred onto 5 mL methylene blue sucrose solution (spp 
gravity 1.13) in a sterile 15 mL Falcon tube (Thermo Fisher Scientific Inc. Waltham, MA).  After 
centrifugation (1300 rpm, 5 min), the top layer of the sucrose gradient was pipetted into a second 
15 mL Falcon tube, and centrifuged again (1300 rpm, 5 min).  The supernatant was poured off, 
the fecal pellet was re-suspended in 1 mL saline solution by vortexing, and 15 μL was pipette 
into the well of a fluorescent microscope slide (Thermo Scientific; Portsmouth, NH).  The slide 
was dried at room temperature (30 min), and 20 μL each of Giard-o-Glo and Crypt-o-Glo 
(Waterborne Inc.; New Orleans, LA) were added.  Following an incubation period (37˚C, 45 
min), a cover slip was added, and the slide was viewed under a fluorescent microscope (40-100x 
magnification).  Cysts and oocysts were counted for the whole slide, and then used to calculate 
cysts or oocysts per gram feces. 
 
Ethics 
The human component of this project was reviewed and approved by the University of 
Saskatchewan’s Biomedical Research Ethics Board (REB 11-07).  Each adult participant 
provided written informed consent, and those under the age of 18 provided written consent from 
a parent or guardian prior to participation.  All results were kept confidential, and we informed 
each individual of their results by mail. We organized a follow-up meeting with community 
members to at the completion of the project to share the results, and to answer outstanding 
questions.  Any person testing positive for exposure to Echinococcus and all children who tested 
positive for T. canis were encouraged to seek free follow-up testing with a human health 
provider.  The canine component of this study was reviewed and approved by the University of 
Saskatchewan Animal Research Ethics Board (2009-0126 and 2010-0159), which adheres to 
Canadian Council on Animal Care (CCAC) standards.  Consent to collect blood from individual 
dogs was provided by their owners, while canine feces around the community were collected 
with permission from community leaders.      
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Statistical methods 
Bivariate analysis was used to identify correlations between survey responses and sero-status for 
individual parasites as well as overall parasite sero-status, with exposed and not exposed 
individuals coded as 1 and 0, respectively.  Using a cut-off value of p<0.2 to determine statistical 
significance, correlated variables were included by forward stepwise addition to build binary 
regression models, using the Likelihood Ratio Test to select the final model (SPSS version 20; 
IMB Corporation, Armonk, NY).   The strength of association between independent variables 
and sero-status was assessed using an odds ratio (OR) with a 95% confidence interval (CI).  All 
variables were treated as categorical.  Confounding was assumed if the inclusion of one risk 
factor changed the effect estimate of another by more than 10%. A Pearson X
2
 test was used to 
determine if canine sero-prevalence to Toxoplasma gondii was significantly different between 
the sampling years, using a 2-sided cut-off value of p<0.05.  The Wilson score interval corrected 
for population size was used to determine the statistical significance of differences in survey 
responses [(OpenEpi version 3.01; Atlanta, GA)].   
 
Results 
Human serology and risk factor assessment 
The participation rate in these communities was approximately 11%: 113 volunteers (female N = 
75; male N = 38) of 1000 residents > 4 years of age (Table 7-2)
 
(8). Titres above the cut-off 
value were observed in 12% (13 of 113) of participants for at least one parasite of interest 
(Tables 7-1 and 7-3). Sero-prevalence for individual pathogens was observed as follows: 
Echinococcus 4.4% (5 of 113); T. canis 4.4% (5 of 113); Trichinella 2.7% (3 of 113); and T. 
gondii 1.8% (2 of 113). Co-exposure to Echinococcus and Trichinella was observed in 2% (2 of 
113) of the study population. 
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Table 7-2: Subset of study population and risk factor variables examined in two Saulteaux 
communities. 
Variable (N*) n % 95% Confidence 
Interval 
Female gender (112) 75 66 58-75 
Age (112) 
4-10 
11-17 
18-35 
36-50 
51-65 
>65 
 
15 
17 
23 
28 
21 
8 
 
13 
15 
21 
25 
19 
7 
 
8-21 
10-23 
14-29 
18-34 
13-27 
4-13 
Pet Ownership (113) 
Dog (yes) 
Cat (yes) 
 
81 
34 
 
72 
30 
 
63-79 
22-39 
Veterinary care (87) 
Pet ever de-wormed 
Pet ever vaccinated 
Does owner use veterinary services 
 
44 
46 
34 
 
51 
53 
40 
 
40-61 
42-63 
30-50 
Allow dog to roam (65) 45 69 57-79 
Believes dogs cause problems in community 
(85) 
59 69 59-78 
Feed raw meat to dog (82) 15 18 11-28 
Desexing (86) 
Pet is already desexed  
Owner is against/unsure about desexing pets  
 
23 
28 
 
27 
33 
 
19-37 
24-43 
Dog bite frequency (89) 
Never 
Once 
2-3 times 
>3 times 
 
56 
18 
11 
4 
 
63 
20 
12 
4 
 
53-72 
13-30 
7-21 
2-11 
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Hunt/trap (107) 19 18 12-26 
Eat wild meat (109) 
Cooked 
Dried 
Smoked 
Raw 
82 
73 
11 
8 
0 
76 
67 
10 
7 
0 
66-82 
58-75 
6-17 
4-14 
0-3.4 
Eat wild fish (107) 
Cooked 
Dried 
Smoked 
Raw 
30 
28 
4 
1 
1 
28 
26 
4 
1 
1 
20-37 
19-35 
1-9 
0.2-5 
0.2-5 
*N= number of participants who answered the question 
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Table 7-3: Sero-surveillance for four zoonotic parasites in Indigenous communities in Canada 
using the same enzyme-linked immunosorbent assays (ELISA) at the National Reference Centre 
for Parasitology. 
Reference Location Sample 
Size 
(N) 
Toxoplasma 
gondii 
Echinococcus 
granulosus 
Toxocara 
canis 
Trichinella  
 Sero-prevalence (%) 
Cree       
(11) Mistissini, 
QC 
50 10 0 4 0 
(12) Eastern SK 110 NA 11 NA NA 
(13) James Bay, 
QC 
250 5 4 3 1 
(14) James Bay, 
QC 
267 9 0.7 4 0 
Inuit       
(15) Inuvialuit, 
NT 
362 4 0.6 0.6 0.6 
(16) Nunatsiavut, 
NU 
310 7 0.3 1 1 
(17) Nunavik, QC 917 NA 8 4 NA 
Dene       
 (18) Northwestern 
SK 
201 14 48 13 16 
Saulteaux        
This study Southeastern 
SK 
113 2 4 4 3 
 
      
       
Bivariate analysis identified age (P=0.13), owning a cat (P=0.14), owning a dog (P=0.007) and 
feeding pets raw meat (P=0.007) as potential risk factors for Echinococcus exposure.  Potential 
risk factors for the remaining parasites were as follows: T. canis - age (P=0.058) and history of 
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dog bites (P=0.007); Trichinella – age (P=0.14) and dog ownership (P=0.14); T. gondii – age 
(P=0.13) and history of not deworming pets (P=0.17).  Only one variable was correlated to 
overall positive sero-status – feeding dogs raw meat (P= 0.11).  Binary logistic analysis 
demonstrated that three variables were significantly associated with positive sero-status: (1) non-
dog owners were more likely to be exposed to Echinococcus than dog owners (OR=11.4, 95% CI 
1.2-107, P=0.03); (2) children (4-17 years) were more likely to be exposed to T. canis than adults 
(OR: 49, 95% CI: 3.9-624; P=0.003); and (3) individuals with prior dog bite experience (at least 
one time) were more likely to be exposed to T. canis than those who had never been bitten 
(OR:13.5, 95% CI: 1.02-179; P=0.048).  No children under the age of 11 (N=15) showed 
evidence of exposure to T. canis. 
 
Survey results including potential routes for parasite transmission and food preparation habits are 
described in Table 7-2.  Community members owned more dogs than cats (P<0.001), consumed 
more wild caught meat than wild caught fish (P<0.001), and prepared meat by cooking rather 
than by drying, smoking, or consuming raw (P<0.001).  Many believed that dogs caused 
problems in the community, with overpopulation, aggression, scavenging garbage bins, running 
loose, and disease transmission given as the main reasons.  Approximately 60% of pet owners 
did not use veterinary care regularly (many dogs had received puppy vaccination/de-worming by 
the breeder/seller only), and reasons included cost, distance to a clinic (the nearest clinic is 20 
km away), and lack of perceived need.  Feeding raw meat to dogs, allowing them to roam freely 
in the community, and lack of de-worming were common practices. 
 
Forty-nine pet owners, three of whom resided outside the communities, brought their animals to 
the remote clinic in November 2012.  Additional dogs were treated at their homes by a mobile 
team, and several strays were brought in for treatment by community members.  The mean age of 
owned dogs (n=64) brought to the remote clinic was 2.3 years, with 34 males, 26 females, and 4 
for whom sex was not determined (1.3:1 male to female ratio).  Of owned dogs, 33% were 
known to have visited a veterinarian in their lifetime, 50% had received only their first set of 
vaccines, and 6% were known to have been surgically sterilized.  Thirty-four percent of dogs had 
been dewormed (in several cases by our team going door to door in Nov 2011), and 28% owners 
117 
 
reported observing ectoparasites on their dogs (14% ticks).  There were also 19 cats brought to 
the clinic (ratio of 3 dogs:1 cat). 
 
Canine serology and fecal analysis 
Overall, 21% (16 of 78) of dogs were sero-positive to T. gondii; sero-positivity was significantly 
higher (p=0.042) in November 2012 than in November 2011 (28%, 13 of 46 and 9%, 3 of 32, 
respectively).   For B. burgdorferi, 3% (2 of 77) of dogs were sero-positive overall, with 4% (2 
of 46) of dogs sero-positive in 2012, and no sero-positives in 2011.  Cryptosporidium, Giardia, 
Alaria, T. canis, Toxascaris leonina, Uncinaria stenocephala, and Sarcocystis species were 
detected in canine fecal samples (Table 7-4).  The proportion of samples positive for at least one 
parasite was 62% (16 of 26) in June 2013 and 20% (5 of 25) in November 2011.  Parasite 
richness (number of species) and median egg counts were higher in June 2013 than November 
2011.   
 
Table 7-4: Prevalence of eggs and cysts of endoparasites in canine fecal samples collected from 
the ground in November 2011 (N=25) and June 2012 (N=26). 
 Prevalence 
(%) 
 
 Intensity  
Mean, Median, Minimum-Maximum (eggs per 
gram) 
Collection year 2011 2013  2011 2013 
Toxocara canis 8 15  6, 6, 5-8 22, 22, 3-43 
Toxascaris leonina 4 27  4670, NA, NA 36, 18, 8-65 
Uncinaria 
stenocephala 
0 8  0 28, 28, 5-50 
Alaria 0 8  0 4, 4, 3-5 
Sarcocystis 0 8  0 845, 845, 130-1560 
Giardia 4 12  233, NA,NA 229, 250, 63-375 
Cryptosporidium 4 8  133, NA, NA 906, 906, 875-938 
*Overall  20 62    
*Overall prevalence was calculated as the number of samples with at least one parasite type 
divided by the total sample number. 
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Discussion 
This joint animal and human (One Health) study offers valuable information on dietary 
preferences, risks and routes of parasite exposure, issues relating to dog ownership, and use of 
veterinary services in two Saulteaux Ojibway communities in western Canada (Tables 7-2 and 7-
3).  The overall sero-prevalence of four parasitic zoonoses was low (12%) in relation to previous 
studies conducted with Dene and Inuit communities in northern Canada. Sero-prevalence for T. 
canis, T. gondii, Echinococcus, and Trichinella were similar to levels observed in Cree 
communities in northcentral Canada, likely reflecting similar preferences for cooked meat 
(13,14).  However, the exposure to Echinococcus in the Saulteaux population in the current study 
(4% of 113) was lower than in a nearby Cree community (11% of 110) where a clinical case was 
detected; although it should be noted that the latter study considered equivocal serological results 
as positive (12).  As compared to the general North America population, sero-prevalence of T. 
canis and T. gondii in our study population was low. However, detection of exposure to 
Echinococcus and Trichinella would be considered unusual in the general North American 
population, suggesting that there is some level of exposure to these potentially serious pathogens 
in the study communities.  Antibodies to Trichinella are thought to persist for 9-18 months, 
while those for E. canadensis and T. canis could be life-long (17). 
 
We observed a variety of potentially zoonotic parasites in dog feces collected from the 
environment in the community, including T. canis, Cryptosporidium, and Giardia.  Although the 
number of fecal samples obtained in 2011 and 2013 was low, the combined prevalence (21 of 51; 
41%) is comparable to endoparasite levels in canine fecal samples collected from the ground in 
other Indigenous communities in Saskatchewan (19).  The difference in prevalence between 
sampling years is likely due to seasonal and annual variation in climate and diet, with dogs 
shedding higher numbers of parasites in spring/summer than in fall/winter.  Overall, the level of 
parasitism observed in canine samples from the study community was 10 times higher than 
levels observed in owned dogs in urban Saskatchewan (20), which likely reflects the relatively 
young age of the dogs in the population (~2 years was the mean age of dogs brought to the 
remote clinic), as well as the fact that most dogs in the study communities live outdoors, either 
exclusively or intermittently, and many are permitted to roam freely.  Access to raw meat, lack 
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of deworming, and scavenging of wildlife and discarded offal, are likely routes of parasite 
infection. 
 
  We detected evidence of exposure to B. burgdorferi, the causative agent of Lyme disease, in the 
dog population of these communities.  The sensitivity (99%, 95% CL: 94.3-99.9%) and 
specificity (99.9%, 95% CL: 97.4-99.9%) of this test are both high, suggesting a high level of 
confidence in our results (21).  This tick-borne pathogen can cause serious illness in infected 
people, and public health officials should be aware of its presence in southeastern Saskatchewan.  
Approximately 14% of dog owners in the study communities reported finding ticks on their dogs 
in the past year.  Although these were most likely adult ticks of Dermacentor variabilis, D. 
andersoni, or Ixodes kingi, this suggests that these dogs are at high risk of exposure to ticks, 
including adults and nymphs of Ixodes scapularis, the host for B. burgdorferi. Therefore, this 
may reflect a westward expansion of the tick Ixodes scapularis from the currently limited 
endemic region in southern Manitoba in western Canada, or adventitious ticks that have traveled 
from more southern areas with migratory birds.  These serological findings precede diagnosis of 
human cases in this region of SK, further supporting the idea that dogs are highly suitable as 
sentinels for this emerging disease, given their higher level of exposure to ticks than people. 
 
We report a relatively low human sero-prevalence for T. canis (4%) on par with several other 
northern studies (Table 7-3), but lower than the national American average (14%) reported by 
the Third National Health and Nutrition Examination Survey
 
(22).  This low human sero-
prevalence may reflect the fact that many dogs defecated in surrounding bush areas, and thus 
were less likely to contaminate human environments through parasite eggs in their feces.  As 
well, extremely cold winter conditions may also decrease the human risk of exposure to some 
infective parasite eggs from dog feces.  For example, eggs of T. canis have reduced survival 
when frozen at temperatures of -20 to -30°C, which are normal winter temperatures in this region 
(23).  This supports an observed latitudinal gradient in prevalence of T. canis in dogs and wild 
canids, with prevalence decreasing as one moves north and the parasite being relatively unknown 
at latitudes greater than 60°N in Canada
 
(7).  Our regression analysis did not identify dog 
ownership or feeding raw meat to dogs as significant risk factors for T. canis exposure.  This 
finding is similar to two other Canadian studies (14,24), and suggests that contact with infective 
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eggs in the environment may be the primary exposure route for people, especially in 
communities where stray dogs are abundant.  This study is consistent with previous findings that 
youth (ages 11-17) are more likely to be exposed to T. canis than adults or younger children, 
highlighting the importance of de-worming, and keeping dogs out of areas frequented by youth, 
such as schoolyards and sandboxes (18,25).  Because this age group is more likely to develop 
ocular, rather than visceral, larval migrans, follow-up should include retinal examination
 
(26).  
Our finding of dog bite history as a risk factor for T. canis exposure has not previously been 
reported. Toxocara canis is not transmitted through dog bites, suggesting that our finding is more 
reflective of frequent exposure to environments contaminated by dog feces.   
 
The sero-prevalence of Echinococcus in these communities was similar to that observed in 
northern Quebec, but lower than levels reported in eastcentral and northwestern Saskatchewan 
(12,18).  Although we did not find E. canadensis in dog feces, infected definitive and 
intermediate host species are present in the area (27).  Our analysis identified dog ownership to 
be protective against exposure to this parasite; however, the wide confidence interval suggests 
that this finding be interpreted with caution.  One possibility is that dog owners have higher 
awareness of the risks associated with contamination of the environment with dog feces, or 
higher awareness of the need for hand hygiene.  Results from this study did not identify gender, 
age or hunting/trapping as important risk factors for E. canadensis exposure as reported 
previously (6,17,18), which could be due to the low sample size.  However, our findings are 
similar to a related project conducted in a nearby SK community (12).   
 
We observed evidence of human exposure to T. gondii at a level lower than the American 
average of approximately 11% in 1999-2004 (28).  This may reflect dietary preferences for 
cooked meat as well as a relatively small felid population (the definitive host for T. gondii), but 
the estimate might be limited by sample size.  The community exposure prevalence for T. gondii 
was higher in dogs than in people, which supports the premise that dogs are more highly exposed 
and therefore serve as sensitive sentinels for public health.  The survey data for these Saulteaux 
communities identifies risk factors for T. gondii exposure as well as protective mechanisms.  
Commonly accepted risk factors for exposure include female gender, drinking contaminated 
water, contact with infected cat feces, having three or more kittens, and ingestion of raw meat, 
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milk or shellfish (29,30).  In northern Canada, risk factors include female gender, increasing age 
and frequency of fishing, berry picking, bird handling, cleaning domestic water reservoirs, and 
consumption of marine mammals, fish, and birds (31). In our communities, we observed many 
cats living outdoors, where hunting and eating intermediate hosts (ie. rodents, birds) is a likely 
source of infection.  Approximately one-fifth of human participants were involved with 
hunting/trapping and skinning/butchering activities, with approximately equal representation 
between males and females.  No participants ate raw meat, and although smoked or dried meat 
could potentially contain infective tissue cysts, food-borne transmission does not appear to be a 
major risk factor for exposure in these communities.   
 
Trichinellosis has been rare in southern Canada since the domestic swine herd was declared to be 
Trichinella-free.  However, feral swine have recently become endemic to southern 
Saskatchewan, and could possibly act as a source of human infection, although the infection 
status of these animals is not yet clear (32).  In northern areas, the relative risk of human 
infection is high, and outbreaks have been linked to the consumption of raw bear or walrus meat 
(4,33).  Risk factors for hospitalization due to trichinellosis are male gender and age (≥21 years) 
(6).  The sero-prevalence for Trichinella in the current study (3%) was low, similar to that 
reported in Inuit and Cree communities (0-1%) elsewhere in Canada, but lower than that reported 
in a Dene community in northwestern Saskatchewan (16%) (11,13,18,25).  In other Dene 
communities in northern Saskatchewan, outbreaks of trichinellosis associated with consumption 
of black bear have been reported
 
(4).  Saultaux cultural practices, which include cooking game 
and avoiding consumption of bear meat, are likely the primary reason for low Trichinella levels 
in this community. 
 
Our survey of the general population participating in the human sero-surveillance study 
demonstrated that few people used veterinary services regularly, and that common practices such 
as de-worming, vaccination and surgical alteration to control reproduction, are not widely 
accepted.  Although there were cultural barriers to utilizing vet services, cost and distance were 
also frequently stated as barriers to using veterinary services, and about 5% of the total 
population of the two communities brought pets to the remote, low-cost clinic that was based in 
the community.   Interestingly, clinical history data taken from pet owners at a remote veterinary 
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clinic in November 2012 indicated even lower rates of deworming (34%), vaccination (31%), 
and surgical desexing (6%) in the 64 owned dogs brought to the clinic, although the ratio of dogs 
to cats brought to the clinic (3:1) was similar to that reported in the survey (2.4:1).  In addition, 
the gender ratio of dogs brought to the clinic (1.3 male: 1 female) confirms anecdotal discussions 
with community members that male dogs are preferred to female dogs, because of the nuisance 
of female dogs in heat and the burden of raising puppies. Despite this, follow-up discussions 
with the community indicated that they did not wish to pursue surgical methods of dog 
population control at this time. 
 
In contrast with more northern Indigenous populations (34), the overall risk of human exposure 
to zoonotic parasites appears to be low in these study communities located in southeastern SK.  
Although it is difficult to make direct comparisons, we interpreted our results in the context of 
similar studies using identical laboratory methods in other Canadian Indigenous communities.  
Community-level differences in parasite exposure and risk factors reflect the presence of 
important regional, cultural, and dietary differences, and highlights the importance of targeted 
surveillance and intervention programs tailored specifically for different cultural groups and 
communities.  Finally, we suggest that a One Health approach must go beyond sero-surveillance 
studies to ensure that surveillance is linked to actions, such as providing reduced cost, culturally 
acceptable veterinary services to underserved regions, ensuring that study participants have 
access to follow up diagnostic testing and treatments, and that researchers need to work with 
community liaisons (or “brokers”) to ensure translation of the results to community members and 
leaders. 
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Transition Statement 
Elements of this thesis, such as the canine parasite surveillance component, were originally 
conceived when a First Nations child in a northern SK community was diagnosed with cystic 
hydatid disease, caused by Echinococcus canadensis.  Echinococcus species are endemic to 
many countries, and some have implemented Echinococcus control programs, with varying 
degrees of success.  This chapter examines incidence rates of human echinococcosis across 
health regions, and uses a public payer perspective to model the cost utility of introducing an 
Echinococcus control program in the highest risk health region (Kelsey Trail, SK) in Canada.    
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Abstract 
Echinococcosis is a rare but endemic condition in people in Canada, caused by a zoonotic 
cestode for which the source of human infection is ingestion of eggs shed by canids.  The 
objectives of this study were to identify risk factors associated with infection, and to measure the 
cost-utility of introducing an echinococcosis prevention program in a rural area.  We analyzed 
human case reports submitted to the Canadian Institutes for Health Information between 2002 
and 2011.  Over this 10 year period, there were 48 cases associated with E. granulosus/E. 
canadensis, 16 with E. multilocularis, and 251 cases of echinococcosis for which species was not 
identified (total 315 cases).  Nationally, annual incidence of echinococcosis was 0.14 cases per 
100 000 people, which is likely an underestimate due to under-diagnosis and under-reporting.  
Risk factors for echinococcosis included female gender, age (>65 years), and residing in one of 
the northern territories (Nunavut, Yukon, or Northwest Territories). The average cost of treating 
a case of cystic echinococcosis in Canada was 10,668$ CAD.  Cost-utility analysis revealed that 
dosing dogs with praziquantel (a cestocide) at six week intervals to control cystic echinococcosis 
is not currently cost-effective, even in a health region with the highest incidence rate in Canada.  
Threshold analysis revealed that a relatively small increase (incidence= 8 per 100,000) of cystic 
echinococcosis or alveolar echinococcosis could result in a PZQ dosing program having a 
favourable cost-utility ratio.   Our findings and a discussion of current gaps in echinococcosis 
surveillance and management may be of interest to veterinary and public health authorities in 
Canada and other nations in which echinococcosis remains a neglected disease.   
 
Introduction 
Echinococcosis in people, also known as hydatid disease, is a potentially fatal condition caused 
by zoonotic cestodes of the genus Echinococcus, and is widely distributed worldwide (1).  In 
Canada, human cases are considered rare, resulting in approximately 0.72 hospitalizations per 
million people per year (2).  Two species of this parasite are endemic to Canada: E. 
multilocularis, which causes alveolar echinococcosis (AE); and E. canadensis (formerly known 
as the G8 and G10 genotypes of E. granulosus), which causes cystic echinococcosis (CE) (1, 
3,4).  Autochthonous cases are thought be caused almost exclusively by E. canadensis, and occur 
more commonly in northern latitudes (>55˚), in women, and in groups of Indigenous descent 
(2,3,5,6).  Foreign-acquired cases of echinococccosis could be caused by other species not 
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present in Canada (eg. E. granulosus sensu strictu).  Echinococcosis is under-diagnosed in the 
human population due to prolonged disease progression, asymptomatic  or nonspecific 
symptoms, and the difficulty of definitive diagnosis – especially in northern areas where medical 
imaging services are limited (1,7,8).  It is also under-reported, as there is no formal requirement 
to report human cases to national public health authorities in Canada.  Recent studies highlight 
the need to better determine the incidence and health care burden associated with human 
echinococcosis in Canada, especially in remote, northern, and Indigenous communities (2,9,10). 
 
The lifecycle of E. canadensis is indirect, and utilizes wild cervids such as moose (Alces alces), 
elk (Cervus canadensis), and caribou (Rangifer tarandus) as intermediate hosts.  Canids 
including wolves (Canis lupus), coyotes (C. latrans), and domestic dogs (C. familiaris) serve as 
definitive hosts (11–13).  Neither intermediate hosts nor definitive hosts are thought to suffer 
serious adverse effects as a result of infection; however, intermediate hosts may be at higher risk 
of predation due to decreased pulmonary function (14,15).   Similar to E. canadensis, E. 
multilocularis utilizes canid definitive hosts (eg. foxes [Vulpes spp.], wolves, coyotes and dogs), 
and a wide variety of small mammals as normal intermediate hosts (1).  In contrast to E. 
canadensis, intermediate hosts of E. multilocularis experience serious pathological changes, and 
aberrant intermediate hosts, such as dogs and primates, occur more frequently (16).  People are 
infected by accidentally ingesting eggs, and domestic dogs have been identified as high risk 
reservoirs for human exposure to both species of Echinococcus.  This is especially true in areas 
where dogs eat offal or seek out wildlife as a food source, and where poverty is prevalent 
(1,17,18).  Echinococcus eggs shed by infected dogs are identical to those of all other taeniid 
tapeworm species, making definitive identification costly and difficult.   
 
Worldwide, echinococcosis affects 2-3 million people per year, at an estimated cost of $750 
million USD (19).  In countries were Echinococcus is highly endemic, this disease represents a 
significant economic burden to healthcare systems, as well as to animal production systems 
(1,20,21).  The direct costs of this disease vary between healthcare systems but are 
straightforward to calculate if good health records outlining diagnostic and treatment procedures 
are maintained (22).  Calculating the indirect costs presents a far greater challenge, as infected 
individuals experience under-employment and long-term health consequences, even when they 
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have undergone treatment (20–22).  For all forms of echinococcosis there is the possibility for 
recurrence and for long-term sequelae following treatment, further increasing the burden of 
disease (1,23).  
 
Multiple countries have implemented programs to control and/or eradicate CE using a variety of 
methods to limit the transmission of the parasite between dogs, humans and sometimes livestock 
(1).  The most effective strategy is 6-weekly cestocide treatment (praziquantel [PZQ]) of dogs in 
concert with human, canine and livestock surveillance (1).  Some programs drastically reduced 
dog populations, implemented animal control legislation and/or introduced public health 
education.  Currently there are no control programs in Canada, with status quo being simply to 
treat infected people.  Only a few studies have calculated the cost effectiveness of various 
echinococcosis control programs and none have been done in Canada (24–26).   The goals of this 
paper are to 1) report the incidence of echinococcosis based on existing national datasets, and 2) 
determine the cost-utility of using a preventative PZQ dog dosing strategy at 6 week intervals in 
comparison to status quo, for a high risk health region in Canada using a public pay perspective. 
 
Materials and Methods 
Database 
We obtained case records for Canadians diagnosed with echinococcosis from the Discharge 
Abstract Database (DAD) and National Ambulatory Care Reporting System (NACRS) for 2002-
2011 through the Canadian Institute for Health Information (CIHI).  Nationally, all cases 
identified through day surgery, outpatient clinics and emergency department visits are reported 
to the NACRS database; while DAD captures hospital inpatient cases, including deaths, 
discharges and hospital transfers.  Cases were coded using version 10 of the International 
Classification of Diseases (ICD-10) coding system of the World Health Organization.  NACRS 
and DAD did not report data from one province (QC - Quebec) unless a resident was treated out 
of province, but did report data from all other provinces and territories (BC – British Columbia, 
AB – Alberta, SK – Saskatchewan, MB – Manitoba, ON – Ontario, NL – Newfoundland and 
Labrador, NS – Nova Scotia, NB – New Brunswick, YT – Yukon Territories, NT – Northwest 
Territories, NU – Nunavut).  Other omissions included MB and NB data for 2002/2003 and NB 
data for 2003/2004 due to delays in transitioning from ICD-9 to ICD-10 coding.  Due to the 
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small population in the 3 northern territories (YT, NT, NU), these cases were grouped together to 
avoid identifying patients or communities.  Our dataset did differentiate between international 
patients and citizens, but did not report travel history or whether a person had recently 
immigrated to Canada.  Cost and length of stay estimates were only available for 2009/2010 and 
2010/2011, and did not include physician compensation. 
 
Anonymized patient records from the NACRS and DAD databases were analyzed using SPSS 
statistical software (version 20; Chicago, Illinois, USA).  Individual health card identification 
numbers (issued by provinces and territories to individual residents enabling free access to health 
care services) were assigned a Meaningless But Unique Number (MBUN), which we used to 
ensure that each individual was counted only once over the study period.  Length of stay 
estimates and treatment costs of individuals hospitalized multiple times were combined for that 
individual.  Rural/urban and neighbourhood quintile income classifications were based on an 
individual’s postal code, and geographic location was reported by health region (according to a 
patient’s health card).  Rural/urban residence categories adhered to Statistics Canada definitions: 
(1) Rural (outside or fringe of Census Metropolitan Areas (CMAs) or Census Agglomerations 
(CAs); (2) Urban Core (large urban area with ≥50 000 people for CMA or ≥10 000 people for 
CA); (3) Urban Fringe (small urban areas inside CMA or CA but separated from the urban core); 
(4) Urban areas outside CMAs/CAs (small towns with a population of 1000-10000 people and 
population density of ≥400 persons/km2) (27).  Other variables included age (categorized as <14, 
15-64 and >65 years), gender, province where treatment occurred, and discharge status (ie. a 
patient’s health status or anticipated location after leaving the hospital).  Population proportions 
of infections were compared between genders, age groups, and urban/rural location using the Z-
test, with statistical significance reported at the P<0.05 level.  Only individuals over 14 years of 
age were included in the rural/urban comparison, and incidence was reported as the median rate 
over 10 years (28).   
 
Economic evaluation 
We conducted a cost-utility analysis comparing a strategy for CE prevention (PZQ dog dosing) 
with status quo (no prevention) to capture the costs associated with CE, along with its impact on 
quantity and quality of life. We modelled one cohort, representing the health region with the 
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highest incidence rate (Kelsey Trail, SK) and including residents of all ages, over the lifetime of 
the patient to fully represent the long term consequences of the disease and the possibility for 
recurrence. Consistent with the Canadian Agency for Drugs and Technologies in Health 
(CADTH) guidelines, a public payer perspective was chosen to represent the funders of both the 
prevention program and the health care system.   
 
Modelling 
We used decision analysis to construct a Markov cohort simulation model within Treeage
©
 to 
determine incremental cost-utility. The model ran for 43 years, from average age of infection to 
average life expectancy, with Markov cycles occurring at one year iterations. For both PZQ 
treatment and status quo, the model considered the transition between five CE health states 
(Healthy, In Treatment, Sequelae, Fully Recovered, Dead), each with associated costs and 
utilities (Figure 8-1). Transition probabilities determined the likelihood of moving between 
states.  
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Figure 8-1: Markov model flow chart outlining the transition between health states of people 
infected with cystic echinococcosis. 
 
Data inputs 
We calculated the risk of developing CE in the Kelsey Trail Health Region using the incidence 
of hospitalization from the CIHI databases (AE cases were excluded from the model). The 
course of disease and the likelihood of different outcomes, including the risk of recurrent 
echinococcosis, risk of sequelae, fatality rates and all cause mortality rates were derived from the 
literature (1,22,23,29,30).  Costs and utilities were both discounted at a rate of 5% as 
recommended in the CADTH guidelines, with sensitivity analysis at 0% and 3% discount levels 
(31). Base case estimates and sensitivity analyses are outlined in Table 8-1. 
 
  
Healthy 
In 
Treatment 
Sequelae 
Fully 
recovered 
Dead 
Prevention vs. Usual Care 
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Table 8-1: Summary of data inputs, base estimates, and sensitivity analyses for cystic 
echinococcosis control in Canada. 
Variable Base estimate Sensitivity analysis References 
Utilities 
Utility- Healthy 0.93 1-0.86 Mittmann et al. (1999) 
Utility- in treatment 0.72 0.58-0.86 (33,34) 
Utility- Treated 
permanent disease 
0.89 0.8-0.93 (20) 
Utility- Dead 0 0 N/A 
Costs   
Cost Treatment 2182.69$ per day 
in hospital*LOS 
(4.89)= 10,673.35$ 
5093.09$-13909.09$ DAD/NACRS 
Cost- PZQ program 
(total) 
1.93 71,000-84,000 Expert opinion- Health 
Region 
Cost- Dead 0 0 N/A 
Probabilities   
Echinococcosis Risk 0.000016 0.00000707-
0.000033 
DAD/NACRS 
Relative Risk  0.17 (after 10yrs) 0.4-0.05 (23)  
Risk Recurrence  0.16 0.05-0.27 (1) 
Risk Sequelae 0.075 0.02-0.15 (22,50)  
Fatality Rate  0.03 0.01-0.05 (22,23,29) 
Risk All-Cause 
Mortality 
0.0057 0.0056-0.0059 (30) 
Discount rate 0.05 0 & 0.03 (31) 
 
We calculated the baseline relative risk of a PZQ dosing strategy versus status quo from CE 
incidence estimates in Chile before and after the implementation of a similar PZQ program (23). 
We chose this relative risk because it represented a similar pathogen (E. granulosus sensu 
strictu) to that observed in Canada, as well as being one of few successful programs conducted 
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on a continent rather than an island (23). We conducted sensitivity analysis using the variation in 
effectiveness in Chile, as well as estimates for the effectiveness of PZQ treatment of Alaskan 
dogs to eliminate E. multilocularis in a study population similar to the Kelsey Trail health region 
in Canada (32) 
 
Utilities were used to value the outcomes observed in each health state, with dead having a utility 
of zero and the healthy average Canadian having a utility of 0.93. The treatment utility (0.72) 
was based on estimates for hepatic resection and liver cancer, as these illnesses have similar 
treatments and outcomes (33,34).  Post treatment, those who fully recovered were assumed to 
return to the healthy state utility of 0.93, whereas those with sequelae had a slightly lower utility 
of 0.89. The sequelae utility was based on a SF-36 quality of life study of treated echinococcosis 
patients, which was then converted to a utility score using the Beaver Dam health outcomes 
study regression equation (35).  
 
Two types of costs were considered: treatment costs of CE, and program costs of delivering 
PZQ. Treatment costs of CE provided by CIHI were only available for 2 years, and therefore we 
estimated average costs per case for the years 2002-2011 by calculating the mean cost per day 
times the length of stay (LOS) in the hospital.  We are aware that treatment costs were 
underestimated because CIHI does not report physician costs.  Program costs were provided by a 
SK health region director (H. Beatch, pers comm.), and included hiring an Environment Health 
Officer (EHO) or veterinarian, travel costs in and between communities, and the wholesale cost 
of treating all dogs in the Kelsey Trail Health Region with PZQ (2013 Associate Veterinary 
Purchasing Company Ltd.) at 6 week intervals.  We estimated the average number of dogs by 
counting all dogs (owned and stray) in two SK rural Indigenous communities, and extrapolating 
our dog population estimate to Kelsey Trail (36).  All costs were provided in 2011 Canadian 
dollars.  We also conducted a budget impact analysis to determine the overall cost sustained and 
averted to the health region, and to more adequately represent the costs of the prevention 
program.  
 
To ensure the validity of the model and the robustness of the findings we conducted one-way 
sensitivity analysis on all variables using plausible ranges.  For the primary CIHI data, plausible 
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ranges were derived by calculating 95% confidence intervals for the risk of CE in Canada, and 
using the inter-quartile range for costs to account for non-normal distribution.  For all other 
variables, the plausible range was drawn from the literature (Table 8-1).  Finally, a threshold 
analysis was conducted to determine the level at which PZQ dosing would be cost-saving, and to 
identify the minimum incidence rate that would result in a cost-effectiveness of <$20,000 per 
QALY (Quality Adjusted Life Year). 
 
Ethics 
This project was reviewed and approved by the University of Saskatchewan Biomedical Ethics 
Review Board (REB protocol number 13-51), which adheres to national standards set out by the 
Tri-Council for research involving humans.  We report data at the level of the public health 
region to avoid inadvertently identifying individual patients or communities. 
 
Results  
Statistical analysis 
Between 2002 and 2011, 384 discharge abstracts were submitted to the DAD and NACRS 
databases for patients under-going echinococcosis treatment  Of these, 69 abstracts were 
removed from descriptive analyses either because they were duplicates (the same individual 
obtaining medical care on multiple occasions), or because they lacked sufficient information to 
be assigned an MBUN.  We report a median incidence rate of 0.14 cases per 100 000 people 
annually.  The median age of an infected patient was 46 years.  The highest frequency of cases 
was observed in females, those residing in an urban core, those aged 15-64, and those residing in 
neighbourhoods with the lowest income quintile ranking (Table 8-2).  Relative to the 
female:male ratios reported by the 2006 Census (28), the proportion of female cases was 
significantly higher than the proportion of male cases at the national level (13:7, P>0.001) and in 
three provinces (BC- 13:6, P=0.012; AB- 25:6, P=0.032, ON- 18:11, P=0.001).  The proportion 
of cases in the top age category (<65 years) was significantly higher than the other two 
categories at the national level (P<0.001), and in AB, ON, and MB (P=0.001, P<0.001, and 
P=0.01, respectively).  In BC the proportion of cases in the top age category was significantly 
higher than the proportion of cases in the youngest age category (P=0.02), but not the middle age 
group.   
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Table 8-2: Description of patients receiving care for echinococcosis in Canada from 2002-2011. 
Descriptor Frequency % of cases
1 
Proportion x 10
6 
P-value 
Gender 
Female 
Male 
 
209 
106 
 
66.3 
33.7 
 
13 
7 
 
<0.001 
Age (years) 
0-14 
15-64 
≥65 
 
22 
207 
86 
 
7.0 
65.7 
27.3 
 
4 
5 
20 
 
<0.001 
<0.001 
Reference 
Urban/Rural 
Rural 
Urban core 
Urban fringe 
Urban area outside CMA/CA
2
 
Missing 
 
29 
208 
5 
17 
56 
 
11.2 
80.3 
1.9 
6.6 
- 
 
9 
11 
5 
10 
- 
 
0.27 
Reference 
0.11 
0.65 
- 
Neighbourhood Income Quintile
3
 
1-  $14 800 
2 - $25 800 
3 - $35 300 
4 - $46 900 
5 - $78 800 
Missing 
 
91 
65 
59 
50 
46 
4 
 
29.3 
20.9 
19.0 
16.1 
14.8 
- 
 
- 
- 
- 
- 
- 
- 
 
- 
- 
- 
- 
- 
- 
Province
4
 
BC 
AB 
SK 
MB 
ON 
QC
5 
NL 
NS 
 
38 
51 
17 
17 
178 
1 
2 
3 
 
12.1 
16.2 
5.4 
5.4 
56.5 
0.3 
0.6 
1.0 
 
9 
15 
18 
15 
15 
- 
4 
3 
 
0.10 
0.72 
0.48 
0.97 
Reference 
- 
0.04 
<0.01 
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NB 
YK, NT, NU 
2 
6 
0.6 
1.9 
3 
59 
<0.01 
<0.001 
1
Percent of cases where descriptor data is available 
2
 Only cases aged >14years used in rural/urban analysis; CMA-Census Metropolitan Area and 
CA-Census Agglomeration  
3
Average adjusted after-tax income for individuals calculated for 2006 in 2009 constant dollars 
(http://www.statcan.gc.ca/pub/75-202-x/2009000/analysis-analyses-eng.htm#a2) 
4
According to patient health card 
5
Only QC residents who received medical care out of province 
 
We observed no significant differences in urban versus rural incidence among patients older than 
14 years.  The highest proportion of cases were observed in the territories (NU, NT, YK), while 
the lowest were observed in Atlantic Canada (NL, NS, PE, NB).  The proportion of cases in 
these provinces and territories were all significantly different from the proportion of cases in ON.  
Our data suggests that the majority of echinococcosis patients were treated within their province 
of residence (311/323, 96%), except for those residing in the territories who were all treated 
elsewhere (NL, MB, or AB).  At the regional level, annual incidence rates were highest in the 
Kelsey Trail Health Region (1.7 cases/100 000) in SK and the Norman Regional Health 
Authority (1.2 cases/100 000) in MB (Figure 8-2). 
139 
 
 
 
Figure 8-2: Total cumulative echinococcosis cases per 100 000 people for the years 2002-2011 
reported by the Discharge Abstract Database and the National Ambulatory Care Reporting 
System and mapped by patient health region (except *QC). 
 
Only 60% of case records reported cyst location within the body (188/315), and only 20% 
(64/315) reported Echinococcus species (CE versus AE; Table 8-3).  For CE, the most 
commonly reported cyst location was lung, followed by liver, multiple sites, and bone; whereas 
liver and multiples sites were the most common descriptors for AE.  Between 2002 and 2011, 
2.3% of the 305 cases where discharge disposition was noted ended in fatality. 
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Table 8-3: Frequency of cyst locations and species of Echinococcus human cases in Canada 
(2002-2011). 
ICD-10 code Species Cyst location Frequency % of cases 
B67.0
 
E. granulosus
1
 Liver 16 5.1 
B67.1 E. granulosus Lung 21 6.7 
B67.2 E. granulosus Bone 2 0.6 
B67.3 E. granulosus Multiple sites 8 2.5 
B67.4 E. granulosus Unspecified site 1 0.3 
B67.5 E. multilocularis Liver 8 2.5 
B67.6 E. multilocularis Multiple sites 6 1.9 
B67.7 E. multilocularis Unspecified site 2 0.6 
B67.8 Echinococcus
2 
Liver 141 44.8 
B67.9 Echinococcus Unspecified site 110 34.9 
1
 Presumably E. canadensis under new taxonomy 
2
Species unspecified  
 
Economic evaluation 
We based our model on the Kelsey Trail Health Region (SK), which had the highest CE 
incidence rate in Canada.  The incremental cost-utility ratio (ICUR) for the base case was 185, 
484$ per QALY gained. Even though the costs to treat someone with CE are quite high 
(10,668$), the cost per person for ‘status quo’ was quite low, at 7.29$ per person over the time 
horizon.  The cost per person of the prevention program was also relatively low at 36.61$ per 
person, signifying a small cost difference between the strategies at 29.31$ per person. Therefore, 
the reasonably large ICUR for this prevention program is likely attributable to the very small 
utility from prevention compared to status quo (Incr. QALY= +0.0001582), with the outcome 
values in both strategies producing approximately 15.85 QALYs.  The overall cost of running a 
prevention program in the Kelsey Trail Health Region, was approximately 71,327.93$, which 
included total program costs (80,198.4$) minus costs averted from not treating as many cases 
(8,8870.47$; Table 8-4).  
 
  
141 
 
Table 8-4: Base case incremental cost per QALY and total costs (Can$). 
Program Cost per year Average 
costs  
Average 
QALY 
Incremental cost-
utility ratio Total Averted Overall 
Status quo 10687.31  10687.31 7.2913 15.9379  
Prevention 
(PZQ) 
80,198.4 8870.47 71327.93 36.6065 15.9381  
Incremental    +29.3152 +0.0001582 185, 284.07$ per 
QALY 
 
One-way sensitivity analysis demonstrated that none of the cost-utility ratios for any of the 
plausible variable ranges were under 80,000$ per QALY. The best cost-utility ratio came at the 
high range of the plausible risk of CE (0.0000316 or incidence of 3.16 per 100,000) where the 
cost per QALY was approximately 82,258$. The results also appeared to be sensitive to fatality 
rate, with an ICUR varying from 310,837.72-133,716$ per QALY and discounting which, at a 
0% discount rate, produced a cost per QALY of 90,487$ (Table 8-5). Varying other data inputs 
did not significantly change the outcomes, most likely because the starting incidence was so low, 
thereby making other probabilities irrelevant. Sensitivity of the analysis to the risk of developing 
CE, prompted us to complete a threshold analysis to determine at what incidence the prevention 
program may be considered cost-effective. This analysis found at an incidence of 8 per 100,000 
(risk=0.00008) the cost per QALY would be approximately 20,000$, while at an incidence of 14 
per 100,000 (risk=0.000014) the program would start becoming cost-saving (Table 8-5).  
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Table 8-5: Base case incremental cost per QALY and sensitivity analysis. 
Variable Cost per QALY 
(Can$) 
Base case  
Status quo vs. Prevention 185,294.07 
Risk of disease  
Low (0.00000707) 208006.20 
High (0.0000316) 82258.37 
Threshold (0.00008) 20,000 
Threshold (0.00014) 0 
Fatality Rate  
Low (0.01) 310837.72 
High (0.05) 133716.36 
Discount  
3% 137506.49 
 
Discussion 
We report an echinococcosis incidence rate of 0.14 cases per 100 000 people annually, which is 
slightly higher than a previous Canadian estimate, likely because we included cases where 
echinococcosis was not the primary diagnosis.  This is lower than CE incidence rates in other 
endemic countries including Spain, Portugal, Italy, Greece, and China; but is higher than 
countries such as New Zealand and Tasmania which are provisionally free following the success 
of control programs (1,23).  As well, we believe that our incident rate under-estimates the true 
incidence as CE is not nationally notificable, some cases were removed from analysis due to 
incomplete identifier information, and because up to 60% of CE cases are thought to be 
asymptomatic (1).  Based on the best data currently available, we were not able to determine 
what proportion of cases were foreign-acquired; however, the universal nature of health care in 
Canada means that costs of treatment of foreign-acquired cases are still incurred.   
 
Although the majority of case reports did not differentiate between CE and AE, highlighting 
another weakness in reporting, our findings suggest that most CE cases were likely to be 
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domestically-acquired.  The highest incidence rates were in northern areas (Kelsey Trail and 
Keewatin Yatthe Health Regions [SK]; the territories [YK, NU and NT]; and Norman and 
Burntwood Regional Health Authorities [MB]) as opposed to regions where large metropolises 
are present.  Of the top primary, secondary and tertiary immigration destinations in English-
speaking Canada (Toronto, Vancouver, Calgary, Edmonton, Winnipeg, Hamilton, Ottawa, 
Saskatoon, Victoria, Regina, and Halifax), all had very low incidence rates (37).  Sixteen 
individuals were diagnosed with AE over the ten year study period.  In Canada, these are 
generally thought to be foreign-acquired, as no autochthonous cases have been reported in 
Canada since 1928 (38).  However, six of these individuals resided in northern health regions 
(the territories [YK, NU, NT], North Zone [AB], Northeast Local Health Integration Network 
[ON], Northern Health [BC]), where immigration rates are low. 
 
Our findings that echinococcosis was diagnosed most frequently in females and in older adults 
are supported by other Canadian studies (2,6).  CE cases were most likely to have pulmonary or 
hepatic involvement, which is a common finding for the cervid strains in people, and these 
findings of gender, age and cyst tissue predilection are risk factors shared by wildlife cervid 
hosts (6,12,39).  The highest frequency of CE cases occurred in low income neighborhoods but 
we were unable to determine if the proportion of cases relative to other income quintiles was 
significantly different.  Low income individuals could be at higher risk of CE if they fed raw 
offal to pets and were unable to afford regular cestocidal dosing.       
 
We report a CE treatment cost that is similar to that in the UK (10 215$ USD), but far higher 
than that in other countries such as Jordan (524$ USD) (22).  Based on the base case analysis and 
one-way sensitivity analysis, the PZQ prevention program at an ICUR of 185,284$ per QALY, is 
not cost-effective relative to other funded health care programs and current willingness to pay 
guidelines (31).  Although the communities would have to incur costs for a few years while 
seeing little to no benefit, the overall costs of the PZQ strategy (≈71,300$) are quite small in 
comparison to other prevention programs, such as rabies dog vaccination and HPV vaccination 
(40).   
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Several factors may impact the cost-utility and feasibility of the PZQ prevention program.  First, 
veterinarians use PZQ to treat animals against a wide range of cestode species other than E. 
canadensis, including Diphyllobothrium, Taenia, Dipylidium caninum, and Mesocestoides, some 
of which can infect people and/or livestock.  Other treatments to prevent zoonotic diseases in 
dogs, such as nematocides or rabies vaccination, could easily be added to the PZQ program 
infrastructure at a lower cost than administering all treatments separately.  Second, the World 
Health Organization suggests the echinococcosis control go through multiple phases: 1) 
planning; 2) attack (costly and intensive control measures implemented); 3) consolidation (only 
high risk animals and people targeted); and 4) maintenance (1).  While complete eradication is 
not feasible in Canada due to the presence of wildlife reservoir hosts, future prevention cost 
reductions are possible.  For example, after echinococcosis rates in people and animals 
decreased, this low risk status could be maintained through cheaper methods (eg. education, less 
frequent owner-administered PZQ).  Third, our threshold analysis demonstrated that an increased 
echinococcosis incidence could greatly impact the cost-utility of a prevention program. There is 
evidence that AE is expanding its range and emerging/re-emerging in many populations, both 
human and animal (41–44). In Canada, E. multilocularis has been documented in coyotes in 
several urban core areas, raising concerns of infection for domestic dogs, and possibly people 
(43).  As well, dogs with European strain alveolar hydatid cysts have been documented in BC, 
AB, SK, and ON (45–47) (K. Gesy, pers comm.) demonstrating a widespread distribution for 
this emerging zoonosis.  Range expansion of AE has been attributed to socio-economic factors, 
ecological disruptions, and potentially to climate changes, and is of particular concern as it 
generally results in worse health outcomes and significantly higher treatment costs than for CE 
(42,44,48).  Fourth, this program would target often underserved and vulnerable populations that 
have poorer health outcomes, and therefore, the benefit of preventing disease in these risk groups 
may help to reduce health inequalities.  Lastly, our results indicated that all YK, NU and NT 
patients travelled out of territory for treatment, which can be very expensive for the health care 
system. In NU, more than 25% of the operations budget is spent sending patients to southern 
referral centres to obtain care that is unavailable in the north, and this is a critical barrier to 
obtaining digital imaging results (required for CE diagnosis) in a timely manner (49).  
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Conclusions 
Our study provides baseline human echinococcosis data at a time when European strain AE 
appears to be emerging in aberrant hosts across Canada and the risk of human exposure might be 
increasing.  Improvements to echinococcosis surveillance could include developing serological 
tests that are optimal for Canadian strains (eg. E. canadensis G8 and G10), improved 
classification of echinococcosis by physicians (ie. to species level), increased awareness of 
echinococcosis among physicians in areas where this parasite is prevalent, and adding this 
parasite to the list of nationally notifiable pathogens. Improving surveillance would allow policy-
makers and governments to make an informed decision about implementing a control program, 
with the knowledge that an increasing incidence greatly improves the cost-utility of an 
echinococcosis prevention program. Although PZQ dosing was not cost effective, it might still 
be warranted in high risk areas, especially as there are added benefits to people, pets and wildlife 
in controlling Echinococcus and other zoonotic cestodes.  Other models using a less expensive 
control strategy over a smaller geographic area, and taking physician salary and indirect costs 
into account might indicate more favourable results for implementing CE prevention programs.  
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CHAPTER 9 - CONCLUSIONS AND RECOMMENDATIONS 
Prevalence and Geographic Distribution of E. canadensis in Canada 
The work contained in this thesis found that infection with E. canadensis was more prevalent in 
wildlife (Chapters 2-3) than in domestic dogs (Chapter 4-5) or people (Chapters 6-8) in 
Saskatchewan.  Since 1952, hydatid cysts have been reported in ungulates nationwide, except for 
the Maritime provinces and the high Arctic islands (1).  Human echinococcosis cases have been 
reported from every province and territory with the highest and lowest incidence observed in the 
northern territories (NT, YK, NU) and Maritime provinces (NS, PE, NB), respectively.  The 
national incidence rate for echinococcosis is 1.4 cases per 1 million per year; however, this is 
most likely an underestimate as this infection is both under-diagnosed and under-reported.  
Historic reports of E. canadensis infection in canids are less trustworthy, as adult cestodes are 
difficult to differentiate from those of E. multilocularis, and because different Taeniidae species 
shed in eggs canid feces that are morphologically identical.  Molecular confirmation of E. 
canadensis (G8 and G10 genotypes) first occurred for elk and moose in 2006, and has since been 
reported in wild canids, stray dogs and other ungulates, but no hydatid material from people in 
Canada has ever been characterized (1–5).  These reports show two distinct genotypes (G8 and 
G10) of E. canadensis, co-existing in sympatric distributions.  To date, G8 has been observed in 
a muskoxen (NU), wolves (BC, AB, SK, and NT) and elk (AB); G10 has been observed in elk 
(AB, MB), moose (MB), caribou (QC), and wolves (BC, AB, SK, MB, NT, YK) (1,2,4,5).  Co-
infections of G8 and G10 have been observed in wolves from one province (SK) and one 
territory (NT), and adult cestodes are morphologically distinct (5,6).  The work of this thesis 
(Chapters 2-3) found that G10 was more prevalent, and more widely distributed in ungulates and 
wild canids than G8. Although taxonomic revisions of the Echinococcus granulosus species 
complex are contentious, our evidence of sympatrically distributed genotypes supports the 
inclusion of species names E. borealis and E. canadensis to describe G8 and G10, respectively. 
 
Prevalence and Geographic Distribution of Other Endoparasites in People and Animals in 
Western Canada 
Our post-mortem examination of wolves from SK, MB and NT indicated that approximately half 
(56% of 165) were infected with one or more helminths.  Cestode infection occurred most 
frequently (Taenia, Echinococcus, and Diphyllobothrium), followed by nematodes (Toxascaris 
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leonina and Uncinaria stenocephala) and flukes (Alaria).  Our report of E. multilocularis in 
wolves was a new host record for this parasite.  Presence of endoparasite ova in client-owned 
dogs and environmentally collected canine fecal samples varied greatly between communities in 
SK (20-83%), but was higher in northern, rural, and remote communities than urban population 
centres (7–12).  Other high risk populations for endoparasitism included dogs surrendered for 
adoption and juveniles (<1 year old) (10).  Overall, ascarid nematodes (Toxocara canis and T. 
leonina) and protozoa (Giardia and Cryptosporidium) were most prevalent in the dog study 
populations.  Other parasites identified less frequently included Uncinaria, Diphyllobothrium, 
Isospora, Sarcocystis, Alaria, Metorchis, Trichuris, Taenia, and Dioctophyma.  Approximately 
19-21% of dog serum collected in three rural SK communities showed evidence of exposure to 
Toxoplasma gondii, which is lower than the canine sero-prevalence reported in AB, ON or NT 
(33-63%) (9,11–14).  Each sampling site had a unique parasite profile, with varying parasite 
richness and prevalence of parasite species.  These results indicate that dogs and wolves feed 
opportunistically on a wide array of terrestrial and marine wildlife, and that there are 
opportunities for sylvatic and domestic life cycles to overlap and amplify zoonoses.     
 
Our assessment of human exposure to T. gondii, Toxocara canis, and Trichinella indicated that 
northern remote residents were exposed more often than southern rural residents in SK.  Risk 
factors significantly correlated to parasite exposure in one community were not significantly 
correlated in the other community except for young age (<18 years), which was a risk factor for 
Toxocara exposure shared in both communities.  It remains unclear why exposure levels were 
different in the two communities, but possible explanations include differences in food 
preparation, access to specific game species, knowledge of sanitation, and cultural practices.  
Similar to our work in Chapter 8, we obtained patient records (CIHI case reports) for individuals 
diagnosed with toxoplasmosis or toxocariasis between 2002 and 2011, and found that both 
conditions were rare in Canada (1.7 and 0.06 cases per 1 million persons per year, respectively).  
Human Immunodeficiency Virus (HIV) was a co-infection in 40% (203/523) of toxoplasmosis 
cases, suggesting that efforts to increase awareness of T. gondii transmission routes in immune-
compromised individuals may be appropriate (Schurer et al., unpublished data). 
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Limitations and Future Directions for E. canadensis Surveillance 
Detection of E. canadensis in wildlife and domestic dogs is challenging, in part because infected 
hosts are often asymptomatic, and also because the tools required for definitive diagnosis are 
expensive or unavailable in remote regions (medical imaging or molecular methods).  Post-
mortem examination of intestinal contents is the most sensitive detection method for canids, but 
can be highly time consuming even for skilled technicians, and is unfeasible for domestic dogs 
ante-mortem (15).  Fecal analysis is more cost-effective, but less sensitive because E. canadensis 
cestodes shed eggs sporadically, or may be pre-patent at the time of testing.  As well, DNA must 
be extracted from taeniid eggs collected from feces in order to identify the species and/or 
genotypes, adding to the cost.  Fecal analysis does provide important information regarding the 
level of environmental contamination by parasite ova.  Coproantigen-ELISA testing is another 
option for Echinococcus detection in canid feces, and is steadily replacing arecoline purgation as 
a highly sensitive screening tool in Echinococcus control programs (15).  Coproantigen-ELISA 
tests are now commercially available in Europe; however, further work is needed to determine 
the sensitivity of these tests for E. canadensis (G8 and G10 genotypes), distinct from other 
Echinococcus species and genotypes (15).   
 
Diagnosis of cervid-strain CE in people is challenging for similar reasons.  Infected individuals 
generally remain asymptomatic for many years or exhibit non-specific symptoms that are 
difficult to characterize.  As well, infection may resolve without intervention, or may remain 
undetected, especially in remote locations where access to medical care is difficult.  Currently, 
echinococcosis is not reportable at the national level, and prevalence estimates are limited to 
small community-based studies (3,9,11,16–22).  The serological tests used in these studies are 
minimally invasive and less expensive than medical imaging, but only measure exposure to E. 
canadensis, and not actual infection.  Cross-reactions (false positives) can occur when test 
subjects are infected with cestodes closely related to E. canadensis. Authors of these studies used 
different surveys to measure risk factors for exposure, and none reported follow-up testing 
results (ie. medical imaging) for sero-positive participants.  As a result, there are disagreements 
in the literature regarding risk factors for echinococcosis.  Most of these sero-surveillance 
projects are not correlated to Echinococcus surveillance in dogs or local canid populations, and 
therefore the source of human exposure is often unclear.  Worldwide, dogs are considered the 
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most important source of human infection; however, we did not find dogs infected by E. 
canadensis at any of our study sites.  Likewise, our regression models failed to identify dog 
ownership as a risk factor for infection, which could indicate low infection prevalence in dogs, or 
that free-roaming dogs spread eggs throughout the townsites, exposing survey respondents 
equally.  We found wolves infected by E. canadensis at all study sites in SK, MB, and NWT 
suggesting that wild canids may be a more important source of E. canadensis infection for 
people than dogs.  Future risk assessments should examine how people interact with wild canids 
and determine levels of soil contamination to resolve these questions. 
  
The Canadian Institute of Health Information has collected CE hospitalization data since 1994 
(23); however due to strict privacy laws, risk factor analysis is limited to a subset of information 
reported in patient medical records.  During our analysis of CIHI data, we noted several issues 
that contribute to CE under-reporting in Canada.  For example, CIHI reports case records as 
opposed to infected individuals, and when critical data such as individual health number and 
geographic location are missing, cases are deleted because they cannot be verified as unique.  
Some information, such as income and urban or rural residence, is based on postal codes and 
may exclude transient and homeless populations.  Because case records provide all diagnostic 
ICD-10 codes at the time of examination, it is difficult to differentiate those undergoing 
treatment for CE from those being treated for a co-existing health condition. As well, physicians 
rarely differentiate between CE and AE in their diagnosis, or describe cyst location.  This is a 
concern because eight cases of AE  as an aberrant presentation in dogs have appeared in five 
provinces over the last five years, suggesting that highly virulent European strains of E. 
multilocularis with less intermediate host specificity are emerging in Canada (24–26; Gesy and 
Peregrine, unpublished data).  With the current echinococcosis reporting flaws and lack of 
physician awareness with regards to differentiating AE from CE, it may be difficult to detect 
increases in AE human incidence.  In addition, case records do not include travel or immigration 
history making it difficult to differentiate foreign from domestically acquired infections, in 
particular because echinococcosis has a long latency period.  Moving forward, our understanding 
of CE risk factors and the location of high risk communities will be greatly enhanced by follow-
up of sero-positive participants of surveillance studies, and by improved physician reporting.  As 
well, hydatid cysts removed from people should be characterized genetically to determine 
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infection origin as well as differences in pathogenicity between species and genotypes of 
Echinococcus.  This may prove challenging, as Canadian physicians often opt to follow a “watch 
and wait” approach in treating echinococcosis. 
  
Parasite Control Strategies 
Despite the fact that people can infect and be infected by their pets, strategies for parasite control 
in people and animals continue to focus on parasite treatment, rather than prevention (27,28).  In 
the veterinary industry, this is likely because practitioner income is based on billed services and 
pharmaceutical sales.  As well, there are few publically funded programs in operation that 
support veterinary public health services for companion animals.  However, human activities 
often contribute to parasitic infections in animals, and education is an important tool for 
decreasing exposure.  Research in developed and developing countries show the same results - 
pet owners have varying knowledge of parasites, and of transmission routes for zoonotic 
transmission (28,29). Although veterinarians are a trusted source of information, the widespread 
success of anthelmintics in decreasing companion animal parasitism has caused some 
practitioners to become complacent about client education (28).  Likewise, some clients might 
become non-compliant with what they perceive as unnecessary, costly, and possibly deleterious 
treatments.  Unfortunately, information provided to clients regarding parasite transmission is 
often incorrect, insufficient, or outdated, and deworming recommendation frequently do not 
match best practice (28–30).  Our surveillance of companion animal shelters in Canada 
suggested that parasite control strategies were often developed with budget as a primary 
consideration (31).  Pharmaceuticals were frequently used extra-label, drugs targeting cestodes 
and ecto-parasites were only distributed to a subset of animals, and fecal diagnostic testing was 
conducted only as needed (31).   
 
Ironically, those who own pets may not be at highest risk of zoonotic parasitism, which could 
suggest increased awareness regarding the zoonotic potential of parasites.  Dog ownership is not 
a risk factor for Echinococcus exposure in Canada, and because free-roaming dogs deposit feces 
haphazardly around human settlements, any person could be at risk of contact with infective eggs 
in the environment (9,11,20,22).  Therefore, Echinococcus control measures require a One 
Health approach where interventions are provided at the community level rather than the 
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household level.  This is supported by our surveys of northern and rural dog owners who 
reported that deworming dogs occurred rarely (if ever), even when veterinary services were 
nearby, and that cost was a primary barrier (11,12).  Successfully eliminating Echinococcus from 
an area requires a highly organized, long-term, and inclusive community-wide approach that 
educates residents about transmission routes and dog population control, and legislates 
appropriate canine deworming (15,32).  In particular, this includes educating pet owners about 
the risks associated with feeding their animals raw meat (Figure 1-1), and encouraging hunters to 
process carcasses ‘on the land’, where community dogs are unlikely to access offal.  In 
communities where human echinococcosis incidence rates are high, surveillance of dogs and 
wild canids is needed to identify sources of infection.  If dogs are shedding eggs, cestocides 
should be provided to all dog owners through subsidized veterinary public health programs to 
ensure that all animals are treated at 6 week intervals, regardless of an owner’s socioeconomic 
status.  When wild canids are infected, control is far more challenging and may require 
praziquantel baiting or depopulation of canids in the surrounding areas.  Although 
echinococcosis is currently considered a rare disease in Canada (33), our analysis indicates that a 
small increase in annual incidence, especially in a small community, would result in the 
Echinococcus control program being cost-saving.  The cost to deworm dogs is low relative to the 
direct and indirect costs of treating human echinococcosis, not to mention the cost of human 
suffering and loss of productivity associated with morbidity and mortality (34).  Additional 
benefits can be achieved by employing broad-spectrum anthelmintics that remove a wide array 
of parasites (eg. T. canis) that cause adverse health conditions in both dogs and people.  Other 
preventative health measures, such as rabies lay vaccinator programs, can easily be added as 
needed, capitalizing on the infrastructure created by the deworming program (and vice-versa).  
Because echinococcosis, toxocariasis, and other zoonotic parasites occur more frequently in 
underserved populations (35,36), control programs should be considered even when the cost is 
not favourable from a public payer perspective. 
 
Challenges and Recommendations for Community-Based Research 
During my brief time working with rural and remote Indigenous communities I experienced or 
observed a variety of obstacles to producing high quality, ethically sound, and ultimately useful 
data. Despite recommendations set forward by the OCAP principles (37), research continues to 
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be driven largely by researchers, whose interest and expertise do not always align with 
community priorities.  Researchers do not always communicate well with each other, and as a 
result, separate groups can work simultaneously in the same community on different projects 
without awareness of each others’ presence.  This is a lost opportunity for conducting higher 
level integrated data analysis, and contributes to the current paradigm of reductionist and 
“patchwork” research, as opposed to approaching health issues holistically.   
 
 Many rural and remote communities have limited resources for conducting self-driven research, 
and collaborations with outside investigators are key to addressing genuine problems that the 
community wants to address.  However, academically based researchers often have different 
expectations relating to timelines, competing priorities, budgeting, data ownership, and privacy 
than community residents.  Outsiders may be less aware of cultural sensitivities, experience 
difficulties identifying key stakeholders, and struggle to communicate with community members 
(especially if telecommunication services are limited, communities are inaccessible for parts of 
the year, or language barriers are present).  Frequent changes to leadership administration and 
unaligned health priorities between leadership and residents can result in time set-backs and lost 
support.   
 
Participatory research is now a gold standard for data collection involving Indigenous peoples, 
rural and remote communities, and groups formed by common interests (eg. occupation, disease 
status, age, sexual orientation, economic status, etc.) (38,39). It requires that investigators and 
community members collaborate on all aspects of research, including project planning, data 
collection and analysis, data interpretation, and communicating results to laypersons and experts.  
It also involves sharing risks (eg. project failure, costs), rewards (eg. financial profit, positive 
media attention), and responsibilities between participants.  Participatory research is an 
important tool for achieving social justice in underserved and marginalized communities for two 
reasons: 1) it empowers participants to initiate positive change, and 2) results can be used to 
lobby policy makers for improved rights and services (37,39).  Empowering communities to 
study and solve their own health problems is a critical element to improving overall health 
promotion and disease prevention (38).  With zoonoses, taking a One Health approach allows us 
to go “upstream” of human cases to exercise prevention in animal and environmental reservoirs.  
158 
 
The following are my recommendations for improving participatory and integrated One Health 
research activities in those remote and/or Indigenous communities where veterinary and medical 
services are limited or do not exist. 
 
1) Improve local capacity by involving local residents in research activities 
Community residents, who may lack formal higher level education, are capable of collecting 
many types of data, and can be trained outside the school setting to become highly qualified 
technicians.  This type of skills training increases local capacity for initiating self-driven 
research in the future, promotes equitable relationships through employment, and provides 
opportunities for long-term sample collection.  As well, locals involved in research planning, 
data collection, and analysis are important allies for translating research goals and outcomes 
to community members (40,41).  Residents who become involved in research activities 
during the initial planning stages provide critical information for culturally appropriate and 
logistically feasible sampling, have a vested interest in supporting research activities, and 
experience research successes first hand (40,41).  Such individuals might be more likely to 
initiate or participate in research activities more readily when future questions arise.  
 
2) Integrate preventative human and animal health services 
Currently, medical and veterinary heath services are delivered completely separately.  Many 
veterinarians and physicians feel unqualified to discuss routes of zoonotic transmission, and 
as a result, the public is often left with erroneous information distributed by the mass media 
(28,30,42).  In SK, permanent veterinary services are absent in the northern half of the 
province (north of Meadow Lake), and pet owners have no access to preventative pet care 
and little recourse when a pet is injured.  As well, some remote communities have primarily 
free-roaming dog populations, in which dogs may have no owners, or ownership changes 
frequently.  Anecdotal reports of nurses stitching up injured pets in their spare time 
demonstrate that human health workers are willing to stretch the confines of their formal job 
description to provide basic first aid to animals.  Logistically, northern health regions could 
employ a veterinarian or animal health technician with public health training to complement 
the skills of human healthcare staff, or nurse practitioners could provide very basic 
preventative health services (eg. deworming, vaccination) to companion animals under the 
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remote supervision of a veterinarian.  As Telehealth and other remote health services are 
becoming commonplace in northern Canada, the latter could capitalize on pre-existing 
infrastructure (43). 
 
3) Provide legal and logistical support for veterinary paraprofessionals 
Northern SK should look to other remote regions in the world where farmers have 
successfully introduced veterinary paraprofessionals, also known as Community-based 
Animal Health Workers (CAHWs), to solve veterinary service shortages (44).  These 
CAHWs are trained by veterinarians to collect and report disease surveillance data, to 
educate animal owners, and to perform primary level tasks such as vaccination and 
deworming (44).  Contrary to popular belief, they do not take business away from practicing 
veterinarians, but often increase demand for services by improving trust, and demonstrating 
the value of owning healthy animals.  Frequently, they work in areas where vets are reticent 
to practice, due to political instability, insufficient client base and income, physical 
separation, or because the client-base is nomadic (44).  In northern SK, Environmental 
Health Officers (EHOs), public health officials, or local residents could be trained to handle 
animals safely and perform community level vaccination and deworming programs for 
owned and free-roaming dogs, thus improving health for both people and animals.  Barriers 
include privatized veterinary services, and legislation prohibiting unqualified workers from 
practicing veterinary medicine.  These could be easily overcome, as the NT already permits 
non-veterinarians, who are trained in the technique by a veterinarian, to administer rabies 
vaccines to dogs, and because CAWH programming could be limited to areas where 
veterinarians already choose not to practice (45).  In northern SK where employment options 
can be scarce (46), introducing CAHW training might be readily accepted, as it offers 
opportunities for year-round employment, mentorship, income generation without leaving 
the community, and involvement in activities that promote health and wellbeing.   
 
4) Conduct human and animal disease surveillance simultaneously 
An additional advantage to integrating human and animal health services is that disease 
incidence changes in either population can be detected and communicated among health 
workers.  In essence, both people and animals become disease sentinels for each other, 
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depending on whether symptoms are more readily detected in one population or the other.  
As well, this allows management of zoonoses to become preventative rather than 
reactionary, fast-tracks collaboration between human and animal health professionals, and 
eliminates issues pertaining to jurisdiction and responsibility.   
 
5) Promote interdisciplinary collaborations 
Increasingly, funding institutions promote research teams that collaborate across disciplines 
(47–49).  The extent to which these teams collaborate can be viewed on a continuum.  
Multidisciplinary collaborations, simply termed, are additive.  Researchers from different 
disciplines study problems sequentially or with different goals, and with minimal 
interaction.  Further along the spectrum, interdisciplinary research is interactive, involves 
shared goals, and generates new perspectives and disciplines of study (eg. bio-informatics, 
ecophilosophy) (47). Lastly, transdisciplinary collaborations cross the traditional boundaries 
of multiple disciplines to study complex problems with a dynamic and holistic approach 
(47).  Specialists within the team work simultaneously, cohesively, and towards common 
goals, often teaching each other skills associated with their expertise and contributing to role 
expansion (47).  
 
It is not unusual for a principal investigator to work on a project until his or her scope of 
expertise is exhausted, and then impart their findings in the literature or pass the project 
along to another group.  In a community-based setting, this approach is inefficient because 
start-up efforts (eg. building trust, identifying key stakeholders, gaining familiarity with 
cultural norms) are time intensive and costly.  This approach does not utilize the vast amount 
of qualitative or anecdotal information that a researcher might unconsciously obtain.  To 
combat this segmented approach, community-based research should be transdisciplinary, 
and include front-line practitioners, community members, laboratory experts, and policy 
makers from start to finish.  Multiple disciplines should be represented, including social 
science, anthropology, veterinary and human medicine, environmental science, economy, 
and public policy.  Such teams are best equipped to study whole systems, and are able to 
assess perceived healthcare issues, identify cultural or community barriers, conduct 
surveillance, propose interventions, and assess attitudes towards and uptake of the pilot 
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intervention.  They are also efficient because research designs and interventions that lack 
logistic feasibility, are too costly, or clash with local attitudes can immediately be discarded.  
Lastly, multiple disciplinary teams may have greater success in identifying common funding 
incentives, and maintaining long-term community presence.    
 
Our research team experienced the benefits of transdisciplinary collaboration firsthand in a 
community where pet sterilization clinics were held following a fatal dog attack (12).  The 
team included EHOs, nurses, veterinarians, community elders, a not-for-profit charitable 
organization, and an expert in policy and environmental sustainability.  Through door-to-
door visits and storytelling circles, we learned that rural dog populations impacted 
community health negatively when they were too large (eg. due to dog-related injuries, fear 
for disease transmission) or when they were too small (fear of wildlife, loneliness, lack of 
security).  The impact was positive when dog populations were within a healthy range 
because residents participated in outdoor physical activities with less fear of dog packs or 
roaming wildlife, and because people felt more connected to their pets (Schurer et al, in 
prep).  This information suggests that dog culls, which are a common reaction to dog-related 
injury, do not promote long-term health or wellness.  From a funding perspective, those 
interested in sustainable dog population management could find common ground with those 
working on the growing prevalence of lifestyle diseases (obesity, diabetes) (50).  
 
Just as the concept of One Health is not new, many of the ideas outlined above have been 
implemented in different countries and at difference times.  For transdisciplinary One Health 
research to reach its full potential, academics and large scale funding agencies will need to 
modify expectations with respect to productivity, timelines, data ownership, teamwork, and 
acknowledgement of success.  Otherwise, principal investigators will have little motivation to 
step outside the comfort of their expertise, and take on the risks associated with highly 
collaborative teamwork.  My own experiences in transdisciplinary work have been vastly 
educational, engaging, and ultimately contributed to a broad network of collaborators.  This 
approach has also allowed me to understand syndemics in a real world context – by meeting 
those affected by unfavourable social determinants of health, as well as those working to 
alleviate human and animal healthcare issues at the individual and community levels.  I strongly 
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believe that research would more often lead to successful healthcare interventions if scientists 
stayed involved from the benchtop to the policy level.  I hope that the push for community-led, 
transdisciplinary, and conservation-focused research continues to grow as the world is faced with 
ever-faster disease emergence at the human-animal interface.  
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Appendix C – Human Serology Surveys and Consent 
 
INFORMATION AND CONSENT  
 
Title of Study: "Parasite surveillance in northern Aboriginal communities" 
 
 
Investigator: 
Dr. Emily Jenkins, University of Saskatchewan, Phone: 306-966-2569 
 
Sub-investigators: 
Dr. Stuart Skinner, University of Saskatchewan, Phone: 306-655-1785 
Janna Schurer, University of Saskatchewan, Phone: 306-966-7213 
 
 
 
INTRODUCTION 
 
This study aims to look at the amount of disease due to parasites transmissible between 
animals and people in northern and indigenous communities in Saskatchewan.  
 
Your participation is entirely voluntary. It is up to you to decide whether or not to take part in this 
study. Before you decide, it is important for you to understand what the research involves. This 
consent form will tell you about the study, why the research is being done and the possible 
benefits, risks and discomforts.  
 
If you wish to participate, you will be asked to sign this form. If you decide to take part in this 
study, you are still free to withdraw at any time and without giving any reasons for your decision. 
If you do not wish to participate, you do not have to provide any reason for your decision. You 
will not lose the benefit of any medical care to which you are entitled or are presently receiving.  
 
Please read this form carefully and feel free to discuss it with your family, friends, nurse, or 
doctor before you decide. 
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NATURE AND PURPOSE OF STUDY 
 
Parasites are known to be present in dogs and people in some northern and indigenous 
communities in Saskatchewan. The purpose of this study is to determine how much, if any, 
infection is present in the community in both humans and dogs. If there is infection we would 
like to determine how much is present and determine what puts people at risk.  With this 
information, we can help provide advice on how to avoid becoming infected, and if necessary, 
on how to treat infections.  
 
 
PROCEDURES TO BE FOLLOWED  
 
If you agree to participate, then you will be asked to give one blood sample (about 5mL = 1 
teaspoon) to determine if you have been exposed to parasitic infection.  You have the option to 
submit a stool sample that would be tested for active parasitic infections (ie. eggs and cysts of 
common gastrointestinal parasites).  You will also be asked to fill out a questionnaire asking 
about any health concerns that may be caused by parasites and activities that may put you in 
contact with them. It will require about 20 minutes to complete the questionnaire and to have 
your blood taken. 
 
You will be informed of the results of your test by mail. The results will either inform you  that 
you have been exposed to parasites (a positive test) or not exposed to parasites (a negative 
test). An accompanying letter will advise you whether or not you should discuss your results 
with your health care provider (family doctor or nurse practitioner). For some positive test 
results, public health will be notified. The test results will also be provided to the primary care 
physician or nurse practitioner who you identify, if you choose. Your primary care physician can 
provide follow up on positive results with further examination and/ or treatment.  This may 
include ultrasound, x-rays, eye exams, or further blood or stool sampling. 
 
DISCOMFORTS AND RISKS 
 
There are no significant risks associated with this study. You may experience some temporary 
discomfort when the blood sample is taken.  There is a small risk of bruising, infection or 
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swelling at the site where the needle is inserted; and some minor discomfort.  Some people may 
feel faint and dizzy.  If providing a stool sample, ensure that you wash your hands well after 
handling. 
 
POTENTIAL BENEFITS  
 
The study can tell us if you have been exposed to parasites, and a doctor can provide you with 
treatment, if necessary. As well, we hope to determine what puts people at risk for these 
infections so we can help keep people from being infected. 
 
COST/REIMBURSEMENT 
 
You will not be charged for the study or any research-related procedures. You will receive a gift 
card for participating in this study if you provide blood and/or stool samples and complete the 
questionnaire.  In order to receive a gift card for themselves and/or their children, adults will 
need to provide a social insurance number.  
 
WITHDRAWAL FROM THE STUDY 
 
Participation in this study is voluntary and you can withdraw from the study at any time. You do 
not have to answer any of the questions on the questionnaire that you do not want to. 
 
CONFIDENTIALITY  
While absolute confidentiality cannot be guaranteed, every effort will be made to ensure that the 
information you provide for this study is kept entirely confidential.  Your name will not be 
attached to any information, including your blood test, nor mentioned in any study report, nor be 
made available to anyone except the research team.   
 
If you test positive, you will be informed by mail and you will be the only one who will be told of 
the test result, unless you indicate that you would like us to notify your physician/health care 
provider.  
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It is the intention of the research team to publish results of this research in scientific journals and 
to present the findings at related conferences and workshops, but your identity will not be 
revealed. 
QUESTIONS  
If you have any questions or concerns about this study, you should contact the investigators at 
the above phone numbers. 
 
If you have any questions regarding your rights as a research subject or concerns about your 
experiences while participating in this study, you should contact the Chair of the Biomedical 
Research Ethics Board (Bio-REB), c/o, University of Saskatchewan at 306-966-4053. 
 
 
STATEMENT OF SUBJECT 
I have read, or had read to me, the above information before signing this consent form.  The 
nature and procedures of the study have been fully explained to me.  I understand the benefits 
and risks involved in taking part in this research study.   
 
I have had time and opportunity to ask questions and all my questions have been answered.  I 
have read all pages of this consent form and the risks described.  If I do not participate or if I 
discontinue my participation in this study I will not be penalized, my future medical care will not 
be affected and I will not give up my legal rights.  The issue of confidentiality has been 
explained to me and I understand who will have access to my medical records.  I volunteer to 
take part in this study.   
 
I understand I will receive a signed copy of this consent form. 
 
    Please check if you would like your healthcare provider to be informed of your results 
 
 
_________________________________  __________________________________ 
Print name of subject      Name of healthcare provider 
 
 
_________________________________  __________________________________ 
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Signature of subject     Date (dated by subject) 
 
 
__________________________________   
Printed name of person explaining consent   
 
 
 
__________________________________  __________________________________ 
Signature of person explaining consent  Date (dated by person explaining consent) 
 
 
 
___________________________________________________________________________ 
Mailing Address of Subject 
 
 
 
    Please initial if you have received an honorarium for your participation. 
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REB 11-07 Survey for Human Blood Collection clinics 
 
1) What is your gender? 
a) Male   b) Female 
 
2) What is your age? 
 a) 4-10 yrs    b) 11-17 yrs   c) 18-35 yrs d) 36-50 yrs e) 51-65 yrs f) >65 yrs 
 
Do you have children under the age of 18 donating blood today? 
Gender and ages of children:      __________________________________________ 
    __________________________________________ 
  
 
3) How many dogs does your house have?     a) 1          b) 2         c) 3        d) 4         e) 5         f) >5 
 
4) How many cats does your house have?      a) 1          b) 2         c) 3        d) 4         e) 5         f) >5 
 
5) Have your animals ever been vaccinated (eg. rabies)?        a) Yes      b) No 
 
6) Have your pet(s) ever been dewormed?                                 a) Yes      b) No 
 
7) Do you regularly seek veterinary services for your pet(s)?  a) Yes      b) No 
 
 a. If no: why not? a) Cost      b) Distance to vet clinic    c) Not necessary   d) Other (explain)  
 
8) Are your pets spay/neutered?                                                   a) Yes      b) No  
 
9) Would you allow your pets to be spay/neutered?                 a) Yes      b) No 
 a. If yes: would you be willing to pay for this service?    a) Yes      b) No 
 
 b. If no: why not?     a) Cost      b) Other (please explain____________________________) 
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10) Have you ever been bitten by a dog?                                      a) Yes      b) No  
 If yes: 
 a. How many times have you been bitten?                       a) 1x         b) 2-3x    c) >3 times  
 
 b. For the most recent bite, was the dog your own, stray or somebody else’s dog?  
 
11) Do dogs cause problems in this community?                        a) Yes      b) No 
 
 a. If yes: what problems?   __________________________________________________) 
 
12) How many times do you feed your pets per day?  
 a) 1x         b) 2x     c) 3       d)>3x    e) Other (explain) 
 
 
13) What do you feed your pet(s)?  
 a) Commercial mix     b) Leftover food, hunted meat/fish)  c) Other (please explain) 
 
14) Do you ever feed your pet(s) raw meat or fish?                     a) Yes      b) No   
  
15) Do your pets live: 
 a. Indoors always  b. Outdoors always c. Both indoors and outdoors 
 
16) When outside, are your pet(s): 
 a) Always kept in an enclosed area (eg. chained or in a fenced yard)  
 b) Sometimes free-roaming (less than two times per week) 
 c) Always free-roaming 
 
17) Do you hunt or trap?                                                                    a) Yes      b) No 
 If yes, where do you dispose of the inedible portions? 
 a) On the land b) At the dump c) Feed to pet(s) d) Other (please explain) 
 
18) Do you skin or butcher animals?                                                a) Yes      b) No 
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19) Do you eat wild caught meat?                                                    a) Yes      b) No 
 If yes, how? (Circle all that apply) 
  a. Raw  
  b. Dried 
  c. Smoked 
  d. Cooked 
  e. Other (please describe) _________________________________ 
   
20) Do you eat wild caught fish?                                                         a) Yes      b) No 
 If yes, how? (Circle all that apply) 
a. Raw 
b. Dried  
c. Smoked 
d. Cooked 
e. Other (please describe) _________________________________ 
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Appendix D – Addenda to Previously Published Paper in Chapter 7 
 
We initially used Pearson’s chi-square test to determine if there were significant differences in 
dog exposure to Toxoplasma gondii between 2011 and 2012, and found that sero-prevalence 
differed at the 5% level (P=0.042).  A more appropriate test would have been Fisher’s exact test, 
which is optimized to detect prevalence differences when sample sizes are small.  When applied 
to this dataset, this test yielded a non-significant result (P=0.058).  In this case, it is appropriate 
to report the pooled estimate of dog sero-prevalence to T. gondii over the two years (21%, 
16/78). 
 
We reported a multivariate regression model for Toxocara canis, which included both age and 
history of dogbites as independent variables.  This model was a better predictor of outcome 
(Likelihood Ratio Test: X
2
 [df=1, alpha=0.05] = 13.261) than a model with age alone; however, 
the survey questions for dogbite history were not as reliably answered as age.  As a result, we 
believe the model with age alone may better predict T. canis exposure status, and we report an 
odds ratio of 11 (95% CL: 1.2-105).  This is also consistent with previous reports of young age 
as a risk factor for exposure to T. canis, and is biologically meaningful, since dog bites are not 
thought to directly transmit T. canis - they may indirectly indicate contact with dogs and a shared 
environment. 
 
The sensitivity and specificity of the Borrelia burgdorferi serology test (IDEXX Laboratories, 
Inc.; Westbrook, Maine) were reported as 99%, 95% CL: 94.3-99.9% and 99.9%, 95% CL: 97.4-
99.9%, respectively.  These estimates are actually for heartworm (Dirofilaria immitis), which is 
one of the four pathogens tested for in the IDEXX 4Dx snap test.  The correct estimates for B. 
burgdorferi are: sensitivity 94.1% 95% CL 88.3-97.6%, and specificity 96.5% 95% CL 92.9-
98.3%.  Although these estimates are slightly lower, we believe that the two sero-positive dogs 
were unlikely to be false positives given their close proximity to endemic areas in Manitoba and 
models forecasting the western spread of ticks that carry this pathogen.  
 
 
